,Drug Name,Drug Class,LigandType,ModeOfAction,DrugAliases,TargetCategory,Gene,EntryName,Uniprot,Class,Target class,Subfamily,Target_novelty,INDEX,Trial name,Indication(s),Phase,PhaseDate,ClinicalStatus,Status,Approval,Note
0,adenosine,small molecule,Nucleotide ,agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2267,"adenogesic, adenosine (intravenous)",Analgesics,4,,-,approved,1989,
1,bg-9928,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,345,bg-9928,congestive heart failure,2,2008,Terminated,in trial,-,
2,caffeine,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,NRDD072,-,Central Nervous System Stimulants,4,,-,approved,1999,
3,ctp-499,small molecule,Nucleotide ,not available,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2268,ctp-499,diabetic nephropathy,2,2011,Completed,in trial,-,
4,cvt-3619,small molecule,Nucleotide ,partial agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,568,cvt-3619,Antihyperlipidemic,1,2010,Completed,in trial,-,
5,fk352b,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,799,fk352b,Antihypertensive,2,2005,discontinued,in trial,-,
6,ino-8875,small molecule,Nucleotide ,agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,985,ino-8875,Antiglaucomic,3,2015,Completed,in trial,-,
7,pbf-680,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAmar2016_0115,pbf-680,Anti-Asthmatic,2,2015,recruiting,in trial,-,
8,pbf-999,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAapril2016_0022,pbf-999,Huntington's disease,1,2016,Terminated,in trial,-,Terminated due to change in therapeutic indication
9,rolofylline,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1780,"rolofylline, mk-7418, kw-3902",congestive heart failure,3,2007,discontinued,in trial,-,
10,t-62,small molecule,Nucleotide ,agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1930,t-62,Analgesics,2,2008,discontinued,in trial,-,"discontinued because patients experienced asymptomatic, transient elevations in liver transaminases"
11,tecadenoson,small molecule,Nucleotide ,agonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1973,tecadenoson,Anti-Arrhythmia,3,2009,discontinued,in trial,-,
12,theophylline,small molecule,Nucleotide ,antagonist,,primary,ADORA1,aa1r_human,P30542,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,53,"adc4022, low-dose inhaled theophylline",Bronchodilator,4,,-,approved,1976,
13,adenosine,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2267,"adenogesic, adenosine (intravenous)",Analgesics,4,,-,approved,1989,
14,apadenoson,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_315,apadenoson,atrial fibrillation,3,2011,discontinued,in trial,-,
15,avr118,peptide nucleic acid,Nucleotide ,not available,,secondary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2269,"avr123, AVR118","Antineoplastic agent, wound healing accelerant",2,2011,discontinued,in trial,-,
16,biib014,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2164,vipadenantis,Antiparkinson,2,2006,discontinued,in trial,-,
17,binodenoson,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,363,"binodenoson, mre 0470,corvue",Diagnostic,3,2009,Completed,in trial,-,No development reported
18,bvt.115959,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,411,bvt.115959,Analgesics,2,2007,discontinued,in trial,-,
19,caffeine,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,NRDD072,-,Central Nervous System Stimulants,4,,-,approved,1999,
20,ctp-499,small molecule,Nucleotide ,not available,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2268,ctp-499,diabetic nephropathy,2,2011,Completed,in trial,-,
21,istradefylline,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1043,"istradefylline, kw-6002",Antiparkinson,3,2005,Completed,in trial,-,Not approved by fda -denied in 2008
22,opa-6566,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAmay2016_0512,opa-6566,Antiglaucomic,2,2011,Completed,in trial,-,
23,pbf-509,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAapril2016_0077,pbf-509,Antineoplastic,2,2015,recruiting,in trial,-,
24,pentoxifylline,small molecule,Nucleotide ,antagonist,,secondary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1586,"pentoxifylline, eht0201",amyotrophic lateral sclerosis (ALS),4,,-,approved,1984,
25,pentoxifylline,small molecule,Nucleotide ,antagonist,,secondary,ADORA2A,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_316,pentoxifylline,irritable bowel syndrome,4,,-,approved,1984,
26,preladenant,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1645,"preladenant, sch-420814",Antiparkinson,3,2011,discontinued,in trial,-,
27,regadenoson,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1726,"regadenoson,lexiscan",Diagnostic,4,,-,approved,2008,
28,t111,small molecule,Nucleotide ,agonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAmay2016_0579,"t111, Nalbuphine extended release",pruritus,3,2014,Ongoing,in trial,-,
29,theophylline,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,53,"adc4022, low-dose inhaled theophylline",Bronchodilator,4,,-,approved,1976,
30,tozadenant,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,1926,syn-115,Antiparkinson,3,2017,Not open yet,in trial,-,
31,v81444,small molecule,Nucleotide ,antagonist,,primary,ADORA2A,aa2ar_human,P29274,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAmay2016_0766,"v81444, CPI 444",Antiparkinson,2,2014,Completed,in trial,-,
32,adenosine,small molecule,Nucleotide ,agonist,,primary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2267,"adenogesic, adenosine (intravenous)",Analgesics,4,,-,approved,1989,
33,avr118,peptide nucleic acid,Nucleotide ,not available,,secondary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2269,"avr123, AVR118","Antineoplastic agent, wound healing accelerant",2,2011,discontinued,in trial,-,
34,caffeine,small molecule,Nucleotide ,antagonist,,secondary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_317,caffeine,coronary artery disease,4,,-,approved,1999,
35,cvt-6883,small molecule,Nucleotide ,antagonist,,primary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,569,cvt-6883,Anti-Asthmatic,1,2008,Completed,in trial,-,
36,theophylline,small molecule,Nucleotide ,antagonist,,primary,ADORA2B,aa2br_human,P29275,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,53,"adc4022, low-dose inhaled theophylline",Bronchodilator,4,,-,approved,1976,
37,adenosine,small molecule,Nucleotide ,agonist,,primary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2267,"adenogesic, adenosine (intravenous)",Analgesics,4,,-,approved,1989,
38,avr118,peptide nucleic acid,Nucleotide ,not available,,secondary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,2269,"avr123, AVR118","Antineoplastic agent, wound healing accelerant",2,2011,discontinued,in trial,-,
39,caffeine,small molecule,Nucleotide ,antagonist,,secondary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_319,caffeine,atherosclerosis,4,,-,approved,1999,
40,cf101,small molecule,Nucleotide ,agonist,,primary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_320,"cf101, Piclidenoson",keratoconjunctivitis sicca,3,2015,Not open yet,in trial,-,
41,cf-101,small molecule,Nucleotide ,agonist,,primary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,473,cf-101,Anti-inflammatory ; DMARD,3,2015,Not open yet,in trial,-,
42,cf-102,small molecule,Nucleotide ,agonist,,primary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,474,cf-102,Antineoplastic,2,2014,recruiting,in trial,-,
43,cf602,small molecule,Nucleotide ,agonist,,primary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,MMAapril2016_0230,cf602,sexual dysfunction,1,2017,Not open yet,in trial,-,
44,theophylline,small molecule,Nucleotide ,antagonist,,secondary,ADORA3,aa3r_human,P0DMS8,Class A (Rhodopsin),GPCR;Rhodopsin,Adenosine receptors,established,ASH_Sep2016_318,theophylline,Anti-Asthmatic,4,,-,approved,1976,
45,agn-214868,small molecule,Aminergic ,antagonist,,,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,Terminated,in trial,-,Lack of efficacy
46,alfuzosin,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,107,"alfuzosin,uroxatral",benign prostatic hyperplasia,4,,-,approved,2003,
47,amiodarone,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,160,"amiodarone hcl,amio-aqueous iv",Anti-Arrhythmia,4,,-,approved,1985,
48,asenapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
49,benperidol,small molecule,Aminergic ,not available,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_375,benperidol,Antipsychotic,4,,-,approved,2006,
50,benzphetamine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD046,-,Central Nervous System Stimulants,4,,-,approved,1960,
51,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,
52,carvedilol,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,434,"carvedilol, coreg",congestive heart failure,4,,-,approved,1995,
53,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,Not open yet,in trial,-,Diuretic
54,dapiprazole,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD141,-,opthalmological,4,,-,approved,1990,
55,debrisoquin,small molecule,Aminergic ,not available,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD143,-,Antihypertensive,4,,-,approved,1970,Approved from before 1970
56,dipivefrin,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_88,dipivefrin,Antiglaucomic,4,,-,approved,1980,
57,doxazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD187,-,Anticholesteremic ; Antihypertensive ; Vasodilator,4,,-,approved,1990,
58,dronedarone,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD190,-,Anti-Arrhythmia,4,,-,approved,2009,
59,dronedarone,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2270,dronedarone,Anti-Arrhythmia,4,,-,approved,2009,
60,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
61,ephedrine,small molecule,Aminergic ,not available,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD204,-,Central Nervous System Stimulants,4,,-,approved,1963,
62,epinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,
63,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD209,-,Nootropic ; Vasodilator,4,,-,approved,1953,
64,ergonovine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_367,ergonovine,antihaemorrhagic,4,,-,approved,1946,
65,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_87,ergotamine,Anti-migraine,4,,-,approved,1960,
66,iloperidone,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
67,indoramin,small molecule,Aminergic ,not available,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_432,indoramin,Antihypertensive,4,,-,approved,1993,
68,isometheptene,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmar2016_0022,"tnx-201, single isomer isometheptene, imh",Anti-migraine,4,,-,approved,1962,copy with conflicting subfamily
69,isometheptene,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_417,isometheptene,migraines,4,,-,approved,-,copy with conflicting subfamily
70,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD296,-,Antihypertensive,4,,-,approved,1984,
71,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
72,levonordefrin,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_405,levonordefrin,decongestant,4,,-,approved,1960,
73,levonordefrin,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_429,alpha-methylnoradrenaline,nasal decongestant,4,,-,approved,1960,
74,lisdexamfetamine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD306,-,Central Nervous System Stimulants,4,,-,approved,2007,FDA approval 2007 for ADHD; pro-drug of dextroamphetamine so not NME
75,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD326,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1951,
76,metaraminol,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD333,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1954,
77,methoxamine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD343,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1982,
78,midodrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD365,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1996,
79,min-117,small molecule,Aminergic ,not available,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAapril2016_0206,min-117,Anti-depressant,2,2016,Completed,in trial,-,
80,naphazoline,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_86,naphazoline,nasal obstruction,4,,-,approved,1971,
81,nefazodone,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD380,-,Anti-depressant,4,,-,approved,1994,
82,nicergoline,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD384,-,Nootropic ; Vasodilator,4,,-,approved,-,"Marketed but I don't think fda approved, if so then long ago"
83,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
84,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
85,olanzapine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
86,olanzapine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
87,olanzapine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0204,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
88,olanzapine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
89,olanzapine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
90,oxymetazoline,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1491,oms-103hp,Analgesics,4,,-,approved,1986,
91,pardoprunox,small molecule,Aminergic ,agonist,,,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,
92,phendimetrazine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD427,-,Appetite suppressant,4,,-,approved,1976,
93,phenoxybenzamine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD434,-,Anticonvulsants; Hypnotics and Sedatives,4,,-,approved,1953,
94,phentolamine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,288,"aviptadil,invicorp",sexual dysfunction,4,,-,approved,1952,
95,phenylephrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1675,"psd-503, phenylephrine",incontinence,4,,-,approved,1952,
96,phenylpropanolamine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD439,-,Appetite Depressants; Nasal Decongestants,4,,-,approved,1958,
97,prazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD453,-,Antihypertensive ; antispasmodics,4,,-,approved,1976,
98,promazine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
99,propericiazine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD466,-,schizophrenia,4,,-,approved,-,Not FDA approved but used in other countries
100,propiomazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
101,pseudoephedrine,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,789,fexofenadine + ps/,Anti-Allergic,4,,-,approved,1975,
102,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_84,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter
103,sertindole,small molecule,Aminergic ,antagonist,,secondary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
104,silodosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1852,silodosin,BPH-related urinary symptoms,4,,-,approved,2008,
105,sou-001,small molecule,Aminergic ,not available,,,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1881,"sou-001, drp-001",incontinence,2,2006,discontinued,in trial,-,
106,tamsulosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,675,"dutasteride + tamsulosin,jalyn",benign prostatic hyperplasia,4,,-,approved,1997,
107,tamsulosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1946,"tamsulosin, ym-617,harnal, flomax",urinary symptoms associated with BPH,4,,-,approved,1997,
108,tedatioxetine,small molecule,Aminergic ,antagonist,,,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1173,lu aa24530,Anti-depressant,2,2009,discontinued,in trial,-,discontinued for strategic reasons
109,terazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD514,-,Antineoplastic s; Antihypertensive,4,,-,approved,1987,
110,tetrahydrozoline,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_85,tetrahydrozoline,eye allergy,4,,-,approved,1979,
111,tetryzoline,small molecule,Peptide ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class B1 (Secretin),GPCR;Rhodopsin,Calcitonin receptors,established,ASH_Oct2016_411,tetryzoline,"for eye irritation, decongestant",4,,-,approved,1982,
112,thioproperazine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_376,thioproperazine,Antipsychotic,4,,-,approved,1962,
113,thioridazine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD521,-,schizophrenia,4,,-,approved,1962,
114,tolazoline,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD530,-,Antihypertensive,4,,-,approved,1948,
115,trifluoperazine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD541,-,Antiemetics; Antipsychotic,4,,-,approved,1959,
116,trimipramine,small molecule,Aminergic ,antagonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_89,trimipramine,unipolar depression,4,,-,approved,1979,
117,xylometazoline,small molecule,Aminergic ,agonist,,primary,ADRA1A,ada1a_human,P35348,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_404,xylometazoline,decongestant,4,,-,approved,1959,
118,agn-214868,small molecule,Aminergic ,antagonist,,,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,Terminated,in trial,-,Lack of efficacy
119,alfuzosin,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,107,"alfuzosin,uroxatral",benign prostatic hyperplasia,4,,-,approved,2003,
120,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,
121,carvedilol,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_91,carvedilol,Antihypertensive,4,,-,approved,1995,
122,dapiprazole,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD141,-,opthalmological,4,,-,approved,1990,
123,debrisoquin,small molecule,Aminergic ,not available,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD143,-,Antihypertensive,4,,-,approved,1970,Approved from before 1970
124,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_103,dipivefrin,Antiglaucomic,4,,-,approved,1980,
125,doxazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD187,-,Anticholesteremic ; Antihypertensive ; Vasodilator,4,,-,approved,1990,
126,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
127,epinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,
128,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_100,ergoloid,cardiovascular disease,4,,-,approved,1953,
129,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_99,ergotamine,Anti-migraine,4,,-,approved,1960,
130,indoramin,small molecule,Aminergic ,not available,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_431,indoramin,Antihypertensive,4,,-,approved,1993,
131,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD296,-,Antihypertensive,4,,-,approved,1984,
132,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
133,lisdexamfetamine,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD306,-,Central Nervous System Stimulants,4,,-,approved,2007,FDA approval 2007 for ADHD; pro-drug of dextroamphetamine so not NME
134,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_90,mephentermine,cardiovascular disease,4,,-,approved,1951,
135,metaraminol,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_92,metaraminol,cardiovascular disease,4,,-,approved,1954,
136,methoxamine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD343,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1982,
137,midodrine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD365,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1996,
138,min-117,small molecule,Aminergic ,not available,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAapril2016_0207,min-117,Anti-depressant,2,2016,Completed,in trial,-,
139,naphazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_96,naphazoline,nasal obstruction,4,,-,approved,1971,
140,nefazodone,small molecule,Aminergic ,unknown,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD380,-,Anti-depressant,4,,-,approved,1994,
141,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
142,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
143,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
144,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
145,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0206,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
146,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
147,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
148,oxymetazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_98,oxymetazoline,Antiglaucomic,4,,-,approved,1986,
149,phendimetrazine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD427,-,Appetite suppressant,4,,-,approved,1976,
150,phenoxybenzamine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_95,phenoxybenzamine,adrenal gland pheochromocytoma,4,,-,approved,1953,
151,phentolamine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_102,phentolamine,cardiovascular disease,4,,-,approved,1952,
152,phenylephrine,small molecule,Aminergic ,agonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1675,"psd-503, phenylephrine",incontinence,4,,-,approved,1952,
153,prazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD453,-,Antihypertensive ; antispasmodics,4,,-,approved,1976,
154,promazine,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
155,propericiazine,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD466,-,schizophrenia,4,,-,approved,-,Not FDA approved but used in other countries
156,propiomazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
157,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_93,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter
158,sertindole,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
159,sou-001,small molecule,Aminergic ,not available,,,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1881,"sou-001, drp-001",incontinence,2,2006,discontinued,in trial,-,
160,tamsulosin,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1946,"tamsulosin, ym-617,harnal, flomax",urinary symptoms associated with BPH,4,,-,approved,1997,
161,terazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD514,-,Antineoplastic s; Antihypertensive,4,,-,approved,1987,
162,tetrahydrozoline,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_94,tetrahydrozoline,nasal obstruction,4,,-,approved,1979,
163,thioproperazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_374,thioproperazine,Antipsychotic,4,,-,approved,1962,
164,tolazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_97,tolazoline,cardiovascular disease,4,,-,approved,1948,
165,trimipramine,small molecule,Aminergic ,antagonist,,primary,ADRA1B,ada1b_human,P35368,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_101,trimipramine,unipolar depression,4,,-,approved,1979,
166,agn-214868,small molecule,Aminergic ,antagonist,,,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,Terminated,in trial,-,Lack of efficacy
167,alfuzosin,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,107,"alfuzosin,uroxatral",benign prostatic hyperplasia,4,,-,approved,2003,
168,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,
169,carvedilol,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_107,carvedilol,Antihypertensive,4,,-,approved,1995,
170,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,Not open yet,in trial,-,
171,dapiprazole,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD141,-,opthalmological,4,,-,approved,1990,
172,debrisoquin,small molecule,Aminergic ,not available,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD143,-,Antihypertensive,4,,-,approved,1970,Approved from before 1970
173,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_106,dipivefrin,Antiglaucomic,4,,-,approved,1980,
174,doxazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD187,-,Anticholesteremic ; Antihypertensive ; Vasodilator,4,,-,approved,1990,
175,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
176,epinephrine,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,
177,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_109,ergoloid,cardiovascular disease,4,,-,approved,1953,
178,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_112,ergotamine,Anti-migraine,4,,-,approved,1960,
179,indoramin,small molecule,Aminergic ,not available,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_433,indoramin,Antihypertensive,4,,-,approved,1993,
180,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_116,labetalol,cardiovascular disease,4,,-,approved,1984,
181,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
182,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_105,mephentermine,cardiovascular disease,4,,-,approved,1951,
183,metaraminol,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_110,metaraminol,cardiovascular disease,4,,-,approved,1954,
184,methoxamine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_119,methoxamine,cardiovascular disease,4,,-,approved,1982,
185,midodrine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_104,midodrine,cardiovascular disease,4,,-,approved,1996,
186,naphazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_111,naphazoline,eye allergy,4,,-,approved,1971,
187,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
188,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
189,oxymetazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_115,oxymetazoline,allergic conjunctivitis,4,,-,approved,1986,
190,phenoxybenzamine,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_114,phenoxybenzamine,adrenal gland pheochromocytoma,4,,-,approved,1953,
191,phentolamine,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_117,phentolamine,cardiovascular disease,4,,-,approved,1952,
192,phenylephrine,small molecule,Aminergic ,agonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1675,"psd-503, phenylephrine",incontinence,4,,-,approved,1952,
193,prazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD453,-,Antihypertensive ; antispasmodics,4,,-,approved,1976,
194,promazine,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
195,propericiazine,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD466,-,schizophrenia,4,,-,approved,-,Not FDA approved but used in other countries
196,propiomazine,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
197,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_108,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter
198,sertindole,small molecule,Aminergic ,antagonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
199,sou-001,small molecule,Aminergic ,not available,,,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1881,"sou-001, drp-001",incontinence,2,2006,discontinued,in trial,-,
200,tamsulosin,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1946,"tamsulosin, ym-617,harnal, flomax",urinary symptoms associated with BPH,4,,-,approved,1997,
201,terazosin,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD514,-,Antineoplastic s; Antihypertensive,4,,-,approved,1987,
202,tetrahydrozoline,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_120,tetrahydrozoline,nasal obstruction,4,,-,approved,1979,
203,tolazoline,small molecule,Aminergic ,agonist,,secondary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_113,tolazoline,cardiovascular disease,4,,-,approved,1948,
204,trimipramine,small molecule,Aminergic ,antagonist,,primary,ADRA1D,ada1d_human,P25100,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_118,trimipramine,unipolar depression,4,,-,approved,1979,
205,adx415,small molecule,Aminergic ,NAM,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,63,adx415,Antihypertensive,2,2008,Completed,in trial,-,
206,agn-214868,small molecule,Aminergic ,antagonist,,,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,Terminated,in trial,-,Lack of efficacy
207,apraclonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD032,-,Antiglaucomic,4,,-,approved,1987,
208,asenapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
209,benzphetamine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD046,-,Central Nervous System Stimulants,4,,-,approved,1960,
210,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,
211,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2274,"cd07805/47, sansrosa, col-118",erythema,2,2008,Completed,in trial,-,
212,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,385,"brimonidine tartrate,alphagan",Antiglaucomic,4,,-,approved,1996,
213,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,386,"brimonidine tartrate/timolol maleate,combigan",Antiglaucomic,4,,-,approved,1996,
214,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,Not open yet,in trial,-,
215,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,502,"clonidine lauriad, ba-028",diabetic neuropathy; ADHD; antimucositic,2,2011,Completed,in trial,-,
216,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,220,"arc-4558, 0.1% clonidine hycrochloride gel",diabetic neuropathy; ADHD; antimucositic,3,2016,discontinued,in trial,-,
217,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,501,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",diabetic neuropathy; ADHD; antimucositic,4,,-,approved,1974,
218,debrisoquin,small molecule,Aminergic ,not available,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD143,-,Antihypertensive,4,,-,approved,1970,Approved from before 1970
219,dexmedetomidin,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAapril2016_0144,"dex-in, intranasal dexmedetomidin",Analgesics,4,,-,approved,1999,
220,dexmedetomidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD155,-,Analgesics; Hypnotics and Sedatives,4,,-,approved,1999,
221,dipivefrin,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD178,-,opthalmological,4,,-,approved,1980,
222,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
223,epinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,
224,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD209,-,Nootropic ; Vasodilator,4,,-,approved,1953,
225,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_124,ergotamine,Anti-migraine,4,,-,approved,1960,
226,esmirtazapine,small molecule,Aminergic ,antagonist,,,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,732,"esmirtazapine, org-4420",insomnia; menopausal symptoms,3,2009,discontinued,in trial,-,discontinued by Organon
227,fipamezole,small molecule,Aminergic ,antagonist,,,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,795,"fipamezole , jp-1730",Antiparkinson,2,2010,discontinued,in trial,-,
228,guanabenz,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD261,-,Antihypertensive,4,,-,approved,1982,
229,guanfacine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,889,"guanfacine, spd 503,intuniv",ADHD,4,,-,approved,1986,
230,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_128,labetalol,cardiovascular disease,4,,-,approved,1984,
231,lofexidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1159,"lofexidine,britlofex",opiate withdrawal,4,,-,approved,2006,
232,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_123,mephentermine,cardiovascular disease,4,,-,approved,1951,
233,methamphetamine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1167,low dose intravenous methamphetamine,neuroprotectant,4,,-,approved,1943,
234,methyldopa,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD346,-,Antihypertensive,4,,-,approved,1962,
235,mianserin,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD363,-,Anti-depressant,4,,-,approved,1996,"Doesn't appear to be FDA approved, but analogue mirtazapine is "
236,mirtazapine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1295,"mirtazapine,remeron, remeron soltab, reflex",Anti-depressant,4,,-,approved,1996,
237,naphazoline,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_126,naphazoline,eye allergy,4,,-,approved,1971,
238,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
239,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
240,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
241,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
242,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0189,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
243,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
244,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
245,oxymetazoline,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1491,oms-103hp,Analgesics,4,,-,approved,1986,
246,pardoprunox,small molecule,Aminergic ,agonist,,,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,
247,phenoxybenzamine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_127,phenoxybenzamine,cardiovascular disease,4,,-,approved,1953,
248,phentolamine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD437,-,Antihypertensive,4,,-,approved,1952,
249,phentolamine,small molecule,Aminergic ,antagonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,288,"aviptadil,invicorp",sexual dysfunction,4,,-,approved,1952,
250,phenylpropanolamine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD439,-,Appetite Depressants; Nasal Decongestants,4,,-,approved,1958,
251,pseudoephedrine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,789,fexofenadine + ps/,Anti-Allergic,4,,-,approved,1975,
252,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_121,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter
253,tetrahydrozoline,small molecule,Aminergic ,agonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_122,tetrahydrozoline,eye allergy,4,,-,approved,1979,
254,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2021,"tizanidine hydrochloride,zanaflex",Muscle Relaxants,4,,-,approved,1996,
255,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1458,"nvd-422, tizanidine oral spray",skeletal muscular spasticity,4,,-,approved,1996,
256,tolazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_125,tolazoline,cardiovascular disease,4,,-,approved,1948,
257,xylometazoline,small molecule,Aminergic ,agonist,,primary,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_407,xylometazoline,decongestant,4,,-,approved,1959,
258,yohimbine,small molecule,Aminergic ,antagonist,,,ADRA2A,ada2a_human,P08913,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD564,-,Mydriatics; Anti-impotence,0,2000,discontinued,in trial,-,Inferred dates
259,agn-214868,small molecule,Aminergic ,antagonist,,,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,Terminated,in trial,-,Lack of efficacy
260,apraclonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_135,apraclonidine,Antiglaucomic,4,,-,approved,1987,
261,asenapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
262,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,
263,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2274,"cd07805/47, sansrosa, col-118",erythema,2,2008,Completed,in trial,-,
264,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,385,"brimonidine tartrate,alphagan",Antiglaucomic,4,,-,approved,1996,
265,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,386,"brimonidine tartrate/timolol maleate,combigan",Antiglaucomic,4,,-,approved,1996,
266,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,Not open yet,in trial,-,
267,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,502,"clonidine lauriad, ba-028",diabetic neuropathy; ADHD; antimucositic,2,2011,Completed,in trial,-,
268,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,220,"arc-4558, 0.1% clonidine hycrochloride gel",diabetic neuropathy; ADHD; antimucositic,3,2016,discontinued,in trial,-,
269,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,501,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",diabetic neuropathy; ADHD; antimucositic,4,,-,approved,1974,
270,debrisoquin,small molecule,Aminergic ,not available,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD143,-,Antihypertensive,4,,-,approved,1970,Approved from before 1970
271,dexmedetomidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_130,dexmedetomidine,Analgesics,4,,-,approved,1999,
272,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_143,dipivefrin,Antiglaucomic,4,,-,approved,1980,
273,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
274,epinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,
275,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_141,ergoloid,cardiovascular disease,4,,-,approved,1953,
276,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_140,ergotamine,Anti-migraine,4,,-,approved,1960,
277,esmirtazapine,small molecule,Aminergic ,antagonist,,,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_146,esmirtazapine,insomnia,3,2008,discontinued,in trial,-,
278,etomidate,small molecule,Aminergic ,PAM,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD222,-,Anesthetics; Intravenous,4,,-,approved,1982,
279,fipamezole,small molecule,Aminergic ,antagonist,,,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,796,"fipamezole, jp-1730",Antiparkinson,2,2010,discontinued,in trial,-,
280,guanabenz,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_147,guanabenz,Multiple Sclerosis,1,2015,recruiting,in trial,-,
281,guanfacine,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_133,guanfacine,attention deficit hyperactivity disorder,4,,-,approved,1986,
282,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_138,labetalol,cardiovascular disease,4,,-,approved,1984,
283,lofexidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1159,"lofexidine,britlofex",opiate withdrawal,4,,-,approved,2006,
284,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_145,mephentermine,cardiovascular disease,4,,-,approved,1951,
285,methamphetamine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1167,low dose intravenous methamphetamine,neuroprotectant,4,,-,approved,1943,
286,methyldopa,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_142,methyldopa,Antihypertensive,4,,-,approved,1962,
287,mirtazapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_131,mirtazapine,unipolar depression,4,,-,approved,1996,
288,naphazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_129,naphazoline,nasal obstruction,4,,-,approved,1971,
289,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
290,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
291,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
292,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
293,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0192,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
294,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
295,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
296,opc-28326,small molecule,Aminergic ,antagonist,,,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1501,opc-28326,vasodilator,2,2006,discontinued,in trial,-,
297,oxymetazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_132,oxymetazoline,dry eye,4,,-,approved,1986,
298,phenoxybenzamine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_136,phenoxybenzamine,cardiovascular disease,4,,-,approved,1953,
299,phentolamine,small molecule,Aminergic ,antagonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_137,phentolamine,cardiovascular disease,4,,-,approved,1952,
300,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_144,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter
301,tetrahydrozoline,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_139,tetrahydrozoline,nasal obstruction,4,,-,approved,1979,
302,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2021,"tizanidine hydrochloride,zanaflex",Muscle Relaxants,4,,-,approved,1996,
303,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1458,"nvd-422, tizanidine oral spray",skeletal muscular spasticity,4,,-,approved,1996,
304,tolazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_134,tolazoline,arthralgia,4,,-,approved,1948,
305,xylometazoline,small molecule,Peptide ,agonist,,primary,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Oct2016_406,xylometazoline,decongestant,4,,-,approved,1959,
306,yohimbine,small molecule,Aminergic ,antagonist,,,ADRA2B,ada2b_human,P18089,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD564,-,Mydriatics; Anti-impotence,0,2000,discontinued,in trial,-,Inferred dates
307,agn-214868,small molecule,Aminergic ,antagonist,,,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,85,"agn-214868, Senrebotase",Analgesics; neuralgia,2,2012,Terminated,in trial,-,Lack of efficacy
308,apraclonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_162,apraclonidine,Antiglaucomic,4,,-,approved,1987,
309,asenapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
310,bethanidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD055,-,Antihypertensive,4,,-,approved,1982,
311,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2274,"cd07805/47, sansrosa, col-118",erythema,2,2008,Completed,in trial,-,
312,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,385,"brimonidine tartrate,alphagan",Antiglaucomic,4,,-,approved,1996,
313,brimonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,386,"brimonidine tartrate/timolol maleate,combigan",Antiglaucomic,4,,-,approved,1996,
314,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,Not open yet,in trial,-,
315,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,502,"clonidine lauriad, ba-028",diabetic neuropathy; ADHD; antimucositic,2,2011,Completed,in trial,-,
316,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,220,"arc-4558, 0.1% clonidine hycrochloride gel",diabetic neuropathy; ADHD; antimucositic,3,2016,discontinued,in trial,-,
317,clonidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,501,"clonidine hydrochloride extended release,kapvay, jenloga xr (clonibid)",diabetic neuropathy; ADHD; antimucositic,4,,-,approved,1974,
318,debrisoquin,small molecule,Aminergic ,not available,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD143,-,Antihypertensive,4,,-,approved,1970,Approved from before 1970
319,dexmedetomidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_149,dexmedetomidine,Antineoplastic,4,,-,approved,1999,
320,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_164,dipivefrin,Antiglaucomic,4,,-,approved,1980,
321,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
322,ergoloid,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_155,ergoloid,cardiovascular disease,4,,-,approved,1953,
323,ergotamine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_158,ergotamine,Anti-migraine,4,,-,approved,1960,
324,esmirtazapine,small molecule,Aminergic ,antagonist,,,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_165,esmirtazapine,insomnia,3,2008,discontinued,in trial,-,
325,fipamezole,small molecule,Aminergic ,antagonist,,,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,796,"fipamezole, jp-1730",Antiparkinson,2,2010,discontinued,in trial,-,
326,guanabenz,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_166,guanabenz,Antineoplastic,4,,-,approved,1982,
327,guanfacine,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_152,guanfacine,obstructive sleep apnea,4,,-,approved,1986,
328,iloperidone,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
329,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_156,labetalol,cardiovascular disease,4,,-,approved,1984,
330,lofexidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1159,"lofexidine,britlofex",opiate withdrawal,4,,-,approved,2006,
331,lurasidone,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAapril2016_0235,"cyclurad, d-cycloserine + lurasidone",schizophrenia,4,,-,approved,2010,
332,lurasidone,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1184,"lurasidone, sm-13496,latuda",schizophrenia,4,,-,approved,2010,
333,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_161,mephentermine,cardiovascular disease,4,,-,approved,1951,
334,methamphetamine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1167,low dose intravenous methamphetamine,neuroprotectant,4,,-,approved,1943,
335,methyldopa,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_157,methyldopa,Antihypertensive,4,,-,approved,1962,
336,mirtazapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_148,mirtazapine,unipolar depression,4,,-,approved,1996,
337,naphazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_150,naphazoline,nasal obstruction,4,,-,approved,1971,
338,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
339,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
340,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
341,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
342,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0193,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
343,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
344,olanzapine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
345,opc-28326,small molecule,Aminergic ,antagonist,,,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1501,opc-28326,vasodilator,2,2007,discontinued,in trial,-,
346,oxymetazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_151,oxymetazoline,dry eye,4,,-,approved,1986,
347,phenoxybenzamine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_153,phenoxybenzamine,adrenal gland pheochromocytoma,4,,-,approved,1953,
348,phentolamine,small molecule,Aminergic ,antagonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_163,phentolamine,cardiovascular disease,4,,-,approved,1952,
349,rauwolfia serpentina,small molecule,Aminergic ,antagonist,,,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_160,rauwolfia serpentina,Antihypertensive,4,,-,approved,-,active ingrediant seems to be resperine - which targets Synaptic vesicular amine transporter
350,tetrahydrozoline,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_159,tetrahydrozoline,nasal obstruction,4,,-,approved,1979,
351,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2021,"tizanidine hydrochloride,zanaflex",Muscle Relaxants,4,,-,approved,1996,
352,tizanidine,small molecule,Aminergic ,agonist,,primary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1458,"nvd-422, tizanidine oral spray",skeletal muscular spasticity,4,,-,approved,1996,
353,tolazoline,small molecule,Aminergic ,agonist,,secondary,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_154,tolazoline,arthralgia,4,,-,approved,1948,
354,yohimbine,small molecule,Aminergic ,antagonist,,,ADRA2C,ada2c_human,P18825,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD564,-,Mydriatics; Anti-impotence,0,2000,discontinued,in trial,-,Inferred dates
355,acebutolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD001,-,Antihypertensive,4,,-,approved,1984,
356,alprenolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD019,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1966,"No longer marketed, but may still be available"
357,amiodarone,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,160,"amiodarone hcl,amio-aqueous iv",Anti-Arrhythmia,4,,-,approved,1985,
358,arbutamine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD034,-,Cardiotonic,4,,-,approved,1997,
359,atenolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD038,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1981,
360,betaxolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD052,-,Antihypertensive,4,,-,approved,1985,
361,bevantolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD056,-,Antihypertensive,2,1989,discontinued,in trial,-,Decided 1989 not to market it in US and elsewhere
362,bisoprolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD058,-,Antihypertensive,4,,-,approved,1992,
363,bopindolol,small molecule,Aminergic ,partial agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_371,bopindolol,Antihypertensive,4,,-,approved,-,
364,bucindolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,396,"bucindolol hydrochloride,gencaro",heart failure,2,2013,recruiting,in trial,-,
365,budiodarone,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,404,"budiodarone, ati-2042",Anti-Arrhythmia,2,2005,Completed,in trial,-,
366,bupranolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_369,bupranolol,Antihypertensive,4,,-,approved,-,
367,carteolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD084,-,Antiglaucomic,4,,-,approved,1988,
368,carvedilol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,435,"carvedilol,coreg",cardiovascular disease,4,,-,approved,1995,
369,celiprolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_370,celiprolol,Antihypertensive,4,,-,approved,-,
370,desipramine,small molecule,Aminergic ,unknown,,secondary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD148,-,Anti-depressant,4,,-,approved,1964,
371,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_167,dipivefrin,Antiglaucomic,4,,-,approved,1980,
372,dobutamine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD182,-,Cardiotonic,4,,-,approved,1978,
373,dopamine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_169,dopamine,hypotension,4,,-,approved,1974,
374,dronedarone,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD190,-,Anti-Arrhythmia,4,,-,approved,2009,
375,dronedarone,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2270,dronedarone,Anti-Arrhythmia,4,,-,approved,2009,
376,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
377,epinephrine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,
378,esmolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD212,-,Anti-Arrhythmia,4,,-,approved,1986,
379,isoetharine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_361,isoetharine,Anti-Asthmatic,4,,-,approved,1979,
380,isoetharine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD290,-,Bronchodilator,4,,-,approved,1979,
381,isoproterenol,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD293,-,Bronchodilator ; Cardiotonic,4,,-,approved,1956,
382,isoproterenol,small molecule,Peptide ,agonist,,primary,ADRB1,adrb1_human,p08588,Class A (Rhodopsin),GPCR;Rhodopsin,Thyrotropin-releasing hormone receptors,established,ASH_Oct2016_402,isoprenaline,cardiovascular ; Anti-Asthmatic ,4,,-,approved,1956,
383,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD296,-,Antihypertensive,4,,-,approved,1984,
384,levobunolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD299,-,Antiglaucomic,4,,-,approved,1985,
385,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_171,mephentermine,cardiovascular disease,4,,-,approved,1951,
386,metipranolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD354,-,Anti-Arrhythmia ; Antihypertensive ; Anti-glaucoma,4,,-,approved,1989,
387,metoprolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD359,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1978,
388,metoprolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1270,"metoprolol succinate,toprol-xl",Antihypertensive,4,,-,approved,1978,
389,nadolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD376,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1979,
390,nebivolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1394,"nebivolol ,bystolic",Antihypertensive,4,,-,approved,2007,
391,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
392,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
393,ot-730,small molecule,Aminergic ,antagonist,,,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1533,ot-730,Antiglaucomic,2,2009,discontinued,in trial,-,
394,oxprenolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD405,-,Antihypertensive ; Anti-Arrhythmia,4,,-,approved,1983,
395,penbutolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD417,-,Antihypertensive,4,,-,approved,1987,
396,pindolol,small molecule,Aminergic ,partial agonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD444,-,Antihypertensive,4,,-,approved,1982,
397,practolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD449,-,Anti-Arrhythmia,4,,-,approved,-,
398,propafenone,small molecule,Aminergic ,antagonist,,secondary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_170,propafenone,cardiac arrhythmia,4,,-,approved,1989,
399,propranolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2183,vt-122,cancer cachexia,4,,-,approved,1967,
400,sotalol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_168,sotalol,atrial fibrillation,4,,-,approved,1992,
401,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,386,"brimonidine tartrate/timolol maleate,combigan",Antiglaucomic,4,,-,approved,1981,
402,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1095,"latanoprost + timolol,xalcom, xalacom",Antiglaucomic,4,,-,approved,1981,
403,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB1,adrb1_human,P08588,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2071,"travoprost + timolol,extravan, duotrav",Antiglaucomic,4,,-,approved,1981,
404,abediterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_190,abediterol,Anti-Asthmatic,2,2016,Completed,in trial,-,
405,albuterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_173,albuterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,1981,
406,alprenolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD019,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1966,"No longer marketed, but may still be available"
407,arformoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD036,-,Bronchodilator,4,,-,approved,2006,
408,arformoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2276,brovana,Bronchodilator,4,,-,approved,2006,
409,asm-024,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0687,asm-024,Anti-Asthmatic ; COPD,2,2015,Completed,in trial,-,
410,azd3199,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_191,azd3199,chronic obstructive pulmonary disease (COPD),2,2011,discontinued,in trial,-,Appears to be discontinued
411,batefenterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_188,batefenterol,chronic obstructive pulmonary disease (COPD),2,2016,Completed,in trial,-,
412,bedoradrine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_189,bedoradrine,Anti-Asthmatic,2,2009,Completed,in trial,-,No development reported
413,bitolterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_183,bitolterol,obstructive lung disease,4,,-,approved,1984,
414,bucindolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,396,"bucindolol hydrochloride,gencaro",heart failure,2,2013,recruiting,in trial,-,
415,carmoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_187,carmoterol,chronic obstructive pulmonary disease (COPD),2,2008,discontinued,in trial,-,
416,carteolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_176,carteolol,cardiovascular disease,4,,-,approved,1988,
417,carvedilol,small molecule,Aminergic ,antagonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,435,"carvedilol,coreg",cardiovascular disease,4,,-,approved,1995,
418,celiprolol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_372,celiprolol,Antihypertensive,4,,-,approved,-,
419,cicletanine ,small molecule,Aminergic ,not available,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2271,cicletanine hydrochloride,Antihypertensive,2,2016,Not open yet,in trial,-,
420,clenbuterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD113,-,Bronchodilator,4,,-,approved,-,Not approved in US
421,desipramine,small molecule,Aminergic ,antagonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD148,-,Anti-depressant,4,,-,approved,1964,
422,dipivefrin,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_185,dipivefrin,Antiglaucomic,4,,-,approved,1980,
423,dobutamine,small molecule,Aminergic ,agonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_179,dobutamine,heart failure,4,,-,approved,1978,
424,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
425,epinephrine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2066,"transdermal lidocaine/epinephrine patch,lidosite",Anesthetics,4,,-,approved,1976,
426,esmolol,small molecule,Aminergic ,antagonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_184,esmolol,tinnitus,4,,-,approved,1986,
427,fenoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD229,-,Bronchodilator ; Tocolytic,4,,withdrawn,approved,-,
428,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2275,apd209,Appetite stimulant,2,2013,Completed,in trial,-,
429,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1861,"skyepharma,flutiform",Bronchodilator,3,2010,Completed,in trial,-,Approved in Europe but not FDA
430,formoterol,small molecule,Aminergic ,agonist,,,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1682,"pt005, formoterol fumarate hydrofluoroalkane metered dose inhaler",chronic obstructive pulmonary disease (COPD),3,2015,discontinued,in trial,-,
431,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,481,"chf-1535, beclomethasone dipropionate + formoterol fumarate",Anti-Asthmatic,4,,-,approved,2001,
432,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0044,aclidinium,Anti-Asthmatic ; COPD,4,,-,approved,2001,
433,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,397,"budesonide + formoterol,symbicort",Bronchodilator,4,,-,approved,2001,
434,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,815,"formoterol ,foradil",Bronchodilator,4,,-,approved,2001,
435,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1215,map-0005,Bronchodilator,4,,-,approved,2001,
436,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,816,"formoterol fumarate,perforomist",chronic obstructive pulmonary disease (COPD),4,,-,approved,2001,
437,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1325,"mometasone furoate + formoterol fumarate dihydrate,dulera",Anti-Asthmatic,4,,-,approved,2010,
438,formoterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1681,"pt003, glycopyrrolate + formoterol inhalation aerosol",chronic obstructive pulmonary disease (COPD),4,,-,approved,2016,
439,glycopyrronium,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1702,"qva149, glycopyrronium + i/",chronic obstructive pulmonary disease (COPD),4,,-,approved,1961,
440,gsk-961081,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,881,gsk-961081,Bronchodilator,2,2015,Completed,in trial,-,
441,indacaterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,969,indacaterol,Bronchodilator,4,,-,approved,2009,
442,inv102,small molecule,Aminergic ,inverse agonist,nadolol,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0225,"inv102, nadolol",for inflammatory lung disease,2,2013,Ongoing,in trial,-,
443,isoetharine,small molecule,Aminergic ,agonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_182,isoetharine,obstructive lung disease,4,,-,approved,1979,
444,isoproterenol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD293,-,Bronchodilator ; Cardiotonic,4,,-,approved,1956,
445,isoproterenol,small molecule,Peptide ,agonist,,primary,ADRB2,adrb2_human,P07550,Class B1 (Secretin),GPCR;Rhodopsin,Corticotropin-releasing factor receptors,established,ASH_Oct2016_403,isoprenaline,cardiovascular ; Anti-Asthmatic ,4,,-,approved,1956,
446,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD296,-,Antihypertensive,4,,-,approved,1984,
447,las-100977,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1092,las-100977,Bronchodilator,2,2011,Completed,in trial,-,
448,levobunolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD299,-,Antiglaucomic,4,,-,approved,1985,
449,levosalbutamol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_174,levosalbutamol,Anti-Asthmatic,4,,-,approved,1999,
450,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_186,mephentermine,cardiovascular disease,4,,-,approved,1951,
451,metaproterenol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_175,metaproterenol,Anti-Asthmatic,4,,-,approved,1973,
452,metipranolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD354,-,Anti-Arrhythmia ; Antihypertensive ; Anti-glaucoma,4,,-,approved,1989,
453,milveterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1290,"milveterol. td-3327, gsk-159797",Bronchodilator,2,2005,discontinued,in trial,-,
454,mn-221,unknown,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1317,mn-221,Anti-Asthmatic,2,2008,Completed,in trial,-,no information on next phase plans
455,nadolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD376,-,Anti-Arrhythmia ; Antihypertensive,4,,-,approved,1979,
456,nebivolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_172,nebivolol,Antihypertensive,4,,-,approved,2007,
457,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
458,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
459,olodaterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0592,tiotropium + olodaterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,2014,
460,orciprenaline,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD399,-,Bronchodilator,4,,-,approved,1973,
461,ot-730,small molecule,Aminergic ,antagonist,,,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1533,ot-730,Antiglaucomic,2,2009,discontinued,in trial,-,
462,oxprenolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD405,-,Antihypertensive ; Anti-Arrhythmia,4,,-,approved,1983,
463,penbutolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD417,-,Antihypertensive,4,,-,approved,1987,
464,pf-00610355,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1591,pf-00610355,Bronchodilator,2,2009,discontinued,in trial,-,
465,pindolol,small molecule,Aminergic ,partial agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD444,-,Antihypertensive,4,,-,approved,1982,
466,pirbuterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_181,pirbuterol,obstructive lung disease,4,,-,approved,1986,
467,procaterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD459,-,Bronchodilator,3,2015,recruiting,in trial,-,
468,propafenone,small molecule,Aminergic ,antagonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_177,propafenone,atrial fibrillation,4,,-,approved,1989,
469,propranolol,small molecule,Aminergic ,antagonist,,secondary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_178,propranolol,Antihypertensive,4,,-,approved,1967,
470,pw2101,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1690,pw2101,Antihypertensive,1,2005,discontinued,in trial,-,
471,ritodrine,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD485,-,Tocolytic,4,,-,approved,1987,
472,salbutamol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,102,"albuterol,ventolin",Bronchodilator,4,,-,approved,1981,
473,salbutamol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1116,levalbuterol,Bronchodilator,4,,-,approved,1981,
474,salbutamol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1021,"ipratropium bromide + albuterol sulfate,duoneb",chronic obstructive pulmonary disease (COPD),4,,-,approved,1981,
475,salbutamol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1146,"lipo-102, salmeterol xinafoate + fluticasone propionate",symptomatic exophthalmos associated with thyroid-related eye disease,4,,-,approved,1981,
476,salmeterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,61,advair/seretide/adoair,Bronchodilator,4,,-,approved,1994,
477,salmeterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1839,serevent,Bronchodilator,4,,-,approved,1994,
478,sotalol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_180,sotalol,cardiovascular disease,4,,-,approved,1992,
479,syl040012,sirna,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1922,"syl040012, Bamosiran",Antiglaucomic,2,2014,Completed,in trial,-,
480,terbutaline,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD515,-,Bronchodilator ; Tocolytic,4,,-,approved,1974,
481,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,386,"brimonidine tartrate/timolol maleate,combigan",Antiglaucomic,4,,-,approved,1981,
482,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1095,"latanoprost + timolol,xalcom, xalacom",Antiglaucomic,4,,-,approved,1981,
483,timolol,small molecule,Aminergic ,antagonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2071,"travoprost + timolol,extravan, duotrav",Antiglaucomic,4,,-,approved,1981,
484,vilanterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmar2016_0195,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",chronic obstructive pulmonary disease (COPD),3,2016,Ongoing,in trial,-,
485,vilanterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0779,fluticasone furoate and vilanterol inhalation powder,chronic obstructive pulmonary disease (COPD),4,,-,approved,2013,
486,vilanterol,small molecule,Aminergic ,agonist,,primary,ADRB2,adrb2_human,P07550,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0619,umeclidinium bromide (gsk573719) + vilanterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,2013,
487,amibegron,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,158,"amibegron, sr 58611",Anti-depressant,3,2008,discontinued,in trial,-,
488,carteolol,small molecule,Aminergic ,antagonist,,secondary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_194,carteolol,Antiglaucomic,4,,-,approved,1988,
489,carvedilol,small molecule,Aminergic ,antagonist,,secondary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_192,carvedilol,Antihypertensive,4,,-,approved,1995,
490,dipivefrin,small molecule,Aminergic ,agonist,,secondary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_197,dipivefrin,Antiglaucomic,4,,-,approved,1980,
491,droxidopa,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2272,droxidopa,orthostatic hypotension,4,,-,approved,2014,
492,isoproterenol,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_193,isoproterenol,Anti-Asthmatic,4,,-,approved,1956,
493,isoproterenol,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_401,isoprenaline,cardiovascular ; Anti-Asthmatic ,4,,-,approved,1956,
494,kuc-7483,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1082,"kuc-7483, Ritobegron",overactive bladder,3,2009,Completed,in trial,-,"Article from 2012 suggests may be worth more research, but also possibly discontinued"
495,labetalol,small molecule,Aminergic ,antagonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_195,labetalol,cardiovascular disease,4,,-,approved,1984,
496,mephentermine,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Sep2016_196,mephentermine,cardiovascular disease,4,,-,approved,1951,
497,mirabegron,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,MMAmay2016_0790,"ym178, mirabegron",incontinence,4,,-,approved,2012,
498,mn-246,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1318,mn-246,overactive bladder,1,2010,discontinued,in trial,-,
499,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,NRDD395,-,Antihypotensive ; Vasoconstrictor,4,,-,approved,1950,
500,norepinephrine,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2273,dermx,for prevention of dermatitis during radiotherapy,4,,-,approved,1950,
501,solabegron,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,1874,"solabegron, gw 427353",Antidiabetic; irritable bowel syndrome; incontinence,1,2016,recruiting,in trial,-,"Had Phase 2 trials for IBS and overactive bladder in 2007, but now after 10 year break clinical trials starting again"
502,ym-178,small molecule,Aminergic ,agonist,,primary,ADRB3,adrb3_human,P13945,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,2229,"ym-178, Mirabegron",overactive bladder,3,2016,recruiting,in trial,-,
503,azilsartan medoxomil,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,315,"azilsartan medoxomil, tak-491",Antihypertensive,4,,-,approved,2011,
504,azilsartan medoxomil,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,MMAmay2016_0371,"edarbyclor, azilsartan medoxomil + chlorthalidone",Antihypertensive,4,,-,approved,2011,
505,candesartan cilexetil,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,427,"candesartan cilexetil,atacand",Antihypertensive,4,,-,approved,1998,
506,dsc127,peptide,Peptide ,agonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,2280,dsc127,diabetic foot ulcers,3,2013,discontinued,in trial,-,
507,eprosartan,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,NRDD207,-,Antihypertensive,4,,-,approved,1997,
508,forasartan,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,NRDD248,-,Antihypertensive,4,,-,approved,-,"Never approved by fda, used from long time ago"
509,irbesartan,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,1023,"irbesartan,avapro, irbetan",Antihypertensive,4,,-,approved,1997,
510,ljpc-501,peptide,Peptide ,agonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,MMA2015_0090,athos-3,Hepatorenal syndrome-catecholamine-resistant hypotension (CRH),3,2015,Completed,in trial,-,
511,losartan,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,NRDD310,-,Antihypertensive,4,,-,approved,1995,
512,losartan,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,MMAmay2016_0431,inv-144,Antihypertensive ; for Diabetic neuropathy,4,,-,approved,1995,
513,olmesartan medoxomil,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,1479,"olmesartan, de-092",Antiglaucomic,4,,-,approved,2002,
514,olmesartan medoxomil,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,557,"cs-8663, amlodipine + olmesartan,azor, sevikar",Antihypertensive,4,,-,approved,2002,
515,olmesartan medoxomil,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,1478,"olmesartan medoxomil (cs-866),benicar",Antihypertensive,4,,-,approved,2002,
516,olmesartan medoxomil,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,2080,tribenzor,Antihypertensive,4,,-,approved,2002,
517,olmesartan medoxomil,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,ASH_Sep2016_250,olmesartan medoxomil,cardiovascular disease,4,,-,approved,2002,
518,ps433540,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,1673,ps433540,"Focal segmental glomerulosclerosis, Antihypertensive",2,2012,recruiting,in trial,-,
519,re-021,small molecule,Peptide ,antagonist,sparsentan,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,MMAapril2016_0044,"re-021, sparsentan",kidney disease; nephropathy,2,2012,Completed,in trial,-,
520,saprisartan,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,NRDD489,-,Antihypertensive,2,1997,discontinued,in trial,-,
521,tasosartan,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,NRDD509,-,Antihypertensive,3,2000,discontinued,in trial,-,Disontinued due to safety profile
522,telmisartan,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,1977,"telmisartan,micardis, micardis hct",Antihypertensive,4,,-,approved,1998,
523,trv120027,protein,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,2279,trv120027,Antihypertensive,2,2013,recruiting,in trial,-,
524,valsartan,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,MMAmay2016_0742,sacubitril + valsartan,Antihypertensive,4,,-,approved,2012,
525,valsartan,small molecule,Peptide ,antagonist,,primary,AGTR1,agtr1_human,P30556,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,established,2122,"valsartan,diovan",Antihypertensive,4,,-,approved,2012,
526,ema401,small molecule,Peptide ,antagonist,,primary,AGTR2,agtr2_human,P50052,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,not established,MMAmay2016_0377,ema401,peripheral neuropathic pain; post herpetic neuralgia,2,2017,Not open yet,in trial,-,
527,ljpc-501,peptide,Peptide ,agonist,,primary,AGTR2,agtr2_human,P50052,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,not established,MMA2015_0091,athos-3,Hepatorenal syndrome-catecholamine-resistant hypotension (CRH),3,2015,Completed,in trial,-,
528,ps433540,small molecule,Peptide ,antagonist,,primary,AGTR2,agtr2_human,P50052,Class A (Rhodopsin),GPCR;Rhodopsin,Angiotensin receptors,not established,1673,ps433540,"Focal segmental glomerulosclerosis, Antihypertensive",2,2012,recruiting,in trial,-,
529,apelin,peptide,Peptide ,not available,,primary,APLNR,apj_human,P35414,Class A (Rhodopsin),GPCR;Rhodopsin,Apelin receptors,not established,MMAjun2016_0045,apelin,Cardiovascular disorders; Insulin sensitivity,1,2013,Completed,in trial,-,ligand
530,api246,small molecule,Peptide ,antagonist,srx246,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,MMAjun2016_0005,"api246,  srx246",Treatment of affective and anger disorders,2,2016,Completed,in trial,-,
531,conivaptan,small molecule,Peptide ,antagonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,519,"conivaptan, ym-087,vaprisol",hyponatremia,4,,-,approved,2005,
532,desmopressin,peptide,Peptide ,not available,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1537,"nocdurna,  desmopressin",Antidiuretic,4,,-,approved,1978,
533,felypressin,peptide,Peptide ,agonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,NRDD226,-,Hemostatic s; Vasoconstricting,1,2010,Completed,in trial,-,"Not approved in US, but used here and elsewhere"
534,selepressin,protein,Peptide ,agonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Sep2016_288,selepressin,septic shock,3,2015,recruiting,in trial,-,
535,terlipressin,small molecule,Peptide ,agonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1986,"terlipressin,lucassin",hepatorenal syndrome,4,,-,approved,2003,
536,va111913,small molecule,Peptide ,antagonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2116,va111913,dysmenorrhea,2,2010,Completed,in trial,-,
537,vasopressin,peptide,Peptide ,agonist,,primary,AVPR1A,v1ar_human,P37288,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,NRDD560,-,Antidiuretic,4,,-,approved,1982,
538,desmopressin,peptide,Peptide ,not available,,primary,AVPR1B,v1br_human,P47901,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1537,"nocdurna,  desmopressin",Antidiuretic,4,,-,approved,1978,
539,terlipressin,small molecule,Peptide ,agonist,,primary,AVPR1B,v1br_human,P47901,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1986,"terlipressin,lucassin",hepatorenal syndrome,4,,-,approved,2003,
540,va111913,small molecule,Peptide ,antagonist,,secondary,AVPR1B,v1br_human,P47901,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2116,va111913,dysmenorrhea,2,2010,Completed,in trial,-,
541,vasopressin,peptide,Peptide ,agonist,,primary,AVPR1B,v1br_human,P47901,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,NRDD560,-,Antidiuretic,4,,-,approved,1982,
542,conivaptan,small molecule,Peptide ,antagonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,519,"conivaptan, ym-087,vaprisol",hyponatremia,4,,-,approved,2005,
543,desmopressin,peptide,Peptide ,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1537,"nocdurna,  desmopressin",Antidiuretic,4,,-,approved,1978,
544,lixivaptan,small molecule,Peptide ,antagonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1157,lixivaptan,hyponatremia,3,2010,Completed,in trial,-,"Some information from 2012 but does not appear to labeled discontinued, just postponed"
545,m0002,small molecule,Peptide ,antagonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1204,m0002,ascites,2,2010,discontinued,in trial,-,
546,opc-51803,small molecule,Peptide ,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1503,"opc-51803, sou-003",incontinence,2,2006,discontinued,in trial,-,
547,terlipressin,small molecule,Peptide ,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,1986,"terlipressin,lucassin",hepatorenal syndrome,4,,-,approved,2003,
548,tolvaptan,small molecule,Peptide ,antagonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2037,"tolvaptan, opc-41061,samsca",Antihypertensive,4,,-,approved,2009,
549,va106483,small molecule,Peptide ,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2115,"va106483, Fedovapagon",BPH-related urinary symptoms,3,2015,recruiting,in trial,-,
550,va111913,small molecule,Peptide ,antagonist,,secondary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2116,va111913,dysmenorrhea,2,2010,Completed,in trial,-,
551,vasopressin,peptide,Peptide ,agonist,,primary,AVPR2,v2r_human,P30518,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,NRDD560,-,Antidiuretic,4,,-,approved,1982,
552,icatibant,small molecule,Peptide ,antagonist,,secondary,BDKRB1,bkrb1_human,P46663,Class A (Rhodopsin),GPCR;Rhodopsin,Bradykinin receptors,established,ASH_Oct2016_434,"firazyr, icatibant, je049",hereditary angioedema,4,,-,approved,2008,
553,anatibant,small molecule,Peptide ,antagonist,,primary,BDKRB2,bkrb2_human,P30411,Class A (Rhodopsin),GPCR;Rhodopsin,Bradykinin receptors,established,177,anatibant,traumatic brain injury,2,2007,discontinued,in trial,-,
554,icatibant,small molecule,Peptide ,antagonist,,primary,BDKRB2,bkrb2_human,P30411,Class A (Rhodopsin),GPCR;Rhodopsin,Bradykinin receptors,established,797,"firazyr, icatibant, je049",hereditary angioedema,4,,-,approved,2008,
555,ccx168,small molecule,Peptide ,antagonist,,primary,C5AR1,c5ar1_human,P21730,Class A (Rhodopsin),GPCR;Rhodopsin,Complement peptide receptors,not established,448,ccx168,Anti-inflammatory,3,2016,recruiting,in trial,-,
556,calcitonin human,small molecule,Peptide ,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,2154,viaderm-calcitonin,Anti-osteoporotic,1,2011,Completed,in trial,-,
557,calcitonin human,small molecule,Peptide ,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,376,"bn-002,capsitonin",Anti-osteoporotic,2,2013,Completed,in trial,-,
558,calcitonin human,protein,Peptide ,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,ASH_Sep2016_324,calcitonin human,parathyroid disease,4,,-,approved,1986,
559,calcitonin salmon recombinant,peptide,Peptide ,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,817,fortical,Anti-osteoporotic,3,2008,discontinued,in trial,-,
560,calcitonin salmon recombinant,protein,Peptide ,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,ASH_Sep2016_323,calcitonin salmon,postmenopausal osteoporosis,4,,-,approved,1978,
561,calcitonin salmon recombinant,protein,Peptide ,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,ASH_Sep2016_321,calcitonin salmon recombinant,osteitis deformans,4,,-,approved,2005,
562,calcitonin salmon recombinant,peptide,Aminergic ,agonist,,primary,CALCR,calcr_human,P30988,Class A (Rhodopsin),GPCR;Secretin,Adrenoceptors,established,ASH_Oct2016_418,calcitonin (salmon),Paget's disease,4,,-,approved,2005,
563,davalintide,protein,Peptide ,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,ASH_Sep2016_325,davalintide,Anti-obesity,2,2008,discontinued,in trial,-,
564,pramlintide acetate,peptide,Peptide ,agonist,,primary,CALCR,calcr_human,P30988,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,established,1924,"pramlintide acetate, symlin",Antidiabetic,4,,-,approved,2005,
565,amg 334,antibody,Peptide ,antagonist,,primary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,MMAapril2016_0116,"amg 334, Erenumab",Anti-migraine,3,2017,Completed,in trial,-,
566,cgrp,peptide,Peptide ,agonist,,primary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,477,"cgrp, Akela Pharma",Anti-Asthmatic,2,2013,discontinued,in trial,-,EU
567,davalintide,protein,Peptide ,agonist,,secondary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,ASH_Sep2016_328,davalintide,Anti-obesity,2,2008,discontinued,in trial,-,
568,rimegepant,small molecule,Peptide ,antagonist,,primary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,ASH_Sep2016_329,rimegepant,Anti-migraine,2,2011,discontinued,in trial,-,
569,telcagepant,small molecule,Peptide ,antagonist,,primary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,ASH_Sep2016_326,telcagepant,Anti-migraine,3,2008,discontinued,in trial,-,
570,ubrogepant,small molecule,Peptide ,antagonist,,primary,CALCRL,calrl_human,Q16602,Class B1 (Secretin),GPCR;Secretin,Calcitonin receptors,not established,ASH_Sep2016_327,ubrogepant,Anti-migraine,3,2016,recruiting,in trial,-,
571,cinacalcet,small molecule,Ion ,PAM,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,NRDD105,-,Calcimimetics,4,,-,approved,2004,
572,cinacalcet,small molecule,Ion ,PAM,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,2327,"cinacalcet hcl, amg 073,sensipar",hyperparathyroidism,4,,-,approved,2004,
573,etelcalcetide,peptide,Ion ,agonist,"amg 416,  velcalcetide,  kai-4169,  ono-5163",primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,MMAapril2016_0047,"etelcalcetide, amg 416, velcalcetide, kai-4169, ono-5163",parathyroid disorders,4,,-,approved,2017,new fda approval in Feb 2017
574,nps-2143,small molecule,Ion ,antagonist,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,1441,nps-2143,Anti-osteoporotic,0,2015,Completed,in trial,-,
575,npsp795,small molecule,Ion ,antagonist,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,MMAmar2016_0202,npsp795,hypocalcaemia,2,2014,Completed,in trial,-,
576,ronacaleret,small molecule,Ion ,antagonist,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,1782,"ronacaleret, 751689",Anti-osteoporotic,2,2007,discontinued,in trial,-,discontinued due to lack of evidence of efficacy
577,strontium ranelate,small molecule,Ion ,agonist,,primary,CASR,casr_human,P41180,Class C (Glutamate) ,GPCR;Glutamate,Calcium-sensing receptors,established,1905,"strontium ranelate, s12911",Anti-osteoporotic,3,2015,Completed,in trial,-,European trials and marketed
578,ceruletide,small molecule,Peptide ,agonist,,primary,CCKAR,cckar_human,P32238,Class A (Rhodopsin),GPCR;Rhodopsin,Cholecystokinin receptors,established,NRDD085,-,Diagnostic,4,,-,approved,1982,
579,dexloxiglumide,small molecule,Peptide ,antagonist,,primary,CCKAR,cckar_human,P32238,Class A (Rhodopsin),GPCR;Rhodopsin,Cholecystokinin receptors,established,626,"dexloxiglumide, cr 2017",motilitant,3,2005,discontinued,in trial,-,
580,pentagastrin,small molecule,Peptide ,agonist,,primary,CCKBR,gasr_human,P32239,Class A (Rhodopsin),GPCR;Rhodopsin,Cholecystokinin receptors,established,NRDD418,-,Diagnostic,4,,-,approved,1974,
581,tt-223,injectible islet neogenesis therapy,Peptide ,agonist,,,CCKBR,gasr_human,P32239,Class A (Rhodopsin),GPCR;Rhodopsin,Cholecystokinin receptors,established,2092,tt-223,Antidiabetic; injectable islet neogenesis therapy for diabetes,2,2008,discontinued,in trial,-,
582,ccx354,small molecule,Protein ,antagonist,,primary,CCR1,ccr1_human,P32246,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,450,ccx354,Anti-inflammatory ; DMARD,2,2010,Completed,in trial,-,
583,azd2423,small molecule,Protein ,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,2331,azd2423,chronic obstructive pulmonary disorder;Analgesics; neuropathic pain,2,2010,discontinued,in trial,-,
584,ccl2-lpm,protein,Protein ,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,445,ccl2-lpm,Anti-inflammatory,1,2009,Terminated,in trial,-,Terminated due to resources and slow enrollment not safety
585,ccx140,small molecule,Protein ,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,447,ccx140,Anti-inflammatory ; Antidiabetic,2,2011,Completed,in trial,-,
586,ccx872,small molecule,Protein ,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,MMAapril2016_0147,ccx872,Antineoplastic ; pancreatic cancer,1,2015,Ongoing,in trial,-,
587,cenicriviroc,small molecule,Protein ,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_292,cenicriviroc,antiviral ; HIV,3,2017,recruiting,in trial,-,
588,incb3284,small molecule,Protein ,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,966,incb3284,Anti-inflammatory ; DMARD,2,2005,discontinued,in trial,-,
589,mln-1202,antibody,,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1310,mln-1202,Antineoplastic,1,2016,recruiting,in trial,-,added entry - new indication
590,mln-1202,antibody,Protein ,antagonist,,primary,CCR2,ccr2_human,P41597,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1310,mln-1202,Anti-inflammatory ; DMARD; Diabetic neophropathy,2,2009,discontinued,in trial,-,
591,tpi-asm8,antisense oligo,Protein ,antagonist,,primary,CCR3,ccr3_human,P51677,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,2049,tpi-asm8,Anti-Asthmatic,2,2010,discontinued,in trial,-,
592,mogamulizumab,antibody,Protein ,antagonist,,primary,CCR4,ccr4_human,P51679,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAjun2016_0001,mogamulizumab,Antineoplastic,3,2012,Ongoing,in trial,-,
593,mogamulizumab,antibody,Protein ,antagonist,,primary,CCR4,ccr4_human,P51679,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAjun2016_0001,mogamulizumab,Antineoplastic,3,2012,Ongoing,in trial,-,
594,cal-1,cell therapy,Protein ,not available,autologous t cell and blood stem cell therapy,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAapril2016_0320,"cal-1, autologous t cell and blood stem cell therapy",antiviral ; HIV,2,2012,Ongoing,in trial,-,
595,cenicriviroc,small molecule,Protein ,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,ASH_Sep2016_293,cenicriviroc,antiviral ; HIV,3,2017,recruiting,in trial,-,
596,maraviroc,small molecule,Protein ,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1834,selzentry,antiviral ; HIV,4,,-,approved,2007,
597,pro 140,antibody,Protein ,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1649,pro 140,antiviral ; HIV,3,2016,recruiting,in trial,-,
598,tbr-652,small molecule,Protein ,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1962,"tbr-652, tak-652, Cenicriviroc",antiviral ; HIV; Nonalcoholic Steatohepatitis,3,2017,recruiting,in trial,-,
599,vicriviroc,small molecule,Protein ,antagonist,,primary,CCR5,ccr5_human,P51681,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,2157,vicriviroc,antiviral ; HIV,3,2007,discontinued,in trial,-,
600,ccx025,small molecule,Protein ,antagonist,,primary,CCR9,ccr9_human,P51686,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,446,ccx025,Anti-inflammatory,1,2009,Unknown,in trial,-,
601,ccx282,small molecule,Protein ,antagonist,,primary,CCR9,ccr9_human,P51686,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,449,"ccx282, traficet-en",Anti-inflammatory ; Crohn's disease; ulceraite colitis,3,2012,Terminated,in trial,-,Terminated due to lack of efficacy
602,ccx507,small molecule,Protein ,antagonist,,primary,CCR9,ccr9_human,P51686,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,MMAmay2016_0216,ccx507,ulcerative colitis; inflammatory bowel disease,1,2014,Completed,in trial,-,
603,vercirnon,small molecule,Protein ,antagonist,,primary,CCR9,ccr9_human,P51686,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_294,vercirnon,crohn's disease,3,2011,discontinued,in trial,-,
604,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0042,aclidinium bromide + formoterol fumarate,chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,
605,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,44,aclidinium,Bronchodilator,4,,-,approved,2012,
606,acp-104,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,47,acp-104,schizophrenia,2,2007,discontinued,in trial,-,The D2 and D3 partial agonism creates less side effects - different from typical anti-psychotics
607,am-831,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0047,am-831,Antipsychotic ; schizophrenia,1,2011,discontinued,in trial,-,
608,anisotropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD029,-,Antispasmodics; Anti-ulcer,4,,-,approved,1982,
609,atropine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,977,inhaled atropine,nerve  antidote,4,,-,approved,1973,
610,benzquinamide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,
611,benztropine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD049,-,Antiparkinson,4,,-,approved,1954,
612,bethanechol,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD054,-,Parasympathomimetics,4,,-,approved,1948,
613,biperiden,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD057,-,Antidyskinetics,4,,-,approved,1959,
614,buclizine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD064,-,Antiemetics,4,,-,approved,1982,
615,carbachol,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD077,-,Antiglaucomic,4,,-,approved,1972,
616,carbinoxamine,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD080,-,Anti-Allergic,4,,-,approved,2003,
617,cevimeline,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD086,-,Parasympathomimetics,4,,-,approved,2000,
618,clidinium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD114,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,2013,
619,cyclopentolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD132,-,Mydriatics,4,,-,approved,1974,
620,cycrimine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD134,-,Antiparkinson,4,,-,approved,1982,
621,desipramine,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD148,-,Anti-depressant,4,,-,approved,1964,
622,dicyclomine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD162,-,Antispasmodics,4,,-,approved,1950,
623,diphemanil,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_48,diphemanil,digestive system disease,4,,-,approved,1982,
624,diphenidol,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD175,-,Antiemetics,4,,-,approved,1967,
625,doxepin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
626,ethopropazine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD217,-,Antidyskinetics,4,,-,approved,1982,
627,flavoxate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD230,-,Antispasmodics,4,,-,approved,1970,
628,flupentixol,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_389,flupentixol,Antipsychotic,4,,-,approved,1965,
629,glycopyrrolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,864,"glycopyrrolate, fhpc-02,cuvposa",Antineoplastic,4,,-,approved,1961,
630,glycopyrrolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0378,ep-101,chronic obstructive pulmonary disease (COPD),4,,-,approved,1961,
631,glycopyrrolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1680,pt001,chronic obstructive pulmonary disease (COPD),4,,-,approved,1961,
632,glycopyrrolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1681,"pt003, glycopyrrolate + formoterol inhalation aerosol",chronic obstructive pulmonary disease (COPD),4,,-,approved,1961,
633,glycopyrronium,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1457,"nva237, inhaled glycopyrronium bromide",chronic obstructive pulmonary disease (COPD),4,,-,approved,1961,
634,hexocyclium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_52,hexocyclium,digestive system disease,4,,-,approved,1982,
635,homatropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD271,-,GI Anti-Ulcer ; Antimuscarinics,4,,-,approved,1982,
636,hyoscyamine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_394,hyoscyamine,Antispasmodics,4,,-,approved,-,
637,indacaterol,small molecule,Aminergic ,agonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1702,"qva149, glycopyrronium + indacaterol",chronic obstructive pulmonary disease (COPD),4,,-,approved,2009,
638,ipratropium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1021,"ipratropium bromide + albuterol sulfate,duoneb",chronic obstructive pulmonary disease (COPD),4,,-,approved,1986,
639,isopropamide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_51,isopropamide,digestive system disease,4,,-,approved,1957,
640,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
641,mcd-386,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1228,mcd-386,Alzheimer's disease,1,2005,discontinued,in trial,-,
642,mepenzolate,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_47,mepenzolate,digestive system disease,4,,-,approved,1956,
643,methantheline,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD336,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1951,
644,methixene,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_49,methixene,Antiparkinson,4,,-,approved,1982,
645,methscopolamine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_50,methscopolamine,cycloplegia,4,,-,approved,1953,
646,methylscopolamine bromide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD351,-,Antispasmodics,4,,-,approved,1953,conflicting subfamily 
647,methylscopolamine bromide,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_421,methylscopolamine bromide,Anti-ulcer,4,,-,approved,1953,conflicting subfamily 
648,metixene,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD355,-,Antiparkinson,4,,-,approved,1982,
649,metoclopramide,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1355,mt 100,Anti-migraine,3,2005,Completed,in trial,-,"received not approved letter from FDA in 2005, but mt-400 was approved"
650,metoclopramide,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,758,evk-001,diabetic gastroparesis,3,2016,Completed,in trial,-,
651,metoclopramide,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1269,"metoclopramide,emitasol, pramidin",Antiemetics,4,,-,approved,1979,
652,metoclopramide,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1268,"metoclopramide hcl,metzoliv odt",motilitant; gastroesophageal reflux disease,4,,-,approved,1979,
653,ngx267,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1410,ngx267,dry mouth,2,2008,discontinued,in trial,-,
654,olanzapine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
655,olanzapine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
656,olanzapine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0190,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
657,olanzapine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
658,olanzapine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
659,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2351,dr-3001,incontinence,3,2013,discontinued,in trial,-,
660,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,14,aa-2010,incontinence,4,,-,approved,1975,
661,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2067,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",incontinence,4,,-,approved,1975,
662,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,190,"ap-1034,anturol",overactive bladder,4,,-,approved,1975,
663,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0197,jnp-010,overactive bladder,4,,-,approved,1975,
664,oxyphencyclimine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD407,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1982,
665,oxyphenonium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD408,-,Mydriatics,4,,-,approved,1982,
666,pilocarpine,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,4,,-,approved,1974,
667,pirenzepine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD446,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,-,
668,procyclidine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD460,-,Antidyskinetics; Antiparkinson s,4,,-,approved,1955,
669,promazine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
670,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0103,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,Completed,in trial,-,
671,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,
672,propantheline,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD464,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1953,
673,propiomazine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
674,scopolamine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD491,-,Adjuvants; Anesthesia; Antispasmodics; Mydriatics,4,,-,approved,1953,
675,solifenacin,small molecule,Aminergic ,antagonist,,secondary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1876,"solifenacin succinate, ym-905,vesicare",incontinence,4,,-,approved,2004,
676,succinylcholine,small molecule,Aminergic ,agonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD501,-,Muscle Relaxants; Skeletal,4,,-,approved,1952,
677,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD519,-,Antiemetics,4,,-,approved,1961,
678,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0590,tiotropium + olodaterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,2004,
679,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2019,"tiotropium bromide,spiriva",cystic fibrosis; chronic obstructive pulmonary disorder (COPD),4,,-,approved,2004,
680,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,3,2016,Completed,in trial,-,
681,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2036,"tolterodine extended release capsules,detrol la",incontinence,4,,-,approved,1998,
682,tridihexethyl,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD540,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1954,
683,triflupromazine,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD542,-,Antiemetics; Antipsychotic,4,,-,approved,1957,
684,trihexyphenidyl,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD543,-,Antiparkinson,4,,-,approved,1949,
685,trospium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2350,alks 27,chronic obstructive pulmonary disease (COPD),2,2007,discontinued,in trial,-,
686,trospium,small molecule,Aminergic ,antagonist,,primary,CHRM1,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2086,"trospium chloride,sanctura",incontinence,4,,-,approved,2004,
687,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0039,aclidinium bromide + formoterol fumarate,chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,
688,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,44,aclidinium,Bronchodilator,4,,-,approved,2012,
689,anisotropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD029,-,Antispasmodics; Anti-ulcer,4,,-,approved,1982,
690,atropine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,977,inhaled atropine,nerve  antidote,4,,-,approved,1973,
691,batefenterol,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_56,batefenterol,chronic obstructive pulmonary disease (COPD),2,2015,Completed,in trial,-,
692,benzquinamide,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,
693,betanechol,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,648,dm-71,Antidiabetic,4,,-,approved,1970,
694,bethanechol,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_57,bethanechol,eosinophilic esophagitis,4,,-,approved,1948,
695,carbachol,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD077,-,Antiglaucomic,4,,-,approved,1972,
696,darifenacin,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_54,darifenacin,overactive bladder,4,,-,approved,2004,
697,desipramine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD148,-,Anti-depressant,4,,-,approved,1964,
698,dimetindene,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_360,dimetindene,Anti-Allergic,4,,-,approved,-,
699,diphenidol,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD175,-,Antiemetics,4,,-,approved,1967,
700,doxacurium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD185,-,Muscle Relaxants,4,,-,approved,1991,
701,doxacurium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD186,-,Muscle Relaxants,4,,-,approved,1991,
702,doxepin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
703,fesoterodine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_53,fesoterodine,prostate adenocarcinoma,4,,-,approved,2007,
704,flavoxate,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD230,-,Antispasmodics,4,,-,approved,1970,
705,homatropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD271,-,GI Anti-Ulcer ; Antimuscarinics,4,,-,approved,1982,
706,hyoscyamine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_396,hyoscyamine,Antispasmodics,4,,-,approved,-,
707,ipratropium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1021,"ipratropium bromide + albuterol sulfate,duoneb",chronic obstructive pulmonary disease (COPD),4,,-,approved,1986,
708,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
709,methylscopolamine bromide,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_422,methylscopolamine bromide,Anti-ulcer,4,,-,approved,1953,conflicting subfamily 
710,metixene,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD355,-,Antiparkinson,4,,-,approved,1982,
711,mivacurium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD370,-,Muscle Relaxants,4,,-,approved,1992,
712,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
713,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
714,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0185,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
715,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
716,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
717,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2351,dr-3001,incontinence,3,2013,discontinued,in trial,-,
718,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,14,aa-2010,incontinence,4,,-,approved,1975,
719,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2067,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",incontinence,4,,-,approved,1975,
720,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,190,"ap-1034,anturol",overactive bladder,4,,-,approved,1975,
721,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0198,jnp-010,overactive bladder,4,,-,approved,1975,
722,oxyphencyclimine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD407,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1982,
723,pilocarpine,small molecule,Aminergic ,agonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,4,,-,approved,1974,
724,procyclidine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD460,-,Antidyskinetics; Antiparkinson s,4,,-,approved,1955,
725,promazine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
726,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0100,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,Completed,in trial,-,
727,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,
728,propantheline,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_55,propantheline,digestive system disease,4,,-,approved,1953,
729,propiomazine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
730,psd-506,small molecule,Aminergic ,antagonist,,,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1676,psd-506,overactive bladder,2,2009,discontinued,in trial,-,
731,rocuronium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1776,"rocuronium bromide,esmeron, zemuron, eslax",Muscle Relaxants,4,,-,approved,2008,
732,solifenacin,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1876,"solifenacin succinate, ym-905,vesicare",incontinence,4,,-,approved,2004,
733,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD519,-,Antiemetics,4,,-,approved,1961,
734,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0589,tiotropium + olodaterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,2004,
735,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2019,"tiotropium bromide,spiriva",cystic fibrosis; chronic obstructive pulmonary disorder (COPD),4,,-,approved,2004,
736,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,3,2016,Completed,in trial,-,
737,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2036,"tolterodine extended release capsules,detrol la",incontinence,4,,-,approved,1998,
738,tridihexethyl,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD540,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1954,
739,triflupromazine,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD542,-,Antiemetics; Antipsychotic,4,,-,approved,1957,
740,trospium,small molecule,Aminergic ,antagonist,,secondary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2086,"trospium chloride,sanctura",incontinence,4,,-,approved,2004,
741,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmar2016_0193,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",chronic obstructive pulmonary disease (COPD),3,2016,Ongoing,in trial,-,
742,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0618,umeclidinium + vilanterol,Bronchodilator ; COPD,4,,-,approved,2013,
743,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM2,acm2_human,P08172,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0713,"incruse ellipta,  umeclidinium bromide",chronic obstructive pulmonary disease (COPD),4,,-,approved,2013,
744,acetylcholine,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_68,acetylcholine,Antiglaucomic,4,,-,approved,1973,
745,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0043,aclidinium bromide + formoterol fumarate,chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,
746,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,44,aclidinium,Bronchodilator,4,,-,approved,2012,
747,anisotropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD029,-,Antispasmodics; Anti-ulcer,4,,-,approved,1982,
748,atropine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,977,inhaled atropine,nerve  antidote,4,,-,approved,1973,
749,batefenterol,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_82,batefenterol,chronic obstructive pulmonary disease (COPD),2,2016,Completed,in trial,-,
750,benzquinamide,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,
751,bethanechol,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_83,bethanechol,eosinophilic esophagitis,4,,-,approved,1948,
752,carbachol,small molecule,Aminergic ,agonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_80,carbachol,Antiglaucomic,4,,-,approved,1972,
753,cevimeline,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD086,-,Parasympathomimetics,4,,-,approved,2000,
754,cyclopentolate,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_73,cyclopentolate,cycloplegia,4,,-,approved,1974,
755,darifenacin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,598,"darifenacin,enablex, emselex",overactive bladder,4,,-,approved,2004,
756,dicyclomine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_77,dicyclomine,digestive system disease,4,,-,approved,1950,
757,diphemanil,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD173,-,Bronchodilator,4,,-,approved,1976,
758,diphenidol,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD175,-,Antiemetics,4,,-,approved,1967,
759,doxepin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
760,drm04,small molecule,Aminergic ,antagonist,anticholinergic,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAfeb2016_0095,"drm04, anticholinergic",hyperhidrosis,3,2015,Completed,in trial,-,
761,fesoterodine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,788,"fesoterodine fumarate, spm 907,toviaz",overactive bladder syndrome,4,,-,approved,2007,
762,glycopyrrolate,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_71,glycopyrrolate,obstructive lung disease,4,,-,approved,1961,
763,gsk-961081,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,881,gsk-961081,Bronchodilator,2,2015,Completed,in trial,-,
764,hexocyclium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_78,hexocyclium,digestive system disease,4,,-,approved,1982,
765,homatropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD271,-,GI Anti-Ulcer ; Antimuscarinics,4,,-,approved,1982,
766,ipratropium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_72,ipratropium,chronic obstructive pulmonary disease (COPD),4,,-,approved,1986,
767,isopropamide,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_74,isopropamide,digestive system disease,4,,-,approved,1957,
768,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
769,mepenzolate,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_79,mepenzolate,digestive system disease,4,,-,approved,1956,
770,methacholine,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_81,methacholine,Anti-Asthmatic,4,,-,approved,1986,
771,methscopolamine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_75,methscopolamine,digestive system disease,4,,-,approved,1953,
772,metixene,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD355,-,Antiparkinson,4,,-,approved,1982,
773,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
774,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
775,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0194,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
776,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
777,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
778,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2351,dr-3001,incontinence,3,2013,discontinued,in trial,-,
779,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,14,aa-2010,incontinence,4,,-,approved,1975,
780,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2067,"transdermal oxybutynin patch, oxybutynin topical gel,oxytrol, kentera, gelnique",incontinence,4,,-,approved,1975,
781,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,190,"ap-1034,anturol",overactive bladder,4,,-,approved,1975,
782,oxybutynin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0199,jnp-010,overactive bladder,4,,-,approved,1975,
783,oxyphencyclimine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD407,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1982,
784,oxyphenonium,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_76,oxyphenonium,digestive system disease,4,,-,approved,1982,
785,pilocarpine,small molecule,Aminergic ,agonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,4,,-,approved,1974,
786,promazine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
787,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0104,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,Completed,in trial,-,
788,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,
789,propantheline,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_69,propantheline,digestive system disease,4,,-,approved,1953,
790,propiomazine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
791,psd-506,small molecule,Aminergic ,antagonist,,,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1676,psd-506,overactive bladder,2,2009,discontinued,in trial,-,
792,sofpironium bromide,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0805,bbi-4000,Anticholinergics; for thetopical treatment of primary axillary hyperhidrosis,2,2017,recruiting,in trial,-,
793,solifenacin,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1876,"solifenacin succinate, ym-905,vesicare",incontinence,4,,-,approved,2004,
794,svt-40776,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1921,"svt-40776, tarafenacin",incontinence,2,2011,Completed,in trial,-,
795,td-4208,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0081,"td-4208, Revefenacin",chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,
796,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD519,-,Antiemetics,4,,-,approved,1961,
797,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0591,tiotropium + olodaterol,chronic obstructive pulmonary disease (COPD),4,,-,approved,2004,
798,tiotropium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2019,"tiotropium bromide,spiriva",cystic fibrosis; chronic obstructive pulmonary disorder (COPD),4,,-,approved,2004,
799,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,3,2016,Completed,in trial,-,
800,tolterodine,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2036,"tolterodine extended release capsules,detrol la",incontinence,4,,-,approved,1998,
801,tridihexethyl,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD540,-,GI Anti-Ulcer ; anticholinergic; Antispasmodics,4,,-,approved,1954,
802,tropicamide,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Sep2016_70,tropicamide,myopia,4,,-,approved,1960,
803,trospium,small molecule,Aminergic ,antagonist,,secondary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2086,"trospium chloride,sanctura",incontinence,4,,-,approved,2004,
804,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmar2016_0194,"ff/umec/vi, fluticasone furoate + umeclidinium + vilanterol",chronic obstructive pulmonary disease (COPD),3,2016,Ongoing,in trial,-,
805,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0618,umeclidinium + vilanterol,Bronchodilator ; COPD,4,,-,approved,2013,
806,umeclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM3,acm3_human,P20309,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0714,"incruse ellipta,  umeclidinium bromide",chronic obstructive pulmonary disease (COPD),4,,-,approved,2013,
807,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0040,aclidinium bromide + formoterol fumarate,chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,
808,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,44,aclidinium,Bronchodilator,4,,-,approved,2012,
809,atropine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,977,inhaled atropine,nerve  antidote,4,,-,approved,1973,
810,benzquinamide,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,
811,doxepin,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
812,homatropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD271,-,GI Anti-Ulcer ; Antimuscarinics,4,,-,approved,1982,
813,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
814,metixene,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD355,-,Antiparkinson,4,,-,approved,1982,
815,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
816,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
817,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0186,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
818,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
819,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
820,procyclidine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD460,-,Antidyskinetics; Antiparkinson s,4,,-,approved,1955,
821,promazine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
822,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0101,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,Completed,in trial,-,
823,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,
824,propiomazine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
825,solifenacin,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1876,"solifenacin succinate, ym-905,vesicare",incontinence,4,,-,approved,2004,
826,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD519,-,Antiemetics,4,,-,approved,1961,
827,tolterodine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,3,2016,Completed,in trial,-,
828,tolterodine,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2036,"tolterodine extended release capsules,detrol la",incontinence,4,,-,approved,1998,
829,tropicamide,small molecule,Aminergic ,antagonist,,primary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD552,-,Diagnostic,4,,-,approved,1960,
830,trospium,small molecule,Aminergic ,antagonist,,secondary,CHRM4,acm4_human,P08173,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2086,"trospium chloride,sanctura",incontinence,4,,-,approved,2004,
831,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0041,aclidinium bromide + formoterol fumarate,chronic obstructive pulmonary disease (COPD),3,2017,recruiting,in trial,-,
832,aclidinium,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,44,aclidinium,Bronchodilator,4,,-,approved,2012,
833,atropine,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,977,inhaled atropine,nerve  antidote,4,,-,approved,1973,
834,benzquinamide,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,
835,doxepin,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
836,homatropine methylbromide,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD271,-,GI Anti-Ulcer ; Antimuscarinics,4,,-,approved,1982,
837,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
838,metixene,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD355,-,Antiparkinson,4,,-,approved,1982,
839,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
840,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
841,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAmay2016_0188,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
842,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
843,olanzapine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
844,promazine,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
845,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,MMAapril2016_0102,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,Completed,in trial,-,
846,promethazine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,
847,propiomazine,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
848,solifenacin,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,1876,"solifenacin succinate, ym-905,vesicare",incontinence,4,,-,approved,2004,
849,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,NRDD519,-,Antiemetics,4,,-,approved,1961,
850,tolterodine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2013,thvd-201,incontinence,3,2016,Completed,in trial,-,
851,tolterodine,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2036,"tolterodine extended release capsules,detrol la",incontinence,4,,-,approved,1998,
852,trospium,small molecule,Aminergic ,antagonist,,secondary,CHRM5,acm5_human,P08912,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,2086,"trospium chloride,sanctura",incontinence,4,,-,approved,2004,
853,ccx832,small molecule,Protein ,antagonist,,primary,CMKLR1,cml1_human,Q99788,Class A (Rhodopsin),GPCR;Rhodopsin,Chemerin receptor,not established,451,ccx832,Anti-inflammatory ; for treatment for autoimmune disease,1,2011,discontinued,in trial,-,
854,rx-10045,small molecule,Protein ,agonist,,primary,CMKLR1,cml1_human,Q99788,Class A (Rhodopsin),GPCR;Rhodopsin,Chemerin receptor,not established,2317,rx-10045,dry eye,2,2014,Completed,in trial,-,
855,ajulemic acid,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,2361,"ip 751, ct-3",Analgesics;neuropathic pain,2,2017,Not open yet,in trial,-,May have improved CB2 selectivity but still had CB1 affinity
856,ave-1625,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,284,ave-1625,Anti-obesity ; Alzheimer's disease,2,2007,discontinued,in trial,-,
857,cannabidiol,small molecule,Lipid ,agonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0296,"zyn002, Topical cannabidiol gel",Anticonvulsants; Antiepileptics,0,2017,Not open yet,in trial,-,
858,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0328,"epidiolex, oral liquid cannabidiol, gwp42003",schizophrenia,2,2013,Completed,in trial,-,
859,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmar2016_0268,cannabidiol,epilepsy,3,2016,Not open yet,in trial,-,
860,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmar2016_0270,"epidiolex, oral liquid cannabidiol, gwp42003",epilepsy,3,2016,recruiting,in trial,-,
861,cannabidivarin,small molecule,Lipid ,antagonist,,secondary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmay2016_0402,"gwp42006, Cannabidivarin",epilepsy,2,2015,recruiting,in trial,-,
862,drinabant,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,ASH_Sep2016_306,drinabant,schizophrenia,2,2007,discontinued,in trial,-,discontinued due to insufficient level of efficacy
863,dronabinol,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,437,"cat-310 , relivar",Analgesics,4,,-,approved,1985,
864,dronabinol,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,667,"dronabinol ,marinol",Appetite stimulant,4,,-,approved,1985,
865,ibipinabant,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,ASH_Sep2016_305,ibipinabant,Antidiabetic,3,2007,discontinued,in trial,-,
866,kn38-7271,small molecule,Lipid ,agonist,,,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1076,"kn38-7271, BAY 7271, BAY-387271",neuroprotectant,2,2005,discontinued,in trial,-,No development reported
867,marinol,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,NRDD314,-,Antiemetics,4,,-,approved,1985,
868,nabilone,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1812,sativex,Analgesics; neuropathic pain; restlegs legs syndrome,3,2014,recruiting,in trial,-,
869,nabilone,small molecule,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1373,"nabilone,cesamet",Antiemetics,4,,-,approved,1985,
870,rimonabant,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1766,rimonabant,Anti-obesity,4,,-,approved,2007,
871,ryi-018,antibody,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0280,ryi-018,liver disease; nonalcoholic steatohepatitis,1,2017,Not open yet,in trial,-,
872,surinabant,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1917,"surinabant, sr 147778","smoking-cessation, obesity",2,2007,discontinued,in trial,-,
873,taranabant,small molecule,Lipid ,inverse agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1952,"taranabant, mk-0364",Anti-obesity ; smoking-cessation,3,2007,discontinued,in trial,-,discontinued because overall profile does not support development for obesity
874,tetrahydrocannabinol,plant extract,Lipid ,agonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1812,sativex,Analgesics; neuropathic pain; restlegs legs syndrome,4,,-,approved,1985,
875,tetrahydrocannabivarin (thcv),small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0329,"gwp42004, Tetrahydrocannabivarin-9",Antidiabetic,2,2014,Completed,in trial,-,
876,tm38837,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,2029,tm38837,Anti-obesity,1,2013,Completed,in trial,-,
877,v24343,small molecule,Lipid ,antagonist,,primary,CNR1,cnr1_human,P21554,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,2112,v24343,Anti-obesity,1,2008,discontinued,in trial,-,
878,ajulemic acid,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,2361,"ip 751, ct-3",Analgesics;neuropathic pain,2,2017,Not open yet,in trial,-,May have improved CB2 selectivity but still had CB1 affinity
879,cannabidiol,small molecule,Lipid ,agonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0297,"zyn002, Topical cannabidiol gel",Anticonvulsants; Antiepileptics,0,2017,Not open yet,in trial,-,
880,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAapril2016_0328,"epidiolex, oral liquid cannabidiol, gwp42003",schizophrenia,2,2013,Completed,in trial,-,
881,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmar2016_0269,cannabidiol,epilepsy,3,2016,Not open yet,in trial,-,
882,cannabidiol,small molecule,Lipid ,antagonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmar2016_0271,"epidiolex, oral liquid cannabidiol, gwp42003",epilepsy,3,2016,recruiting,in trial,-,
883,cannabidivarin,small molecule,Lipid ,antagonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,MMAmay2016_0403,"gwp42006, Cannabidivarin",epilepsy,2,2015,recruiting,in trial,-,
884,dronabinol,small molecule,Lipid ,agonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,438,"cat-310,relivar",Analgesics,4,,-,approved,1985,
885,dronabinol,small molecule,Lipid ,agonist,,secondary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,667,"dronabinol ,marinol",Appetite stimulant,4,,-,approved,1985,
886,kn38-7271,small molecule,Lipid ,agonist,,,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1076,"kn38-7271, BAY 7271, BAY-387271",neuroprotectant,2,2005,discontinued,in trial,-,No development reported
887,nabilone,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1812,sativex,Analgesics; neuropathic pain; restlegs legs syndrome,3,2014,recruiting,in trial,-,
888,nabilone,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1373,"nabilone,cesamet",Antiemetics,4,,-,approved,1985,
889,prs-211375,small molecule,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,429,cannabinor,Analgesics,2,2007,discontinued,in trial,-,
890,tetrahydrocannabinol,plant extract,Lipid ,agonist,,primary,CNR2,cnr2_human,P34972,Class A (Rhodopsin),GPCR;Rhodopsin,Cannabinoid receptors,established,1812,sativex,Analgesics; neuropathic pain; restlegs legs syndrome,4,,-,approved,1985,
891,corticorelin ovine triflutate,small molecule,Aminergic ,agonist,,primary,CRHR1,crfr1_human,P34998,Class A (Rhodopsin),GPCR;Secretin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_409,corticorelin ovine triflutate,Diagnostic,4,,-,approved,-,
892,corticotropin-releasing factor,peptide,Peptide ,agonist,,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,528,"corticotropin-releasing factor,xerecept",peritumoral brain edema,3,2005,discontinued,in trial,-,
893,emicerfont,small molecule,Peptide ,antagonist,,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,ASH_Sep2016_330,emicerfont,irritable bowel syndrome,2,2007,discontinued,in trial,-,
894,pexacerfont,small molecule,Peptide ,antagonist,,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,ASH_Sep2016_331,pexacerfont,anxiety,3,2008,discontinued,in trial,-,
895,verucerfont,small molecule,Peptide ,antagonist,nbi-77860,primary,CRHR1,crfr1_human,P34998,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,MMA2016_0047,"verucerfont, nbi-77860, 561679",Congenital Adrenal Hyperplasia,2,2013,Completed,in trial,-,
896,corticotropin-releasing factor,peptide,Peptide ,agonist,,secondary,CRHR2,crfr2_human,Q13324,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,528,"corticotropin-releasing factor,xerecept",peritumoral brain edema,3,2005,discontinued,in trial,-,
897,urocortin 2,peptide,Peptide ,agonist,,primary,CRHR2,crfr2_human,Q13324,Class B1 (Secretin),GPCR;Secretin,Corticotropin-releasing factor receptors,not established,2105,"urocortin 2, 358-086-15",congestive heart failure,2,2012,discontinued,in trial,-,
898,ladarixin,small molecule,Protein ,antagonist,,primary,CXCR1,cxcr1_human,P25024,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_296,ladarixin,bullous pemphigoid,2,2016,recruiting,in trial,-,
899,pa-401,protein,Protein ,antagonist,,,CXCR1,cxcr1_human,P25024,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1553,"pa-401, pa04-001",Anti-inflammatory ; immunosuppressant,1,2012,discontinued,in trial,-,
900,reparixin,small molecule,Protein ,antagonist,,primary,CXCR1,cxcr1_human,P25024,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,MMAmay2016_0551,reparixin,Antidiabetic; type I diabetes,3,2013,Ongoing,in trial,-,
901,sch-527123,small molecule,Protein ,antagonist,,,CXCR1,cxcr1_human,P25024,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1822,"sch-527123, ps-291822, ps-938285, navarixin",chronic obstructive pulmonary disease (COPD),2,2009,discontinued,in trial,-,
902,danirixin,small molecule,Protein ,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_297,"danirixin, GSK1325756",chronic obstructive pulmonary disease (COPD),2,2017,recruiting,in trial,-,
903,elubrixin,small molecule,Protein ,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_300,elubrixin,ulcerative colitis,2,2007,discontinued,in trial,-,
904,ladarixin,small molecule,Protein ,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,ASH_Sep2016_298,ladarixin,bullous pemphigoid,2,2016,recruiting,in trial,-,
905,pa-401,protein,Protein ,antagonist,,,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1553,"pa-401, pa04-001",Anti-inflammatory ; immunosuppressant,1,2012,discontinued,in trial,-,
906,reparixin,small molecule,Protein ,antagonist,,primary,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,MMAmay2016_0552,reparixin,Antidiabetic; type I diabetes,3,2013,Ongoing,in trial,-,
907,sch-527123,small molecule,Protein ,antagonist,,,CXCR2,cxcr2_human,P25025,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,not established,1822,"sch-527123, ps-291822, ps-938285, navarixin",chronic obstructive pulmonary disease (COPD),2,2009,discontinued,in trial,-,
908,alx- 0651,antibody,Protein ,antagonist,biparatopic nanobody,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAmay2016_0267,"alx- 0651, biparatopic nanobody",Antineoplastic,1,2011,Terminated,in trial,-,
909,amd-070,small molecule,Protein ,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,150,amd-070,antiviral ; HIV,2,2004,discontinued,in trial,-,
910,bl-8040,peptide,Protein ,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,APR13_0001,bl-8040,Antineoplastic,2,2016,recruiting,in trial,-,"discontinued for sole intervention, now in combination trials"
911,bms 936564,antibody,Protein ,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,369,"bms 936564, mdx-1338",Antineoplastic,2,2016,Ongoing,in trial,-,"discontinued for sole intervention, now in combination trials"
912,ctce-9908,protein,Protein ,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,2376,ctce-9908,Antineoplastic,2,2007,discontinued,in trial,-,
913,jvs-100,dna plasmid,Protein ,agonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1056,jvs-100,cardioprotectant,2,2015,recruiting,in trial,-,
914,msx-122,small molecule,Protein ,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1354,msx-122,Antineoplastic,1,2007,discontinued,in trial,-,
915,plerixafor,small molecule,Protein ,partial agonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,1342,mozobil,Antineoplastic,4,,-,approved,2008,
916,q-122,small molecule,Protein ,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAmar2016_0157,q-122,Anti-inflammatory ; hot flashes,1,2014,Completed,in trial,-,
917,tg-0054,small molecule,Protein ,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,2002,"tg-0054, Burixafor",adjuvant to stem cell transplantation,2,2014,Completed,in trial,-,
918,x4p-001,small molecule,Protein ,antagonist,,primary,CXCR4,cxcr4_human,P61073,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,MMAapril2016_0220,x4p-001,Antineoplastic ; renal cell carcinoma,3,2016,recruiting,in trial,-,
919,cinalukast,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,NRDD106,-,Anti-Asthmatic,1,2005,discontinued,in trial,-,
920,montelukast,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,1163,"loratadine + montelukast sodium,claritin + singulair",Anti-Asthmatic,3,2012,Completed,in trial,-,FDA rejected combination form
921,montelukast,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,1327,"montelukast sodium,singulair",Anti-Asthmatic,4,,-,approved,1998,
922,nedocromil,small molecule,Lipid ,not available,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,NRDD379,-,Anti-Allergic ; Anti-Asthmatic,4,,-,approved,1992,
923,pranlukast,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,NRDD451,-,Anti-Asthmatic,4,,-,approved,-,
924,zafirlukast,small molecule,Lipid ,antagonist,,primary,CYSLTR1,cltr1_human,Q9Y271,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,established,2235,"zafirlukast,accolate",Anti-Asthmatic,4,,-,approved,1996,
925,np2 enkephalin,viral gene delivery,Peptide ,agonist,,primary,DOR,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2421,np2 enkephalin,Analgesics,2,2011,discontinued,in trial,-,
926,acepromazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_383,acepromazine,Antipsychotic,4,,-,approved,-,
927,acetophenazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD006,-,schizophrenia,4,,-,approved,1961,
928,amoxapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_200,amoxapine,unipolar depression,4,,-,approved,1980,
929,asenapine,small molecule,Aminergic ,antagonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
930,carphenazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD082,-,schizophrenia,4,,-,approved,1982,
931,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,
932,clozapine,small molecule,Aminergic ,antagonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
933,ecopipam,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,686,ecopipam,Speech and language disorders,3,2016,recruiting,in trial,-,
934,ergoloid,small molecule,Aminergic ,agonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_198,ergoloid,cardiovascular disease,4,,-,approved,1953,
935,etilevodopa,small molecule,Aminergic ,agonist,,,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,749,"etilevodopa, tv-1203",Antiparkinson,3,2003,discontinued,in trial,-,
936,fenoldopam,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,778,"fenoldopam mesylate, skf-82526,corlopam",Antihypertensive,4,,-,approved,1997,
937,flupenthixol,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD240,-,schizophrenia,3,2015,recruiting,in trial,-,"Never approved by fda, clinical trials in Europe in 2005"
938,flupentixol,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_381,flupentixol,Antipsychotic,4,,-,approved,1965,
939,fluphenazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD241,-,schizophrenia,4,,-,approved,1959,
940,iloperidone,small molecule,Aminergic ,antagonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
941,levodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,646,dm-1992,Antiparkinson,2,2012,suspended,in trial,-,
942,levodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0102,"nd0612,  levodopa/carbidopa subcutaneous patch",Antiparkinson,3,2016,recruiting,in trial,-,
943,levodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,712,"entacapone/levodopa/carbidopa,stalevo",Antiparkinson,4,,-,approved,1993,
944,levodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1119,"levodopa + carbidopa,duodopa",Antiparkinson,4,,-,approved,2015,
945,lisuride,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD307,-,Antiparkinson,4,,-,approved,2011,
946,lu 02-750,unknown,Aminergic ,unknown,,,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1170,lu 02-750,Antiparkinson,1,2009,discontinued,in trial,-,
947,lu ae04621,unknown,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1175,lu ae04621,Antiparkinson,1,2016,Completed,in trial,-,
948,melevodopa,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2110,"v-1512, chf-1512,levomet complex, sirio",Antiparkinson,4,,-,approved,2000,
949,methylergonovine,small molecule,Aminergic ,partial agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD347,-,Abortifacient,4,,-,approved,1946,
950,minaprine,small molecule,Aminergic ,antagonist,,,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD368,-,Anti-depressant,4,,withdrawn,approved,1984,Not approved by fda - but used
951,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
952,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
953,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0195,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
954,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
955,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
956,pergolide,small molecule,Aminergic ,agonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD422,-,Antiparkinson,4,,-,approved,1988,
957,perphenazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD425,-,schizophrenia,4,,-,approved,1957,
958,pimozide,small molecule,Aminergic ,antagonist,,secondary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_199,pimozide,psychosis,4,,-,approved,1984,
959,pipotiazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_382,pipotiazine,Antipsychotic,4,,-,approved,1980,
960,promazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
961,propiomazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
962,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,
963,thioridazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD521,-,schizophrenia,4,,-,approved,1962,
964,triflupromazine,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD542,-,Antiemetics; Antipsychotic,4,,-,approved,1957,
965,xp21279,small molecule,Aminergic ,agonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2223,xp21279,Antiparkinson,2,2010,Completed,in trial,-,
966,zuclopenthixol,small molecule,Aminergic ,antagonist,,primary,DRD1,drd1_human,P21728,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD567,-,schizophrenia,4,,-,approved,1962,
967,acepromazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_387,acepromazine,Antipsychotic,4,,-,approved,-,
968,acetophenazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD006,-,schizophrenia,4,,-,approved,1961,
969,acp-104,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,47,acp-104,schizophrenia,2,2007,discontinued,in trial,-,The D2 and D3 partial agonism creates less side effects - different from typical anti-psychotics
970,am-831,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0048,am-831,Antipsychotic ; schizophrenia,1,2011,discontinued,in trial,-,
971,amantadine hcl,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0242,"ads-5102, amantadine hcl extended release",dyskinesias,4,,-,approved,1968,
972,amisulpride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,161,"amisulpride,solian",schizophrenia,1,1999,discontinued,in trial,-,Amulsipride is marketed in Europe for schizophrenia but not past Phase 1 trials in US
973,amisulpride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0704,"apd403, apd421",Antiemetics,3,2013,Completed,in trial,-,
974,amoxapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_64,amoxapine,unipolar depression,4,,-,approved,1980,
975,aplindore,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,203,"aplindore, dab-452",Antiparkinson ; restlegs legs syndrome,2,2008,discontinued,in trial,-,
976,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,206,"apomorphine hcl,uprima, ixense",erectile dysfunction,1,2005,discontinued,in trial,-,
977,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,976,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2012,discontinued,in trial,-,
978,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1009,intranasal apomorphine,sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2006,Completed,in trial,-,
979,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,207,"apomorphine hydrochloride,apokyn, apo-go",anti-parkisonian,4,,-,approved,2004,
980,aripiprazole,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,22,abilify,schizophrenia,4,,-,approved,2002,
981,aripiprazole,unknown,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_58,"aripiprazole lauroxil, alks 9070",psychosis,4,,-,approved,2015,
982,asenapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
983,ati-9242,small molecule,Aminergic ,not available,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2423,ati-9242,schizophrenia,1,2016,Ongoing,in trial,-,
984,benperidol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_384,benperidol,Antipsychotic,4,,-,approved,2006,
985,bifeprunox,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,
986,bim23a760,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,358,bim23a760,Antineoplastic ; treatment for acromegaly,2,2009,discontinued,in trial,-,
987,bl-1020,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2424,bl-1020,schizophrenia,3,2011,Terminated,in trial,-,
988,brexpiprazole,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1502,brexpiprazole,Anti-depressant,4,,-,approved,2015,
989,bromocriptine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,389,"bromocriptine mesylate,cycloset, ergoset",Antidiabetic,4,,-,approved,1978,
990,bromopride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_366,bromopride,Antiemetics,4,,-,approved,-,
991,buspirone,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD066,-,Anti-anxiety,4,,-,approved,1986,
992,cabergoline,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD071,-,Antiparkinson,4,,-,approved,1996,
993,cariprazine,small molecule,Aminergic ,partial agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,433,"cariprazine, rgh-188",schizophrenia,4,,-,approved,2015,
994,carphenazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD082,-,schizophrenia,4,,-,approved,1982,
995,chlorpromazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_59,chlorpromazine,psychosis,4,,-,approved,1957,
996,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,
997,clozapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
998,dexpramipexole,small molecule,Aminergic ,agonist,,,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,627,"dexpramipexole, kns-760704",amyotrophic lateral sclerosis (ALS),3,2012,Terminated,in trial,-,Did not meet its primary efficacy endpoint
999,domperidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD184,-,Antiemetics,2,2015,recruiting,in trial,-,
1000,droperidol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD191,-,Adjuvants; Anesthesia,4,,-,approved,1970,
1001,ergoloid,small molecule,Aminergic ,agonist,,secondary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_60,ergoloid,cardiovascular disease,4,,-,approved,1953,
1002,etilevodopa,small molecule,Aminergic ,agonist,,,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,749,"etilevodopa, tv-1203",Antiparkinson,3,2003,discontinued,in trial,-,
1003,flupenthixol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD240,-,schizophrenia,3,2015,recruiting,in trial,-,"Never approved by fda, clinical trials in 1989"
1004,flupentixol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_385,flupentixol,Antipsychotic,4,,-,approved,1965,
1005,fluphenazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD241,-,schizophrenia,4,,-,approved,1959,
1006,fluphenazine decanoate,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_61,fluphenazine decanoate,psychosis,4,,-,approved,1972,
1007,fluphenazine enanthate,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_66,fluphenazine enanthate,psychosis,4,,-,approved,1967,
1008,fluspirilene,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD244,-,schizophrenia,4,,-,approved,1977,
1009,haloperidol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD266,-,schizophrenia,4,,-,approved,1967,
1010,haloperidol decanoate,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_65,haloperidol decanoate,psychosis,4,,-,approved,1986,
1011,iloperidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1012,iti-007,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1048,"iti-007, iti-722",schizophrenia,3,2016,recruiting,in trial,-,
1013,itopride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1049,"itopride,itax",motilitant,3,2012,Completed,in trial,-,Not approved yet by FDA
1014,jnj-37822681,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1054,jnj-37822681,schizophrenia,2,2013,Completed,in trial,-,
1015,levodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,646,dm-1992,Antiparkinson,2,2012,suspended,in trial,-,
1016,levodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0101,"nd0612,  levodopa/carbidopa subcutaneous patch",Antiparkinson,3,2016,recruiting,in trial,-,
1017,levodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,712,"entacapone/levodopa/carbidopa,stalevo",Antiparkinson,4,,-,approved,1993,
1018,levodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1119,"levodopa + carbidopa,duodopa",Antiparkinson,4,,-,approved,2015,
1019,levomepromazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_63,levomepromazine,psychosis,4,,-,approved,1982,Approved prior to 1982 and then discontinued
1020,lisuride,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD307,-,Antiparkinson,4,,-,approved,2011,
1021,loxapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,304,az-004,schizophrenia,4,,-,approved,1975,
1022,lu 02-750,unknown,Aminergic ,unknown,,,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1170,lu 02-750,Antiparkinson,1,2009,discontinued,in trial,-,
1023,lu ae04621,unknown,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1175,lu ae04621,Antiparkinson,1,2016,Completed,in trial,-,
1024,lurasidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAapril2016_0234,"cyclurad, d-cycloserine + lurasidone",schizophrenia,4,,-,approved,2010,
1025,lurasidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1184,"lurasidone, sm-13496,latuda",schizophrenia,4,,-,approved,2010,
1026,melevodopa,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2110,"v-1512, chf-1512,levomet complex, sirio",Antiparkinson,4,,-,approved,2000,
1027,mesoridazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD331,-,schizophrenia,4,,-,approved,1970,
1028,metoclopramide,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1355,mt 100,Anti-migraine,3,2005,Completed,in trial,-,"received not approved letter from FDA in 2005, but mt-400 was approved"
1029,metoclopramide,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,758,evk-001,diabetic gastroparesis,3,2016,Completed,in trial,-,
1030,metoclopramide,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1269,"metoclopramide,emitasol, pramidin",Antiemetics,4,,-,approved,1979,
1031,metoclopramide,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1268,"metoclopramide hcl,metzoliv odt",motilitant; gastroesophageal reflux disease,4,,-,approved,1979,
1032,minaprine,small molecule,Aminergic ,antagonist,,,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD368,-,Anti-depressant,4,,withdrawn,approved,1984,Not approved by fda - but used
1033,molindone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2425,"spn810 ,zalvari",ADHD,3,2016,recruiting,in trial,-,
1034,molindone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD372,-,schizophrenia,4,,-,approved,1974,
1035,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
1036,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1037,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0191,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1038,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
1039,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
1040,ordopidine,small molecule,Aminergic ,not available,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2422,acr325,Antiparkinson,1,2009,Completed,in trial,-,mode of action termed a 'dopamine stabilizer'
1041,paliperidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1558,"paliperidone er, paliperidone palmitate",schizophrenia,4,,-,approved,2006,
1042,pardoprunox,small molecule,Aminergic ,agonist,,,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,
1043,pergolide,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD422,-,Antiparkinson,4,,-,approved,1988,
1044,perphenazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD425,-,schizophrenia,4,,-,approved,1957,
1045,pimozide,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD443,-,Antidyskinetics; Antipsychotic,4,,-,approved,1984,
1046,pipotiazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_386,pipotiazine,Antipsychotic,4,,-,approved,1980,
1047,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmar2016_0004,p2b001,Antiparkinson,3,2016,Ongoing,in trial,-,
1048,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1293,mirapex,Antiparkinson,4,,-,approved,1997,
1049,pridopidine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1647,"pridopidine, acr-16,huntexil",Huntington's disease,3,2008,Completed,in trial,-,Needs another Phase 3 trial before FDA considers approval
1050,prochlorperazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,301,"az-001, staccato prochlorperazine",Anti-migraine,2,2016,recruiting,in trial,-,
1051,prochlorperazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,395,"buccal prochlorperazine maleate,emezine",Antiemetics,4,,-,approved,1956,
1052,promazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
1053,propiomazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
1054,quetiapine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1840,seroquel,Antipsychotic ; Anti-depressant,4,,-,approved,1997,
1055,remoxipride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD479,-,schizophrenia,4,,-,approved,1990,Withdrawn 
1056,risperidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD484,-,schizophrenia,4,,-,approved,1993,
1057,risperidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1770,risperdal,schizophrenia,4,,-,approved,1993,
1058,ropinirole,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1057,jzp-7,restless legs syndrome,1,2008,discontinued,in trial,-,
1059,ropinirole,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1737,ropinirole,Antiparkinson,4,,-,approved,1997,
1060,rotigotine,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1404,neupro,Antiparkinson,4,,-,approved,2006,
1061,sertindole,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
1062,sulpiride,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD504,-,Antidepressive ; Second-Generation; Antipsychotic,3,2016,recruiting,in trial,-,Not FDA approved but used in other countries
1063,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,
1064,thioproperazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_388,thioproperazine,Antipsychotic,4,,-,approved,1962,
1065,thioridazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD521,-,schizophrenia,4,,-,approved,1962,
1066,thiothixene,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_67,thiothixene,psychosis,4,,-,approved,1967,
1067,trifluoperazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD541,-,Antiemetics; Antipsychotic,4,,-,approved,1959,
1068,triflupromazine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD542,-,Antiemetics; Antipsychotic,4,,-,approved,1957,
1069,trimipramine,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_62,trimipramine,unipolar depression,4,,-,approved,1979,
1070,xp21279,small molecule,Aminergic ,agonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2223,xp21279,Antiparkinson,2,2010,Completed,in trial,-,
1071,ykp-1358,unknown,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2226,"ykp-1358, Relenopride",schizophrenia,2,2008,Completed,in trial,-,Inferred dates
1072,ziprasidone,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2243,"ziprasidone hcl, ziprasidone mesylate,geodon, zeldox",schizophrenia,4,,-,approved,2001,
1073,zuclopenthixol,small molecule,Aminergic ,antagonist,,primary,DRD2,drd2_human,P14416,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD567,-,schizophrenia,4,,-,approved,1962,
1074,acp-104,small molecule,Aminergic ,partial agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,47,acp-104,schizophrenia,2,2007,discontinued,in trial,-,The D2 and D3 partial agonism creates less side effects - different from typical anti-psychotics
1075,amisulpride,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,161,"amisulpride,solian",schizophrenia,1,1999,discontinued,in trial,-,Amulsipride is marketed in Europe for schizophrenia but not past Phase 1 trials in US
1076,amisulpride,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0705,"apd403, apd421",Antiemetics,3,2013,Completed,in trial,-,
1077,amoxapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_210,amoxapine,unipolar depression,4,,-,approved,1980,
1078,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,206,"apomorphine hcl,uprima, ixense",erectile dysfunction,1,2005,discontinued,in trial,-,
1079,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,976,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2012,discontinued,in trial,-,
1080,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1009,intranasal apomorphine,sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2006,Completed,in trial,-,
1081,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,207,"apomorphine hydrochloride,apokyn, apo-go",anti-parkisonian,4,,-,approved,2004,
1082,asenapine,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
1083,bifeprunox,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,
1084,bromocriptine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,389,"bromocriptine mesylate,cycloset, ergoset",Antidiabetic,4,,-,approved,1978,
1085,captodiame,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_399,captodiame,anxiolytic,4,,-,approved,-,
1086,cariprazine,small molecule,Aminergic ,partial agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,433,"cariprazine, rgh-188",schizophrenia,4,,-,approved,2015,
1087,chlorpromazine,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_204,chlorpromazine,psychosis,4,,-,approved,1957,
1088,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,
1089,cocaine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD123,-,local anesthetic,4,,-,approved,1982,
1090,dexpramipexole,small molecule,Aminergic ,agonist,,,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,627,"dexpramipexole, kns-760704",amyotrophic lateral sclerosis (ALS),3,2012,Terminated,in trial,-,Did not meet its primary efficacy endpoint
1091,droperidol,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_201,droperidol,vomiting,4,,-,approved,1970,
1092,ergoloid,small molecule,Aminergic ,agonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_206,ergoloid,cardiovascular disease,4,,-,approved,1953,
1093,etilevodopa,small molecule,Aminergic ,agonist,,,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,749,"etilevodopa, tv-1203",Antiparkinson,3,2003,discontinued,in trial,-,
1094,haloperidol,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_202,haloperidol,gastroparesis,4,,-,approved,1967,
1095,haloperidol decanoate,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_212,haloperidol decanoate,psychosis,4,,-,approved,1986,
1096,iloperidone,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1097,levodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,646,dm-1992,Antiparkinson,2,2012,suspended,in trial,-,
1098,levodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0105,"nd0612,  levodopa/carbidopa subcutaneous patch",Antiparkinson,3,2016,recruiting,in trial,-,
1099,levodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,712,"entacapone/levodopa/carbidopa,stalevo",Antiparkinson,4,,-,approved,1993,
1100,levodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1119,"levodopa + carbidopa,duodopa",Antiparkinson,4,,-,approved,2015,
1101,levomepromazine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_213,levomepromazine,psychosis,4,,-,approved,1982,Approved prior to 1982 and then discontinued
1102,levomepromazine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
1103,loxapine,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_207,loxapine,psychosis,4,,-,approved,1975,
1104,lu 02-750,unknown,Aminergic ,unknown,,,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1170,lu 02-750,Antiparkinson,1,2009,discontinued,in trial,-,
1105,lu ae04621,unknown,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1175,lu ae04621,Antiparkinson,1,2016,Completed,in trial,-,
1106,melevodopa,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2110,"v-1512, chf-1512,levomet complex, sirio",Antiparkinson,4,,-,approved,2000,
1107,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
1108,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1109,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0207,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1110,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
1111,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
1112,pardoprunox,small molecule,Aminergic ,agonist,,,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,
1113,pergolide,small molecule,Aminergic ,agonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_209,pergolide,Antiparkinson,4,,-,approved,1988,
1114,pimozide,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_211,pimozide,psychosis,4,,-,approved,1984,
1115,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmar2016_0006,p2b001,Antiparkinson,3,2016,Ongoing,in trial,-,
1116,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1293,mirapex,Antiparkinson,4,,-,approved,1997,
1117,promazine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_208,promazine,psychosis,4,,-,approved,1956,
1118,ropinirole,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1057,jzp-7,restless legs syndrome,1,2008,discontinued,in trial,-,
1119,ropinirole,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1737,ropinirole,Antiparkinson,4,,-,approved,1997,
1120,rotigotine,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1404,neupro,Antiparkinson,4,,-,approved,2006,
1121,sb-269652,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMA_2017_002,sb-269652,antipsychotic,0,2000,Unknown,in trial,-,
1122,thioridazine,small molecule,Aminergic ,antagonist,,secondary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_205,thioridazine,psychosis,4,,-,approved,1962,
1123,trifluoperazine,small molecule,Aminergic ,antagonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_203,trifluoperazine,psychosis,4,,-,approved,1959,
1124,xp21279,small molecule,Aminergic ,agonist,,primary,DRD3,drd3_human,P35462,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2223,xp21279,Antiparkinson,2,2010,Completed,in trial,-,
1125,amoxapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_221,amoxapine,unipolar depression,4,,-,approved,1980,
1126,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,206,"apomorphine hcl,uprima, ixense",erectile dysfunction,1,2005,discontinued,in trial,-,
1127,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,976,"inhaled apomorphine hydrochloride, vr004, vr-040, vr-400",sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2012,discontinued,in trial,-,
1128,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1009,intranasal apomorphine,sexual dysfunction in women; erectile dysfunction; Antiparkinson,2,2006,Completed,in trial,-,
1129,apomorphine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,207,"apomorphine hydrochloride,apokyn, apo-go",anti-parkisonian,4,,-,approved,2004,
1130,asenapine,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
1131,bromocriptine,small molecule,Aminergic ,agonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_216,bromocriptine,growth hormone excess,4,,-,approved,1978,
1132,chlorpromazine,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_220,chlorpromazine,psychosis,4,,-,approved,1957,
1133,clozapine,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
1134,dexpramipexole,small molecule,Aminergic ,agonist,,,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,627,"dexpramipexole, kns-760704",amyotrophic lateral sclerosis (ALS),3,2012,Terminated,in trial,-,Did not meet its primary efficacy endpoint
1135,droperidol,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_224,droperidol,psychosis,4,,-,approved,1970,
1136,ergoloid,small molecule,Aminergic ,agonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_215,ergoloid,cardiovascular disease,4,,-,approved,1953,
1137,etilevodopa,small molecule,Aminergic ,agonist,,,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,749,"etilevodopa, tv-1203",Antiparkinson,3,2003,discontinued,in trial,-,
1138,haloperidol,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_214,haloperidol,schizophrenia,4,,-,approved,1967,
1139,haloperidol decanoate,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_227,haloperidol decanoate,psychosis,4,,-,approved,1986,
1140,levodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,646,dm-1992,Antiparkinson,2,2012,suspended,in trial,-,
1141,levodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0103,"nd0612,  levodopa/carbidopa subcutaneous patch",Antiparkinson,3,2016,recruiting,in trial,-,
1142,levodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,712,"entacapone/levodopa/carbidopa,stalevo",Antiparkinson,4,,-,approved,1993,
1143,levodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1119,"levodopa + carbidopa,duodopa",Antiparkinson,4,,-,approved,2015,
1144,levomepromazine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_225,levomepromazine,psychosis,4,,-,approved,1982,Approved prior to 1982 and then discontinued
1145,loxapine,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_223,loxapine,psychosis,4,,-,approved,1975,
1146,lu 02-750,unknown,Aminergic ,unknown,,,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1170,lu 02-750,Antiparkinson,1,2009,discontinued,in trial,-,
1147,lu ae04621,unknown,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1175,lu ae04621,Antiparkinson,1,2016,Completed,in trial,-,
1148,melevodopa,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2110,"v-1512, chf-1512,levomet complex, sirio",Antiparkinson,4,,-,approved,2000,
1149,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
1150,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1151,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0196,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1152,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
1153,olanzapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
1154,pardoprunox,small molecule,Aminergic ,agonist,,,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,
1155,pergolide,small molecule,Aminergic ,agonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_226,pergolide,Antiparkinson,4,,-,approved,1988,
1156,pimozide,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_222,pimozide,psychosis,4,,-,approved,1984,
1157,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmar2016_0005,p2b001,Antiparkinson,3,2016,Ongoing,in trial,-,
1158,pramipexole,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1293,mirapex,Antiparkinson,4,,-,approved,1997,
1159,promazine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
1160,propiomazine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
1161,ropinirole,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_218,ropinirole,Antiparkinson,4,,-,approved,1997,
1162,rotigotine,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1404,neupro,Antiparkinson,4,,-,approved,2006,
1163,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,
1164,thioridazine,small molecule,Aminergic ,antagonist,,secondary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_219,thioridazine,psychosis,4,,-,approved,1962,
1165,trifluoperazine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_217,trifluoperazine,psychosis,4,,-,approved,1959,
1166,xp21279,small molecule,Aminergic ,agonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2223,xp21279,Antiparkinson,2,2010,Completed,in trial,-,
1167,zicronapine,small molecule,Aminergic ,antagonist,,primary,DRD4,drd4_human,P21917,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1176,lu-31130,schizophrenia,3,2011,Completed,in trial,-,No development reported
1168,amoxapine,small molecule,Aminergic ,antagonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_228,amoxapine,unipolar depression,4,,-,approved,1980,
1169,carphenazine,small molecule,Aminergic ,antagonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD082,-,schizophrenia,4,,-,approved,1982,
1170,ergoloid,small molecule,Aminergic ,agonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_229,ergoloid,cardiovascular disease,4,,-,approved,1953,
1171,etilevodopa,small molecule,Aminergic ,agonist,,,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,749,"etilevodopa, tv-1203",Antiparkinson,3,2003,discontinued,in trial,-,
1172,fenoldopam,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,778,"fenoldopam mesylate, skf-82526,corlopam",Antihypertensive,4,,-,approved,1997,
1173,levodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,646,dm-1992,Antiparkinson,2,2012,suspended,in trial,-,
1174,levodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0104,"nd0612,  levodopa/carbidopa subcutaneous patch",Antiparkinson,3,2016,recruiting,in trial,-,
1175,levodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,712,"entacapone/levodopa/carbidopa,stalevo",Antiparkinson,4,,-,approved,1993,
1176,levodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1119,"levodopa + carbidopa,duodopa",Antiparkinson,4,,-,approved,2015,
1177,lu 02-750,unknown,Aminergic ,unknown,,,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1170,lu 02-750,Antiparkinson,1,2009,discontinued,in trial,-,
1178,lu ae04621,unknown,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1175,lu ae04621,Antiparkinson,1,2016,Completed,in trial,-,
1179,melevodopa,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2110,"v-1512, chf-1512,levomet complex, sirio",Antiparkinson,4,,-,approved,2000,
1180,olanzapine,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
1181,olanzapine,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1182,olanzapine,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,MMAmay2016_0197,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1183,olanzapine,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
1184,olanzapine,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
1185,pergolide,small molecule,Aminergic ,agonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_231,pergolide,Antiparkinson,4,,-,approved,1988,
1186,pimozide,small molecule,Aminergic ,antagonist,,secondary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Sep2016_230,pimozide,psychosis,4,,-,approved,1984,
1187,xp21279,small molecule,Aminergic ,agonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,2223,xp21279,Antiparkinson,2,2010,Completed,in trial,-,
1188,zuclopenthixol,small molecule,Aminergic ,antagonist,,primary,DRD5,drd5_human,P21918,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,NRDD567,-,schizophrenia,4,,-,approved,1962,
1189,ambrisentan,small molecule,Peptide ,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1111,letairis,Antihypertensive,4,,-,approved,2007,
1190,atrasentan,small molecule,Peptide ,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,270,"atrasentan, abt-627,xinlay",Antineoplastic,3,2005,discontinued,in trial,-,discontinued for this indication
1191,atrasentan,small molecule,Peptide ,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,270,Atrasentan,Diabetic nephropathy,3,2013,recruiting,in trial,-,Added entry because Indication so different
1192,avosentan,small molecule,Peptide ,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,295,"avosentan, spp 301",Diabetic nephropathy,3,2005,Terminated,in trial,-,
1193,bosentan,small molecule,Peptide ,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,2053,tracleer,Antihypertensive,4,,-,approved,2001,
1194,clazosentan,small molecule,Peptide ,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,495,"clazosentan, axv-343434,pivlaz",vasospasm,2,2015,recruiting,in trial,-,
1195,darusentan,small molecule,Peptide ,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,599,darusentan,Antihypertensive,3,2006,discontinued,in trial,-,
1196,macitentan,small molecule,Peptide ,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1209,"macitentan , act-064992",cardiovascular disease,4,,-,approved,2013,
1197,ps433540,small molecule,Peptide ,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1673,ps433540,"Focal segmental glomerulosclerosis, Antihypertensive",2,2012,recruiting,in trial,-,
1198,re-021,small molecule,Peptide ,antagonist,sparsentan,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,MMAapril2016_0045,"re-021, sparsentan",kidney disease; nephropathy,2,2012,Completed,in trial,-,
1199,sitaxentan,small molecule,Peptide ,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Oct2016_368,sitaxentan,Antihypertensive,4,,-,approved,2006,copy and conflicting subfamily
1200,sitaxentan,small molecule,Peptide ,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,2010,"thelin, sitaxentan",Antihypertensive,4,,-,approved,2006,copy and conflicting subfamily
1201,spi-1620,peptide,Peptide ,agonist,,,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1892,spi-1620,adjuvant to chemotherapy,2,2013,discontinued,in trial,-,Appears to not meet efficacy end point
1202,tezosentan,small molecule,Peptide ,antagonist,,,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Sep2016_251,tezosentan,heart failure,3,2006,discontinued,in trial,-,
1203,ym-598,small molecule,Peptide ,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,2230,ym-598,Antineoplastic,2,2002,discontinued,in trial,-,
1204,zibotentan,small molecule,Peptide ,antagonist,,primary,EDNRA,ednra_human,P25101,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,2241,"zibotentan, zd-4054, azd-4054",Antineoplastic,3,2008,discontinued,in trial,-,discontinued because early efficacy review by the Independent Data Monitoring Committee indicated it was unlikely to meet its primary efficacy endpoints
1205,ambrisentan,small molecule,Peptide ,antagonist,,secondary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1111,letairis,Antihypertensive,4,,-,approved,2007,
1206,bosentan,small molecule,Peptide ,antagonist,,primary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,2053,tracleer,Antihypertensive,4,,-,approved,2001,
1207,darusentan,small molecule,Peptide ,antagonist,,secondary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Sep2016_253,darusentan,Antihypertensive,3,2006,discontinued,in trial,-,
1208,macitentan,small molecule,Peptide ,antagonist,,primary,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1210,"macitentan, act-064992",cardiovascular disease,4,,-,approved,2013,
1209,spi-1620,peptide,Peptide ,agonist,,,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,1892,spi-1620,adjuvant to chemotherapy,2,2013,discontinued,in trial,-,
1210,tezosentan,small molecule,Peptide ,antagonist,,,EDNRB,ednrb_human,P24530,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Sep2016_252,tezosentan,heart failure,3,2006,discontinued,in trial,-,
1211,atopaxar,small molecule,Peptide ,antagonist,,primary,F2R,par1_human,P25116,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,ASH_Sep2016_282,atopaxar,acute coronary syndrome,2,2007,discontinued,in trial,-,
1212,rusalatide,peptide,Peptide ,agonist,,,F2R,par1_human,P25116,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2048,"tp-508,chrysalin",diabetic foot ulcers,3,2005,discontinued,in trial,-,
1213,vorapaxar,small molecule,Peptide ,antagonist,,primary,F2R,par1_human,P25116,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2175,"vorapaxar , sch-530348",cardiovascular disease,4,,-,approved,2014,
1214,rusalatide,peptide,Peptide ,agonist,,,F2RL2,par3_human,O00254,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2048,"tp-508,chrysalin",diabetic foot ulcers,3,2005,discontinued,in trial,-,
1215,vorapaxar,small molecule,Peptide ,antagonist,,secondary,F2RL2,par3_human,O00254,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2175,"vorapaxar , sch-530348",cardiovascular disease,4,,-,approved,2014,
1216,rusalatide,peptide,Peptide ,agonist,,,F2RL3,par4_human,Q96RI0,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2048,"tp-508,chrysalin",diabetic foot ulcers,3,2005,discontinued,in trial,-,
1217,vorapaxar,small molecule,Peptide ,antagonist,,secondary,F2RL3,par4_human,Q96RI0,Class A (Rhodopsin),GPCR;Rhodopsin,Proteinase-activated receptors,established,2175,"vorapaxar , sch-530348",cardiovascular disease,4,,-,approved,2014,
1218,tak-875,small molecule,Lipid ,agonist,fasiglifam,primary,FFAR1,ffar1_human,O14842,Class A (Rhodopsin),GPCR;Rhodopsin,Free fatty acid receptors,not established,MMAmay2016_0580,"tak-875, fasiglifam",Antidiabetic,3,2013,discontinued,in trial,-,discontinued due to concerns about liver safety
1219,glpg0974,small molecule,Lipid ,antagonist,,primary,FFAR2,ffar2_human,O15552,Class A (Rhodopsin),GPCR;Rhodopsin,Free fatty acid receptors,not established,MMAmay2016_0156,glpg0974,Anti-inflammatory ; neutrophil driven inflammation; ulcerative colitis,2,2013,Completed,in trial,-,
1220,chorionic gonadotropin,protein,Protein ,agonist,,secondary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD099,-,Fertility,4,,-,approved,1973,
1221,corifollitropin alfa,protein,Protein ,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,526,"corifollitropin alfa,elonva",Fertility,3,2015,recruiting,in trial,-,
1222,follitropin,protein,Protein ,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD246,-,Fertility,4,,-,approved,1997,
1223,follitropin,protein,Protein ,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,MMAmay2016_0738,"bemfola, afolia recombinant follicle stimulating hormone",Fertility,4,,-,approved,1997,
1224,follitropin,protein,Protein ,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,814,"follitropin alpha ,gonal-f",Fertility,4,,-,approved,1997,
1225,fsh-gex,protein,Protein ,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,825,fsh-gex,Fertility,2,2013,Completed,in trial,-,
1226,menotropins,protein,Protein ,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD322,-,Fertility,4,,-,approved,1975,
1227,urofollitropin,protein,Protein ,agonist,,primary,FSHR,fshr_human,P23945,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD554,-,Fertility,4,,-,approved,1986,
1228,omp-18r5,antibody,Protein ,antagonist,,primary,FZD7,fzd7_human,O75084,Class F (Frizzled),GPCR;Frizzled,Frizzled,not established,2457,omp-18r5,Antineoplastic,1,2013,Ongoing,in trial,-,
1229,adx71441,small molecule,Amino acid ,PAM,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0243,adx71441,neurologic disorders,0,2017,Not open yet,in trial,-,
1230,arbaclofen,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,2222,"xp19986, arbaclofen",gastrointestinal reflux disease,2,2009,discontinued,in trial,-,
1231,arbaclofen,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,216,arbaclofen,Fragile X syndrome,3,2011,Completed,in trial,-,
1232,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,115,"alks 29, Baclofen/samidorphan",alcohol dependance,1,2008,discontinued,in trial,-,
1233,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0072,"pxt3003, baclofen + naltrexone + sorbitol",for type 1A Charcot-Marie-Tooth disease,3,2016,recruiting,in trial,-,
1234,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2017_001,baclofen,anti-spastic,4,,-,approved,1977,
1235,deuterium containing analog of sodium oxybate,small molecule,Amino acid ,agonist,gamma hydroxybutyric acid,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0773,jzp-386,sleep disorders; narcolepsy,1,2014,Completed,in trial,-,
1236,gamma hydroxybutyric acid,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,1871,sodium oxybate,Hypnotics and Sedatives,4,,-,approved,2002,
1237,lesogaberan,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,1108,"lesogaberan, azd-3355",gastrointestinal reflux disease,2,2016,Ongoing,in trial,-,Had been discontinued since 2009 - new trial in 2016
1238,progabide,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,NRDD461,-,Anticonvulsants,4,,-,approved,-,Not FDA approved but used in other countries
1239,vigabatrin,small molecule,Amino acid ,agonist,,primary,GABBR1,gabr1_human,Q9UBS5,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,2159,"vigabatrin is a selective, irreversible enzyme-activated gaba transaminase inhibitor. gaba (gamma-aminobutyric acid) is a n/",addiction,4,,-,approved,2009,
1240,adx71441,small molecule,Amino acid ,PAM,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0244,adx71441,neurologic disorders,0,2017,Not open yet,in trial,-,
1241,arbaclofen,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,2222,"xp19986, arbaclofen",gastrointestinal reflux disease,2,2009,discontinued,in trial,-,
1242,arbaclofen,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,216,arbaclofen,Fragile X syndrome,3,2011,Completed,in trial,-,
1243,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,115,"alks 29, Baclofen/samidorphan",alcohol dependance,1,2008,discontinued,in trial,-,
1244,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0071,"pxt3003, baclofen + naltrexone + sorbitol",for type 1A Charcot-Marie-Tooth disease,3,2016,recruiting,in trial,-,
1245,baclofen,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2017_001,baclofen,anti-spastic,4,,-,approved,1977,
1246,deuterium containing analog of sodium oxybate,small molecule,Amino acid ,agonist,gamma hydroxybutyric acid,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,MMAmay2016_0771,jzp-386,sleep disorders; narcolepsy,1,2014,Completed,in trial,-,
1247,gamma hydroxybutyric acid,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,1871,sodium oxybate,Hypnotics and Sedatives,4,,-,approved,2002,
1248,lesogaberan,small molecule,Amino acid ,agonist,,primary,GABBR2,gabr2_human,O75899,Class C (Glutamate) ,GPCR;Glutamate,GABAB receptors,established,1108,"lesogaberan, azd-3355",gastrointestinal reflux disease,2,2016,Ongoing,in trial,-,Had been discontinued since 2009 - new trial in 2016
1249,glucagon,peptide,Peptide ,agonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmar2016_0239,zp-glucagon,Antidiabetic,4,,-,approved,1960,
1250,glucagon,peptide,Peptide ,agonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,NRDD256,-,Antihypoglycemic,4,,-,approved,1960,
1251,glucagon,peptide,Peptide ,agonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2458,dio-901,for prevention of hypoglycemia,4,,-,approved,1960,
1252,glucagon,protein,Peptide ,agonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,ASH_Sep2016_334,glucagon hydrochloride recombinant,hypoglycemia,4,,-,approved,1998,
1253,isis 325568,antisense oligo,Peptide ,antagonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1030,isis 325568,Antidiabetic,1,2007,discontinued,in trial,-,
1254,lgd-6972,small molecule,Peptide ,antagonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0453,lgd-6972,Antidiabetic,2,2016,recruiting,in trial,-,
1255,mk-0893,small molecule,Peptide ,antagonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,ASH_Sep2016_333,mk-0893,Antidiabetic,2,2013,discontinued,in trial,-,
1256,mod-6031,peptide,Peptide ,agonist,long-acting oxyntomodulin,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0899,"mod-6031, long-acting oxyntomodulin",Antidiabetic ; Anti-obesity,1,2016,recruiting,in trial,-,
1257,remd-477,antibody,Peptide ,antagonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAapril2016_0214,remd-477,Antidiabetic,2,2017,recruiting,in trial,-,
1258,tt-401,peptide,Peptide ,agonist,,primary,GCGR,glr_human,P47871,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0612,"tt-401, Pegapamodutide, LY2944876",Antidiabetic,2,2014,Completed,in trial,-,
1259,akl-0707,small molecule,Peptide ,agonist,,primary,GHRH,ghrhr_human,Q02643,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,96,"akl-0707, ghrh analog",hormone replacement,2,2013,discontinued,in trial,-,
1260,dac:grf,peptide,Peptide ,agonist,,primary,GHRHR,ghrhr_human,Q02643,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,591,dac:grf,hormone replacement,2,2007,discontinued,in trial,-,
1261,sermorelin,peptide,Peptide ,agonist,,primary,GHRHR,ghrhr_human,Q02643,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,NRDD494,-,Hormone Replacement,4,,-,approved,1990,
1262,tesamorelin,peptide,Peptide ,agonist,,primary,GHRHR,ghrhr_human,Q02643,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1987,tesamorelin,HIV-associated lipodystrophy,4,,-,approved,2010,
1263,anamorelin,small molecule,Peptide ,agonist,,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,175,"anamorelin, rc-1291",Appetite stimulant,3,2011,Completed,in trial,-,
1264,azp-531,peptide,Peptide ,agonist,unacylated ghrelin,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,MMAapril2016_0315,"azp-531, unacylated ghrelin",Antidiabetic,1,2014,Ongoing,in trial,-,
1265,gtp-200,peptide,Peptide ,agonist,,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,886,gtp-200,Appetite stimulant,2,2006,discontinued,in trial,-,
1266,macimorelin,peptide,Peptide ,agonist,aezs-130,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,MMAmay2016_0080,"macimorelin,  aezs-130","growth hormone deficiency, cancer cachexia",3,2015,Completed,in trial,-,Applied for fda approval in 2013 and rejected in 2014
1267,tzp-102,small molecule,Peptide ,agonist,,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,2096,tzp-102,gastroparesis,2,2012,Terminated,in trial,-,Clinical trial terminated due to Insufficient efficacy in planned interim futility analysis; no development reported on drug itself
1268,ulimorelin,small molecule,Peptide ,agonist,,primary,GHSR,ghsr_human,Q92847,Class A (Rhodopsin),GPCR;Rhodopsin,Ghrelin receptors,not established,2095,"tzp-101, Ulimorelin",gastroparesis,2,2016,Recruiting,in trial,-,
1269,mar701,peptide,Peptide ,agonist,,,GIPR,gipr_human,P48546,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,not established,1217,mar701,Antidiabetic,1,2011,discontinued,in trial,-,
1270,albiglutide,protein,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,101,"albiglutide, gsk716155,syncria",Antidiabetic,4,,-,approved,2014,
1271,dac:glp-1,peptide,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,590,"dac:glp-1, cjc-1131",Antidiabetic,2,2007,discontinued,in trial,-,
1272,dulaglutide,protein,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,ASH_Sep2016_332,dulaglutide,Antidiabetic,4,,-,approved,2014,
1273,efpeglenatide,peptide,Peptide ,agonist,hm11260c,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmar2016_0245,"efpeglenatide, hm11260c",Antidiabetic,2,2014,Completed,in trial,-,
1274,exenatide,peptide,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1046,itca 650,Antidiabetic,3,2017,Not open yet,in trial,-,
1275,exenatide,peptide,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,769,exenatide,Antidiabetic,4,,-,approved,2005,
1276,exendin (9-39) ,peptide,Peptide ,antagonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAjun2016_0019,exendin (9-39) ,hypoglycemia,2,2016,recruiting,in trial,-,Appears pause in research from 2009-2016
1277,exendin-4,peptide,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1572,pc-dac:exendin-4,Antidiabetic,4,,-,approved,2005,
1278,glp,peptide,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,699,eligen pyy-3-36 + glp-1,Appetite suppressant,2,2009,Completed,in trial,-,
1279,glp1 agonist ,unknown,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2155,viaderm-glp1 agonist,Antidiabetic,1,2010,Completed,in trial,-,
1280,gtp-010,protein,Peptide ,antagonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,885,gtp-010,irritable bowel syndrome,2,2008,discontinued,in trial,-,
1281,liraglutide,protein,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0808,"ideglira,  insulin degludec + liraglutide,  nn-9068",Antidiabetic,4,,-,approved,2009,
1282,liraglutide,protein,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1154,liraglutide,Antidiabetic,4,,-,approved,2009,
1283,liraglutide,peptide,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,NRDD305,-,Antidiabetic,4,,-,approved,2010,
1284,lixisenatide,small molecule,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmar2016_0257,"lixilan, lantus (basal insulin) + lyxumia (lixisenatide)",Antidiabetic,4,,-,approved,2016,
1285,mar701,peptide,Peptide ,agonist,,,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1217,mar701,Antidiabetic,1,2011,discontinued,in trial,-,
1286,mkc-253,protein,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1308,mkc-253,Antidiabetic,1,2008,discontinued,in trial,-,
1287,mod-6031,peptide,Peptide ,agonist,long-acting oxyntomodulin,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0898,"mod-6031, long-acting oxyntomodulin",Antidiabetic ; Anti-obesity,1,2016,recruiting,in trial,-,
1288,nn9924,protein,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1429,nn9924,Antidiabetic,3,2016,Ongoing,in trial,-,
1289,ormd-0901,peptide,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1519,"ormd-0901, oral glp-1 analog",Antidiabetic,1,2016,Completed,in trial,-,
1290,pb1023,protein,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1569,"pb1023, glp-1-elp-120,glymera",Antidiabetic,2,2012,Completed,in trial,-,
1291,semaglutide,peptide,Peptide ,agonist,nn9535,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0563,"semaglutide, nn9535 ",Antidiabetic,3,2017,recruiting,in trial,-,
1292,taspoglutide,protein,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1958,"taspoglutide, itm-077, r1583, bim-51077",Antidiabetic,3,2011,discontinued,in trial,-,discontinued due to adverse gastrointestinal reactions
1293,th0318,peptide,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2008,th0318,Antidiabetic,1,2004,discontinued,in trial,-,
1294,tt-223,injectible islet neogenesis therapy,Peptide ,agonist,,,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2092,tt-223,Antidiabetic; injectable islet neogenesis therapy for diabetes,2,2008,discontinued,in trial,-,
1295,tt-401,peptide,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0613,"tt-401, Pegapamodutide, LY2944876",Antidiabetic,2,2014,Completed,in trial,-,
1296,ttp054,small molecule,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmay2016_0113,ttp054,Antidiabetic,2,2012,discontinued,in trial,-,
1297,ttp273,small molecule,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,MMAmar2016_0255,ttp273,Antidiabetic,2,2016,Completed,in trial,-,
1298,vrs-859,peptide,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2182,"vrs-859, Exenatide-XTEN",Antidiabetic,1,2017,Ongoing,in trial,-,
1299,zyd1,peptide,Peptide ,agonist,,primary,GLP1R,glp1r_human,P43220,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2256,zyd1,Antidiabetic,1,2012,Completed,in trial,-,
1300,elsiglutide,peptide,Peptide ,agonist,,primary,GLP2R,glp2r_human,O95838,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2464,zp1846,Antidiuretic,2,2012,Completed,in trial,-,
1301,teduglutide,peptide,Peptide ,agonist,,primary,GLP2R,glp2r_human,O95838,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2463,teduglutide,short bowel syndrome,4,,-,approved,2012,
1302,zp1848,peptide,Peptide ,agonist,,primary,GLP2R,glp2r_human,O95838,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,2251,zp1848,Crohn's disease,2,2016,recruiting,in trial,-,
1303,abarelix,peptide,Peptide ,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,19,"abarelix, plenaxis",Antineoplastic,4,,-,approved,2003,
1304,buserelin,peptide,Alicarboxylic acid ,not available,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,ASH_Oct2016_426,buserelin,LHRH analogue,4,,-,approved,-,
1305,cetrorelix,peptide,Peptide ,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,472,"cetrorelix,cetrotide",Antineoplastic,4,,-,approved,2000,
1306,danazol,small molecule,Peptide ,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD139,-,Antiendometriosis ; Antineoplastic,4,,-,approved,1976,
1307,danazol,small molecule,Peptide ,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2297,optina,diabetic macular edema,4,,-,approved,1976,
1308,degarelix,small molecule,Peptide ,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,610,degarelix,Antineoplastic,4,,-,approved,2008,
1309,elagolix,small molecule,Peptide ,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Sep2016_257,elagolix,endometriosis,3,2016,recruiting,in trial,-,
1310,ep-100,peptide,Peptide ,not available,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,715,ep-100,Antineoplastic,2,2011,Completed,in trial,-,Seems like still investigating as of 2014 article
1311,ganirelix acetate,protein,Peptide ,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Sep2016_256,ganirelix acetate,Fertility,4,,-,approved,1999,
1312,ganirelix acetate,small molecule,Aminergic ,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_412,ganirelix,for prevention of premature ovulation in fertility treatment,4,,-,approved,1999,
1313,gonadorelin,small molecule,Peptide ,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD259,-,Fertility,4,,-,approved,1982,
1314,goserelin,protein,Peptide ,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Sep2016_255,goserelin,Antineoplastic,4,,-,approved,1989,
1315,histrelin,small molecule,Peptide ,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2177,"vp 002, histrelin implant,vantas, supprelin",Antineoplastic,4,,-,approved,1991,
1316,leuprolide,peptide,Peptide ,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1250,memryte,Alzheimer's disease,4,,-,approved,1985,
1317,leuprolide,peptide,Peptide ,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,697,eligard,Antineoplastic,4,,-,approved,1985,
1318,leuprolide,peptide,Peptide ,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1113,leuprolide,Antineoplastic ; endometriosis,4,,-,approved,1985,
1319,leuprolide,peptide,Peptide ,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1114,"leuprolide acetate, tap-144 sr",Antineoplastic ; endometriosis,4,,-,approved,1985,
1320,leuprolide,peptide,Peptide ,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1115,leupromaxx,Antineoplastic ; endometriosis,4,,-,approved,1985,
1321,luteinizing hormone-releasing hormone,peptide,Peptide ,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2097,"tztx-001,teverelix la",Antineoplastic,2,2005,Completed,in trial,-,"Seems to be planning Phase 3, but can't find recent dated information"
1322,nafarelin,small molecule,Peptide ,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD377,-,Antiendometriosis,4,,-,approved,1990,
1323,nbi-42902,small molecule,Peptide ,antagonist,,,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,869,"gnrh receptor antagonist, nbi-42902",postmenopausal symptoms; Antineoplastic,2,2005,discontinued,in trial,-,
1324,nbi-56418,small molecule,Peptide ,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1388,nbi-56418,"Endometriosis, Antineoplastic",3,2016,recruiting,in trial,-,
1325,ozarelix,peptide,Peptide ,antagonist,,,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1891,"spi-153, d-63153,ozarelix",Antineoplastic,2,2010,discontinued,in trial,-,
1326,relugolix,small molecule,Peptide ,antagonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Sep2016_258,relugolix,endometriosis,3,2017,recruiting,in trial,-,
1327,triptorelin,peptide,Peptide ,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2084,"triptorelin pamoate,trelstar, decapeptyl, salvacyl, moapar, pamorelin",Antineoplastic,4,,-,approved,2001,
1328,triptorelin,small molecule,Peptide ,agonist,,primary,GNRHR,gnrhr_human,P30968,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Oct2016_430,triptorelin,palliiative treatment of advanced prostate cancer,4,,-,approved,2001,
1329,danazol,small molecule,Peptide ,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD139,-,Antiendometriosis ; Antineoplastic,4,,-,approved,1976,
1330,danazol,small molecule,Peptide ,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2297,optina,diabetic macular edema,4,,-,approved,1976,
1331,degarelix,small molecule,Peptide ,antagonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,610,degarelix,Antineoplastic,4,,-,approved,2008,
1332,ep-100,peptide,Peptide ,not available,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,715,ep-100,Antineoplastic,2,2011,Completed,in trial,-,Seems like still investigating as of 2014 article
1333,gonadorelin,small molecule,Peptide ,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD259,-,Fertility,4,,-,approved,1982,
1334,histrelin,small molecule,Peptide ,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2177,"vp 002, histrelin implant,vantas, supprelin",Antineoplastic,4,,-,approved,1991,
1335,luteinizing hormone-releasing hormone,peptide,Peptide ,antagonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2097,"tztx-001,teverelix la",Antineoplastic,2,2005,Completed,in trial,-,"Seems to be planning Phase 3, but can't find recent dated information"
1336,nafarelin,small molecule,Peptide ,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,NRDD377,-,Antiendometriosis,4,,-,approved,1990,
1337,nbi-42902,small molecule,Peptide ,antagonist,,,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,869,"gnrh receptor antagonist, nbi-42902",postmenopausal symptoms; Antineoplastic,2,2005,discontinued,in trial,-,
1338,ozarelix,peptide,Peptide ,antagonist,,,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,1891,"spi-153, d-63153,ozarelix",Antineoplastic,2,2010,discontinued,in trial,-,
1339,triptorelin,peptide,Peptide ,agonist,,primary,GNRHR2,gnrr2_human,Q96P88,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,2084,"triptorelin pamoate,trelstar, decapeptyl, salvacyl, moapar, pamorelin",Antineoplastic,4,,-,approved,2001,
1340,int-767,small molecule,Steroid ,agonist,,primary,GPBAR1,gpbar_human,Q8TDU6,Class A (Rhodopsin),GPCR;Rhodopsin,Bile acid receptors,not established,MMAapril2016_0196,int-767,Treatment of liver fibrosis,1,2011,Completed,in trial,-,Appears to be heading to phase 2 trials as of 2015
1341,apd597,small molecule,Lipid ,agonist,,primary,GPR119,gp119_human,Q8TDV5,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,2469,"apd597, JNJ-38431055",Antidiabetic,1,2008,discontinued,in trial,-,
1342,apd668,small molecule,Lipid ,agonist,,primary,GPR119,gp119_human,Q8TDV5,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,194,apd668,Antidiabetic,1,2006,discontinued,in trial,-,
1343,mbx-2982,small molecule,Lipid ,agonist,,primary,GPR119,gp119_human,Q8TDV5,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,1225,mbx-2982,Antidiabetic,2,2009,discontinued,in trial,-,
1344,psn821,small molecule,Lipid ,agonist,,primary,GPR119,gp119_human,Q8TDV5,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,1679,psn821,Antidiabetic,2,2011,discontinued,in trial,-,
1345,cromolyn sodium,small molecule,Orphan ,agonist,,primary,GPR35,gpr35_human,Q9HC97,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,established,MMA_jun2017_010,cromolyn sodium,anti-allergenic,4,-,-,approved,2000,
1346,cromolyn sodium,small molecule,Orphan ,agonist,,primary,GPR35,gpr35_human,Q9HC97,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,established,MMAmar2016_0133,pa101b,autoimmune diseases,2,2016,Completed,in trial,-,
1347,am-211,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,145,am-211,Anti-inflammatory ; antiallergy,1,2011,Unknown,in trial,-,
1348,arry-502,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,MMAapril2016_0314,arry-502,Anti-Allergic,2,2012,Completed,in trial,-,
1349,azd1981,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,ASH_Sep2016_311,azd1981,Anti-Asthmatic,2,2014,discontinued,in trial,-,
1350,fevipiprant,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,ASH_Sep2016_308,fevipiprant,Anti-Asthmatic,3,2017,recruiting,in trial,-,
1351,oc459,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,MMAmay2016_0684,oc459,for allergic rhinitis,2,2016,recruiting,in trial,-,
1352,setipiprant,small molecule,Lipid ,antagonist,,primary,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,ASH_Sep2016_309,setipiprant,seasonal allergic rhinitis,3,2016,recruiting,in trial,-,
1353,vidupiprant,small molecule,Lipid ,antagonist,,,GPR44,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,ASH_Sep2016_310,"vidupiprant, AMG853",Anti-Asthmatic,2,2009,discontinued,in trial,-,
1354,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAapril2016_0296,"zyn002, Topical cannabidiol gel",Anticonvulsants; Antiepileptics,0,2017,Not open yet,in trial,-,
1355,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAapril2016_0328,"epidiolex, oral liquid cannabidiol, gwp42003",schizophrenia,2,2013,Completed,in trial,-,
1356,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAmar2016_0268,cannabidiol,epilepsy,3,2016,Not open yet,in trial,-,
1357,cannabidiol,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAmar2016_0271,"epidiolex, oral liquid cannabidiol, gwp42003",epilepsy,3,2016,recruiting,in trial,-,
1358,cannabidivarin,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAmay2016_0403,"gwp42006, Cannabidivarin",epilepsy,2,2015,recruiting,in trial,-,
1359,vsn16r,small molecule,Lipid ,agonist,,primary,GPR55,gpr55_human,Q9Y2T6,Class A (Rhodopsin),GPCR;Rhodopsin,"GPR18, GPR55 and GPR119",not established,MMAmay2016_0803,vsn16r,Antispasmodics;  for spatisity related to multiple sclerosis,2,2015,recruiting,in trial,-,
1360,glpg1205,small molecule,Orphan ,antagonist,,primary,GPR84,gpr84_human,Q9NQS5,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,MMAapril2016_0323,glpg1205,for ulcerative colitis; IBS,2,2015,Completed,in trial,-,
1361,fasoracetam monohydrate,small molecule,Amino acid ,not available,,secondary,GRM1,grm1_human,Q13255,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0121,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,Completed,in trial,-,
1362,adx-71149,small molecule,Amino acid ,PAM,,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,64,"adx-71149,  JNJ-40411813",Antipsychotic ; Anti-depressant; anxiolytic,2,2011,Completed,in trial,-,
1363,bci-838,small molecule,Amino acid ,antagonist,,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmay2016_0306,bci-838,Anti-depressant,1,2012,Completed,in trial,-,No development reported
1364,decoglurant,small molecule,Amino acid ,NAM,,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,ASH_Sep2016_336,decoglurant,unipolar depression,2,2011,discontinued,in trial,-,
1365,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0125,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,Completed,in trial,-,
1366,ly2140023,small molecule,Amino acid ,agonist,,,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,1190,"ly2140023, Pomaglumetad methionil, LY 404039, LY 2140023",schizophrenia,3,2011,discontinued,in trial,-,Ely Lily discontinued due to lack of efficacy
1367,ts-032,unknown,Amino acid ,agonist,pf-4802540,,GRM2,grm2_human,Q14416,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,2090,"ts-032, pf-4802540",schizophrenia,1,2008,discontinued,in trial,-,
1368,bci-838,small molecule,Amino acid ,antagonist,,primary,GRM3,grm3_human,Q14832,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmay2016_0307,bci-838,Anti-depressant,1,2012,Completed,in trial,-,No development reported
1369,decoglurant,small molecule,Amino acid ,NAM,,primary,GRM3,grm3_human,Q14832,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,ASH_Sep2016_338,decoglurant,unipolar depression,2,2011,discontinued,in trial,-,
1370,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM3,grm3_human,Q14832,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0123,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,Completed,in trial,-,
1371,ly2140023,small molecule,Amino acid ,agonist,,,GRM3,grm3_human,Q14832,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,1190,"ly2140023, Pomaglumetad methionil, LY 404039, LY 2140023",schizophrenia,3,2011,discontinued,in trial,-,Ely Lily discontinued due to lack of efficacy
1372,ts-032,unknown,Amino acid ,agonist,pf-4802540,,GRM3,grm3_human,Q14832,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,2090,"ts-032, pf-4802540",schizophrenia,1,2008,discontinued,in trial,-,
1373,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM4,grm4_human,Q14833,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0125,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,Completed,in trial,-,
1374,pxt002331,small molecule,Amino acid ,PAM,,primary,GRM4,grm4_human,Q14833,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmay2016_0906,pxt002331,Antiparkinson,1,2015,Completed,in trial,-,
1375,acamprosate,small molecule,Amino acid ,antagonist,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,34,"acamprosate,campral",Antineoplastic,4,,-,approved,2004,
1376,adx10059,small molecule,Amino acid ,NAM,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,62,adx10059,Anti-migraine ; gastroesophageal reflux disease,2,2008,discontinued,in trial,-,
1377,adx-48621,small molecule,Amino acid ,NAM,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,2472,adx-48621,Antiparkinson,2,2011,Completed,in trial,-,
1378,azd2066,small molecule,Amino acid ,antagonist,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,308,azd2066,Analgesics; gastroesophageal reflux disease,2,2010,discontinued,in trial,-,
1379,basimglurant,small molecule,Amino acid ,NAM,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,ASH_Sep2016_341,basimglurant,fragile x syndrome,2,2015,Completed,in trial,-,
1380,dipraglurant,small molecule,Amino acid ,NAM,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,ASH_Sep2016_339,dipraglurant,Antiparkinson,2,2011,Completed,in trial,-,
1381,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,MMAmar2016_0122,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,Completed,in trial,-,
1382,mavoglurant,small molecule,Amino acid ,antagonist,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,ASH_Sep2016_340,mavoglurant,obsessive-compulsive disorder,2,2016,recruiting,in trial,-,
1383,ro4917523,small molecule,Amino acid ,antagonist,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,MMAmay2016_0177,ro4917523,"Major depressive disorder, Fragile X syndrome",2,2012,discontinued,in trial,-,discontinued due to negative results
1384,stx107,small molecule,Amino acid ,NAM,,primary,GRM5,grm5_human,P41594,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,established,1906,stx107,Fragile X syndrome,2,2011,Completed,in trial,-,
1385,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM6,grm6_human,O15303,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0125,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,Completed,in trial,-,
1386,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM7,grm7_human,Q14831,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0124,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,Completed,in trial,-,
1387,fasoracetam monohydrate,small molecule,Amino acid ,not available,,primary,GRM8,grm8_human,O00222,Class C (Glutamate) ,GPCR;Glutamate,Metabotropic glutamate receptors,not established,MMAmar2016_0125,nfc-1,attention deficit hyperactivity disorder (ADHD),3,2016,Completed,in trial,-,
1388,gamma hydroxybutyric acid,small molecule,Alicarboxylic acid ,agonist,,secondary,HCAR1,hcar1_human,Q9BXC0,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,ASH_Oct2016_437,sodium oxybate,Hypnotics and Sedatives,4,,-,approved,2002,
1389,acipimox,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,ASH_Oct2016_428,acipimox,lipid-lowering,4,,-,approved,2003,
1390,ari-3037mo,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,226,ari-3037mo,Vitamin B analog; for treatment for hyperlipidemia,2,2015,Completed,in trial,-,
1391,cer627,small molecule: combination,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,MMA2015_0072,cer627,Dyslipidemia with low HDL,1,2010,discontinued,in trial,-,
1392,mepenzolate,small molecule,Alicarboxylic acid ,antagonist,,secondary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,NRDD324,-,Antispasmodics,4,,-,approved,1956,
1393,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,467,cer627,Antidyslipidaemic,1,2010,discontinued,in trial,-,
1394,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1300,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",Antidyslipidaemic,3,2011,discontinued,in trial,-,
1395,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1301,"mk-0542b, extended release niacin + laropiprant +simvastatin",Antidyslipidaemic,3,2011,discontinued,in trial,-,
1396,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1546,"oxycodone hcl + niacin,acurox, oxyadf",substance abuse deterrant,3,2010,discontinued,in trial,-,rejected for approval by FDA in 2010
1397,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,2468,"niacin extended-release tablets,niaspan",Antihyperlipidemic,4,,-,approved,1997,
1398,niacin receptor agonist,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR2,hcar2_human,Q8TDS4,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1412,niacin receptor agonist,Anti-atherosclerotic,2,2009,discontinued,in trial,-,
1399,ari-3037mo,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,226,ari-3037mo,Vitamin B analog; for treatment for hyperlipidemia,2,2015,Completed,in trial,-,
1400,cer627,small molecule: combination,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,MMA2015_0071,cer627,Dyslipidemia with low HDL,1,2010,discontinued,in trial,-,
1401,mepenzolate,small molecule,Alicarboxylic acid ,antagonist,,secondary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,NRDD324,-,Antispasmodics,4,,-,approved,1956,
1402,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,467,cer627,Antidyslipidaemic,1,2010,discontinued,in trial,-,
1403,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1300,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",Antidyslipidaemic,3,2011,discontinued,in trial,-,
1404,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1301,"mk-0542b, extended release niacin + laropiprant +simvastatin",Antidyslipidaemic,3,2011,discontinued,in trial,-,
1405,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1546,"oxycodone hcl + niacin,acurox, oxyadf",substance abuse deterrant,3,2010,discontinued,in trial,-,rejected for approval by FDA in 2010
1406,niacin,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,2468,"niacin extended-release tablets,niaspan",Antihyperlipidemic,4,,-,approved,1997,
1407,niacin receptor agonist,small molecule,Alicarboxylic acid ,agonist,,primary,HCAR3,hcar3_human,P49019,Class A (Rhodopsin),GPCR;Rhodopsin,Hydroxycarboxylic acid receptors,established,1412,niacin receptor agonist,Anti-atherosclerotic,2,2009,discontinued,in trial,-,
1408,almorexant,small molecule,Peptide ,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,119,"almorexant, act-078573",sleep disorder treatment,3,2009,discontinued,in trial,-,Not marketed-dropped in 2011 because of side effects profile
1409,lemborexant,small molecule,Peptide ,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,ASH_Sep2016_278,lemborexant,insomnia,2,2016,recruiting,in trial,-,
1410,sb-649868,small molecule,Peptide ,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,ASH_Sep2016_277,sb-649868,insomnia,2,2007,Completed,in trial,-,Suspected discontinued
1411,suvorexant,small molecule,Peptide ,antagonist,,primary,HCRTR1,ox1r_human,O43613,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,1304,mk-4305,Hypnotics and Sedatives,4,,-,approved,2014,
1412,almorexant,small molecule,Peptide ,antagonist,,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,119,"almorexant, act-078573",sleep disorder treatment,3,2009,discontinued,in trial,-,Not marketed-dropped in 2011 because of side effects profile
1413,lemborexant,small molecule,Peptide ,antagonist,,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,ASH_Sep2016_280,lemborexant,insomnia,2,2016,recruiting,in trial,-,
1414,min-202,small molecule,Peptide ,antagonist,jnj-42847922,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,MMA2016_0029,"min-202, jnj-42847922",Anti-depressant and sleep disorder therapy,2,2015,Completed,in trial,-,
1415,sb-649868,small molecule,Peptide ,antagonist,,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,ASH_Sep2016_279,sb-649868,insomnia,2,2007,Completed,in trial,-,Suspected discontinued
1416,suvorexant,small molecule,Peptide ,antagonist,,primary,HCRTR2,ox2r_human,O43614,Class A (Rhodopsin),GPCR;Rhodopsin,Orexin receptors,established,1304,mk-4305,Hypnotics and Sedatives,4,,-,approved,2014,
1417,aceprometazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD003,-,Hypnotics and Sedatives,4,,-,approved,-,Withdrawn in EU - not sure if ever in trials in US
1418,acrivastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_235,acrivastine,Anti-Allergic,4,,-,approved,1994,
1419,alcaftadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD011,-,Anti-Allergic,4,,-,approved,2010,
1420,antazoline,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_232,antazoline,atrial fibrillation,4,,-,approved,1994,
1421,asenapine,small molecule,Aminergic ,antagonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
1422,astemizole,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD037,-,Anti-Allergic,4,,-,approved,1988,
1423,azatadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD041,-,Anti-Allergic,4,,-,approved,1977,
1424,azelastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,456,"cdx-313, budesonide + azelastine nasal spray",Anti-Allergic,2,2009,Completed,in trial,-,
1425,azelastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,313,azelastine,Anti-Allergic,4,,-,approved,1996,
1426,azelastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,314,"azelastine hydrochloride nasal spray,astepro",Anti-Allergic,4,,-,approved,1996,
1427,azelastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,679,"dymista, azelastine hydrochloride + fluticasone propionate, mp29-02",Anti-Allergic,4,,-,approved,2012,
1428,benzquinamide,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD047,-,Antiemetics; Antipsychotic,4,,-,withdrawn,1974,
1429,bepotastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,336,"bepotastine besilate,bepreve, talion",Anti-Allergic,4,,-,approved,2009,
1430,betahistine,small molecule,Aminergic ,agonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1464,"obe101,histalean,anti-obesity ",Anti-obesity,2,2008,discontinued,in trial,-,
1431,betahistine,small molecule,Aminergic ,agonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmay2016_0919,betahistine,vertigo,4,,-,approved,1970,
1432,bilastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_359,bilastine,Anti-Allergic,4,,-,approved,2010,
1433,bl-1020,small molecule,Aminergic ,agonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,2424,bl-1020,schizophrenia,3,2011,Terminated,in trial,-,
1434,bromodiphenhydramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD062,-,Anti-Allergic,4,,-,approved,1954,
1435,brompheniramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD063,-,Anti-Allergic,4,,-,approved,1957,
1436,buclizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD064,-,Antiemetics,4,,-,approved,1982,
1437,butriptyline,small molecule,Peptide ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Endothelin receptors,established,ASH_Oct2016_363,butriptyline,Anti-depressant,4,,-,approved,1974,
1438,carbinoxamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD080,-,Anti-Allergic,4,,-,approved,2003,
1439,cetirizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,471,"cetirizine hcl,zyrtec",Anti-Allergic,4,,-,approved,2007,
1440,chlophedianol,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD087,-,Antitussive,4,,-,approved,1987,Not available in US- discontinued
1441,chlorcyclizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_358,chlorcyclizine,Anti-Allergic,4,,-,approved,-,
1442,chloropyramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_356,chloropyramine,Anti-Allergic,4,,-,approved,-,
1443,chlorpheniramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD094,-,Anti-Allergic,4,,-,approved,1950,
1444,chlorprothixene,small molecule,Aminergic ,antagonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,
1445,cinnarizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD107,-,Anti-Allergic,4,,-,approved,1989,
1446,clemastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD112,-,Anti-Allergic,4,,-,approved,1977,
1447,clofedanol,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_397,clofedanol,antitussive,4,,-,approved,1987,
1448,clozapine,small molecule,Aminergic ,antagonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
1449,cyclizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD130,-,Antiemetics,4,,-,approved,1982,
1450,cyproheptadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD135,-,Anti-Allergic ; Appetite Stimulant,4,,-,approved,1961,
1451,desipramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD148,-,Anti-depressant,4,,-,approved,1964,
1452,desloratadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,620,"desloratadine , clarinex",Anti-Allergic,4,,-,approved,2001,
1453,dexbrompheniramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD153,-,Anti-Allergic,4,,-,approved,1963,
1454,dexchlorpheniramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_238,dexchlorpheniramine,sunburn,4,,-,approved,1981,
1455,dimenhydrinate,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD170,-,Antiemetics,4,,-,approved,1972,
1456,dimetindene,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_357,dimetindene,Anti-Allergic,4,,-,approved,-,
1457,diphenhydramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD174,-,Anti-Allergic ; Hypnotics and sedatives; Antiemetics; Antipruritics; Antitussives,4,,-,approved,1946,
1458,diphenylpyraline,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD177,-,Anti-Allergic,4,,-,approved,1982,
1459,doxepin,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
1460,doxylamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD188,-,Anti-Allergic ; Antiemetics; Antitussive ; Hypnotics and Sedatives,4,,-,approved,1948,
1461,doxylamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmay2016_0669,diclectin + diclegis; doxylamine succinate + pyridoxine hydrochloride dr tablets,Antihistamine; for nausea and vomiting of pregnancy,4,,-,approved,1948,
1462,emedastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD199,-,Anti-Allergic,4,,-,approved,1997,
1463,epinastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,719,epinastine,Anti-Allergic,4,,-,approved,2003,
1464,esmirtazapine,small molecule,Aminergic ,antagonist,,,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_237,esmirtazapine,insomnia,3,2008,discontinued,in trial,-,
1465,fexofenadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,789,fexofenadine + ps/,Anti-Allergic,4,,-,approved,1996,
1466,flunarizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD236,-,Anticonvulsants; Vasodilator,4,,-,approved,1968,
1467,gsk-1004723,small molecule,Aminergic ,antagonist,,,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,878,gsk-1004723,Anti-Allergic,2,2009,discontinued,in trial,-,
1468,histamine,small molecule,Aminergic ,agonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_239,histamine,Anti-migraine,4,,-,approved,1939,
1469,hydroxyzine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD275,-,Antipruritics; Anxiolytics sedatives and hypnotics,4,,-,approved,1956,
1470,iloperidone,small molecule,Aminergic ,antagonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1471,isothipendyl,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_373,isothipendyl,antipruritic,4,,-,approved,-,
1472,ketotifen,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1074,"ketotifen fumarate,zaditen, zaditor",Anti-Allergic,4,,-,approved,1999,
1473,levocabastine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD301,-,Anti-Allergic,4,,-,approved,1993,
1474,levocetirizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1118,"levocetirizine dihydrochloride,xusal, xyzal",Anti-Allergic,4,,-,approved,2007,Actually approved in 2007 but not considered a NME because enantiomer of cetirizine  I think
1475,levomepromazine,small molecule,Aminergic ,antagonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
1476,loratadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1163,"loratadine + montelukast sodium,claritin + singulair",Anti-Asthmatic,4,,-,approved,1993,
1477,meclizine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD315,-,Antiemetics,4,,-,approved,1957,
1478,mequitazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD329,-,Anti-Allergic,4,,-,approved,-,"Marketed but I don't think fda approved, if so then long ago"
1479,methdilazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD339,-,Anti-Allergic,4,,-,approved,1982,
1480,mianserin,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD363,-,Anti-depressant,4,,-,approved,1996,"Doesn't appear to be FDA approved, but analogue mirtazapine is "
1481,ncx 1510,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1390,"ncx 1510, ox-nla",Anti-Allergic,2,2009,Completed,in trial,-,
1482,olanzapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
1483,olanzapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1484,olanzapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmay2016_0205,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1485,olanzapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
1486,olanzapine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
1487,olopatadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1480,"olopatadine hydrochloride,patanase",Anti-Allergic,4,,-,approved,1996,
1488,orphenadrine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD400,-,Antiparkinson s; Muscle Relaxants; Central,4,,-,approved,1957,
1489,pemirolast,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD416,-,Anti-Allergic,4,,-,approved,1999,
1490,phenindamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_355,phenindamine,Anti-Allergic,4,,-,approved,1949,
1491,pheniramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD431,-,Anti-Allergic,4,,-,approved,1994,
1492,promazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
1493,promethazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAapril2016_0105,"cl-h1t, promethazine + sumatriptan",Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic ; Treat migraines and cluster headaches,3,2013,Completed,in trial,-,
1494,promethazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD463,-,Hypnotics and Sedatives; Anti-anxiety s; Anti-allergic,4,,-,approved,1951,
1495,propiomazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
1496,pyrilamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_236,pyrilamine,pruritus,4,,-,approved,1973,
1497,terfenadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD516,-,Anti-Allergic,4,,-,approved,1985,
1498,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,
1499,tolazoline,small molecule,Aminergic ,agonist,,secondary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_233,tolazoline,cardiovascular disease,4,,-,approved,1948,
1500,trimeprazine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD545,-,Antipruritics,4,,-,approved,1982,
1501,trimipramine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_234,trimipramine,unipolar depression,4,,-,approved,1979,
1502,tripelennamine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD550,-,Anti-Allergic,4,,-,approved,1948,
1503,triprolidine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD551,-,Anti-Allergic,4,,-,approved,1982,
1504,vapitadine,small molecule,Aminergic ,antagonist,,primary,HRH1,hrh1_human,P35367,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,2123,"vapitadine dihydrochloride,hivenyl","Anti-Allergic, pruritus",2,2006,Completed,in trial,-,No development reported
1505,asenapine,small molecule,Aminergic ,antagonist,,secondary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
1506,betazole,small molecule,Aminergic ,agonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD053,-,Diagnostic,4,,-,approved,1982,
1507,cimetidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmay2016_0601,"tl-118, hamsa-1, cyclophosphamide + diclofenac + sulfasalazine + cimetidine",Antihistamines,4,,-,approved,1977,
1508,cimetidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD104,-,GI Anti-Ulcer ; antihistamines,4,,-,approved,1977,
1509,doxepin,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
1510,epinastine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,719,epinastine,Anti-Allergic,4,,-,approved,2003,
1511,famotidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,929,"hzt-501,  ibuprofen + famotidine,duexa",acid reducer,4,,-,approved,1986,
1512,famotidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1539,ox17,acid reducer,4,,-,approved,1986,
1513,famotidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,929,"hzt-501,  ibuprofen + famotidine,duexa",gastric ulcer and gastroesophageal reflux,4,,-,approved,1986,
1514,histamine,small molecule,Aminergic ,agonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,463,ceplene,cytorprotective  during cancer treatment,3,2015,recruiting,in trial,-,Has orphan designation to be used as adjunct with IL-2 for acute myeloid leukemia
1515,histamine,small molecule,Aminergic ,agonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_410,histamine ,for diagnosis of gastric acid secretory function,4,,-,approved,1939,
1516,methantheline,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_240,methantheline,digestive system disease,4,,-,approved,1951,
1517,metiamide,small molecule,Peptide ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Oct2016_349,metiamide,acid reducer,4,,-,approved,-,
1518,nizatidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD394,-,GI Anti-Ulcer ; antihistamines,4,,-,approved,1988,
1519,ranitidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1716,"ranitidine bismuth citrate,tritec",antiulcer,4,,-,approved,1977,
1520,ranitidine,small molecule,Aminergic ,antagonist,,primary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,2238,"zantac,ranitidine hydrochloride",antiulcer,4,,-,approved,1977,
1521,tolazoline,small molecule,Aminergic ,agonist,,secondary,HRH2,hrh2_human,P25021,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_241,tolazoline,arthralgia,4,,-,approved,1948,
1522,apd916,small molecule,Aminergic ,agonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,196,apd916,sleep disorders; narcolepsy,1,2010,Completed,in trial,-,
1523,bavisant,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_243,bavisant,attention deficit hyperactivity disorder,2,2011,withdrawn,in trial,-,No development reported
1524,betahistine,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1464,"obe101,histalean,anti-obesity ",Anti-obesity,2,2008,discontinued,in trial,-,
1525,betahistine,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmay2016_0920,betahistine,vertigo,4,,-,approved,1970,
1526,gsk-1004723,small molecule,Aminergic ,antagonist,,,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,878,gsk-1004723,Anti-Allergic,2,2009,discontinued,in trial,-,
1527,irdabisant,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_246,irdabisant,cognitive impairment,1,2013,Completed,in trial,-,
1528,pf-03654746,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_245,pf-03654746,allergic rhinitis,2,2011,discontinued,in trial,-,
1529,pf-03654764,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_244,pf-03654764,allergic rhinitis,2,2009,discontinued,in trial,-,
1530,pitolisant,small molecule,Aminergic ,inverse agonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_242,pitolisant,Antiparkinson,3,2016,Not open yet,in trial,-,
1531,suvn-g3031,small molecule,Aminergic ,antagonist,,primary,HRH3,hrh3_human,Q9Y5N1,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmar2016_0093,suvn-g3031,Alzheimer's disease,1,2016,recruiting,in trial,-,
1532,clozapine,small molecule,Aminergic ,antagonist,,secondary,HRH4,hrh4_human,Q9H3N8,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
1533,rev131,small molecule,Aminergic ,antagonist,,primary,HRH4,hrh4_human,Q9H3N8,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,1745,rev131,Anti-Allergic,2,2006,discontinued,in trial,-,
1534,sens-111,small molecule,Aminergic ,antagonist,,primary,HRH4,hrh4_human,Q9H3N8,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAapril2016_0282,sens-111,for vertigo and tinnitus,3,2017,recruiting,in trial,-,
1535,toreforant,small molecule,Aminergic ,antagonist,,primary,HRH4,hrh4_human,Q9H3N8,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Sep2016_247,toreforant,Anti-Asthmatic,2,2014,Completed,in trial,-,
1536,zpl-389,small molecule,Aminergic ,antagonist,zpl-3893787,primary,HRH4,hrh4_human,Q9H3N8,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,MMAmar2016_0120,"zpl-389, zpl-3893787",Anti-inflammatory ; atopic dermatitis,2,2015,Completed,in trial,-,
1537,acepromazine,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_391,acepromazine,Antipsychotic,4,,-,approved,-,
1538,alverine,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_395,alverine,Antispasmodics,4,,-,approved,2014,
1539,aripiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,22,abilify,schizophrenia,4,,-,approved,2002,
1540,aripiprazole,unknown,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_1,"aripiprazole lauroxil, alks 9070",psychosis,4,,-,approved,2015,
1541,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
1542,bifeprunox,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,
1543,brexpiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1502,brexpiprazole,Anti-depressant,4,,-,approved,2015,
1544,bupropion/trazodone,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0460,"lorexys, sip-104, bupropion/trazodone",Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,2,2014,Completed,in trial,-,
1545,buspirone,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD066,-,Anti-anxiety,4,,-,approved,1986,
1546,cinitapride,small molecule,Peptide ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,Gonadotrophin-releasing hormone receptors,established,ASH_Oct2016_415,cinitapride,gastrointestinal disorders,4,,-,approved,-,
1547,clozapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
1548,eltoprazine,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0086,eltoprazine,dyskinesias,2,2015,Ongoing,in trial,-,
1549,ergoloid,small molecule,Aminergic ,agonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_0,ergoloid,cardiovascular disease,4,,-,approved,1953,
1550,flibanserin,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,801,flibanserin,sexual dysfunction,4,,-,approved,2015,
1551,gepirone,small molecule,Aminergic ,partial agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,848,gepirone,Anti-depressant,3,1999,Completed,in trial,-,"Was rejected 3 times for fda approval, reversed decision in march 2016 - headed for approval and martketing"
1552,gsk163090,small molecule,Aminergic ,antagonist,,,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_5,gsk163090,unipolar depression,2,2009,discontinued,in trial,-,
1553,iloperidone,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1554,lecozotan,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_2,lecozotan,Alzheimer's disease,3,2006,discontinued,in trial,-,
1555,lisuride,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD307,-,Antiparkinson,4,,-,approved,2011,
1556,lurasidone,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0233,"cyclurad, d-cycloserine + lurasidone",schizophrenia,4,,-,approved,2010,
1557,lurasidone,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1184,"lurasidone, sm-13496,latuda",schizophrenia,4,,-,approved,2010,
1558,methysergide,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD353,-,Anti-migraine s; Vasoconstrictor,4,,-,approved,1962,
1559,min-117,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0204,min-117,Anti-depressant,2,2016,Completed,in trial,-,
1560,mn-305,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1319,mn-305,Anti-depressant; hypnotic,2,2007,discontinued,in trial,-,
1561,naratriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1381,"naratriptan,naramig, amerge",Anti-migraine,4,,-,approved,1998,
1562,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
1563,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1564,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0187,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1565,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
1566,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
1567,opc-14523,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1662,"prs-013, opc-14523",Anti-depressant,2,2009,Completed,in trial,-,No development reported
1568,pardoprunox,small molecule,Aminergic ,agonist,,,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,
1569,piclozotan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_3,piclozotan,stroke,2,2008,discontinued,in trial,-,
1570,pipotiazine,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_390,pipotiazine,Antipsychotic,4,,-,approved,1980,
1571,prx-00023,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1666,"prx-00023, Naluzotan",Anti-depressant,3,2011,discontinued,in trial,-,
1572,psn602,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1678,psn602,Anti-obesity,1,2009,discontinued,in trial,-,
1573,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0106,"cl-h1t, promethazine + sumatriptan",Anti-migraine,3,2013,Completed,in trial,-,
1574,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1438,"np101,zelrix",Anti-migraine,4,,-,approved,1992,
1575,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1914,sumatriptan,Anti-migraine,4,,-,approved,1992,
1576,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1915,"sumatriptan, triptan",Anti-migraine,4,,-,approved,1992,
1577,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1916,"sumatriptan,imitrex",Anti-migraine,4,,-,approved,1992,
1578,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1357,"mt 400,treximet",Anti-migraine,4,,-,approved,2008,
1579,thioproperazine,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_392,thioproperazine,Antipsychotic,4,,-,approved,1962,
1580,trazodone,small molecule,Aminergic ,antagonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2072,"trazodone extended release, dds-04a,oleptro",Anti-depressant,4,,-,approved,1981,
1581,vilazodone,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2160,"vilazodone hydrochloride, sb 659746a",Anti-depressant,4,,-,approved,2011,
1582,vortioxetine,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1171,lu aa21004,Anti-depressant,4,,-,approved,2013,
1583,xaliproden,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2200,"xaliproden, sr 57746a",neuroprotectant,3,2006,discontinued,in trial,-,
1584,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0110,zp-triptan,Anti-migraine,3,2016,Completed,in trial,-,
1585,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1A,5ht1a_human,P08908,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2246,"zolmitriptan,zomig",Anti-migraine,4,,-,approved,1997,
1586,almotriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,120,"almotriptan,axert, almogran, amignul",Anti-migraine,4,,-,approved,2001,
1587,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
1588,dihydroergotamine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1214,"map-0004, tempo migraine,levadex",Anti-migraine,4,,-,approved,1997,
1589,dihydroergotamine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1356,mt 300,Anti-migraine,4,,-,approved,1997,
1590,eletriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_6,eletriptan,Anti-migraine,4,,-,approved,2002,
1591,eltoprazine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0087,eltoprazine,dyskinesias,2,2015,Ongoing,in trial,-,
1592,ergoloid,small molecule,Aminergic ,agonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_7,ergoloid,cardiovascular disease,4,,-,approved,1953,
1593,ergotamine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD210,-,Anti-migraine,4,,-,approved,1960,
1594,frovatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,823,"frovatriptan,frovelan, frova",Anti-migraine,4,,-,approved,2001,
1595,gsk163090,small molecule,Aminergic ,antagonist,,,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_8,gsk163090,unipolar depression,2,2009,discontinued,in trial,-,
1596,naratriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1381,"naratriptan,naramig, amerge",Anti-migraine,4,,-,approved,1998,
1597,nxn-188,small molecule,Aminergic ,antagonist,,,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1460,nxn-188,Anti-migraine,2,2009,discontinued,in trial,-,
1598,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
1599,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1600,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0199,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1601,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
1602,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
1603,rizatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD486,-,Anti-migraine,4,,-,approved,1998,
1604,SL 650472,small molecule,Aminergic ,antagonist,,,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2074,"trelanserin, sl 65.0472",intermittent claudication,2,2006,discontinued,in trial,-,
1605,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0108,"cl-h1t, promethazine + sumatriptan",Anti-migraine,3,2013,Completed,in trial,-,
1606,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1438,"np101,zelrix",Anti-migraine,4,,-,approved,1992,
1607,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1914,sumatriptan,Anti-migraine,4,,-,approved,1992,
1608,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1915,"sumatriptan, triptan",Anti-migraine,4,,-,approved,1992,
1609,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1916,"sumatriptan,imitrex",Anti-migraine,4,,-,approved,1992,
1610,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1357,"mt 400,treximet",Anti-migraine,4,,-,approved,2008,
1611,vortioxetine,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1171,lu aa21004,Anti-depressant,4,,-,approved,2013,
1612,vr-147,small molecule,Aminergic ,not available,,,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2179,vr-147,Anti-migraine,1,2008,discontinued,in trial,-,
1613,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0112,zp-triptan,Anti-migraine,3,2016,Completed,in trial,-,
1614,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1B,5ht1b_human,P28222,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2246,"zolmitriptan,zomig",Anti-migraine,4,,-,approved,1997,
1615,almotriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,120,"almotriptan,axert, almogran, amignul",Anti-migraine,4,,-,approved,2001,
1616,dihydroergotamine,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1214,"map-0004, tempo migraine,levadex",Anti-migraine,4,,-,approved,1997,
1617,dihydroergotamine,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1356,mt 300,Anti-migraine,4,,-,approved,1997,
1618,eletriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1731,relpax,Anti-migraine,4,,-,approved,2002,
1619,ergotamine,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD210,-,Anti-migraine,4,,-,approved,1960,
1620,frovatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,823,"frovatriptan,frovelan, frova",Anti-migraine,4,,-,approved,2001,
1621,gsk163090,small molecule,Aminergic ,antagonist,,,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_9,gsk163090,unipolar depression,2,2009,discontinued,in trial,-,
1622,naratriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1381,"naratriptan,naramig, amerge",Anti-migraine,4,,-,approved,1998,
1623,nxn-188,small molecule,Aminergic ,antagonist,,,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1460,nxn-188,Anti-migraine,2,2009,discontinued,in trial,-,
1624,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
1625,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1626,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0198,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1627,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
1628,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
1629,rizatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD486,-,Anti-migraine,4,,-,approved,1998,
1630,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0107,"cl-h1t, promethazine + sumatriptan",Anti-migraine,3,2013,Completed,in trial,-,
1631,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1438,"np101,zelrix",Anti-migraine,4,,-,approved,1992,
1632,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1914,sumatriptan,Anti-migraine,4,,-,approved,1992,
1633,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1915,"sumatriptan, triptan",Anti-migraine,4,,-,approved,1992,
1634,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1916,"sumatriptan,imitrex",Anti-migraine,4,,-,approved,1992,
1635,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1357,"mt 400,treximet",Anti-migraine,4,,-,approved,2008,
1636,tonabersat,small molecule,Aminergic ,antagonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2038,tonabersat,Anti-migraine,2,2007,discontinued,in trial,-,
1637,vr-147,small molecule,Aminergic ,not available,,,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2179,vr-147,Anti-migraine,1,2008,discontinued,in trial,-,
1638,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0111,zp-triptan,Anti-migraine,3,2016,Completed,in trial,-,
1639,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1D,5ht1d_human,P28221,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2246,"zolmitriptan,zomig",Anti-migraine,4,,-,approved,1997,
1640,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1E,5ht1e_human,P28566,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
1641,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1E,5ht1e_human,P28566,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1642,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1E,5ht1e_human,P28566,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0202,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1643,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1E,5ht1e_human,P28566,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
1644,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR1E,5ht1e_human,P28566,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
1645,eletriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_10,eletriptan,Anti-migraine,4,,-,approved,2002,
1646,lasmiditan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1093,"lasmiditan, col-144, ly-573144",Anti-migraine,3,2015,Ongoing,in trial,-,
1647,naratriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1381,"naratriptan,naramig, amerge",Anti-migraine,4,,-,approved,1998,
1648,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0109,"cl-h1t, promethazine + sumatriptan",Anti-migraine,3,2013,Completed,in trial,-,
1649,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1438,"np101,zelrix",Anti-migraine,4,,-,approved,1992,
1650,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1914,sumatriptan,Anti-migraine,4,,-,approved,1992,
1651,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1915,"sumatriptan, triptan",Anti-migraine,4,,-,approved,1992,
1652,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1916,"sumatriptan,imitrex",Anti-migraine,4,,-,approved,1992,
1653,sumatriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1357,"mt 400,treximet",Anti-migraine,4,,-,approved,2008,
1654,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0113,zp-triptan,Anti-migraine,3,2016,Completed,in trial,-,
1655,zolmitriptan,small molecule,Aminergic ,agonist,,primary,HTR1F,5ht1f_human,P30939,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2246,"zolmitriptan,zomig",Anti-migraine,4,,-,approved,1997,
1656,acepromazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_379,acepromazine,Antipsychotic,4,,-,approved,-,
1657,acp-104,small molecule,Aminergic ,inverse agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,47,acp-104,schizophrenia,2,2007,discontinued,in trial,-,The D2 and D3 partial agonism creates less side effects - different from typical anti-psychotics
1658,am-831,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0049,am-831,Antipsychotic ; schizophrenia,1,2011,discontinued,in trial,-,
1659,amitriptyline,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1491,oms-103hp,Analgesics,4,,-,approved,1961,
1660,apd125,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,192,"apd125, Nelotanserin",Dementia with Lewy Bodies,2,2016,recruiting,in trial,-,Added entry because Indication so different
1661,apd125,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,192,apd125,insomnia,2,2008,discontinued,in trial,-,
1662,apd791,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,195,apd791,antithrombotic,1,2008,Completed,in trial,-,
1663,aripiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,22,abilify,schizophrenia,4,,-,approved,2002,
1664,aripiprazole,unknown,Aminergic ,partial agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_14,"aripiprazole lauroxil, alks 9070",psychosis,4,,-,approved,2015,
1665,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
1666,ati-9242,small molecule,Aminergic ,not available,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2423,ati-9242,schizophrenia,1,2016,Ongoing,in trial,-,
1667,bifeprunox,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,
1668,bl-1020,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2424,bl-1020,schizophrenia,3,2011,Terminated,in trial,-,
1669,brexpiprazole,small molecule,Aminergic ,partial agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1502,brexpiprazole,Anti-depressant,4,,-,approved,2015,
1670,bupropion/trazodone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0461,"lorexys, sip-104, bupropion/trazodone",Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,2,2014,Completed,in trial,-,
1671,butriptyline,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_365,butriptyline,Anti-depressant,4,,-,approved,1974,
1672,bvt.28949,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,412,bvt.28949,Antiglaucomic,2,2010,Unknown,in trial,-,Sweden
1673,chlorpromazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_16,chlorpromazine,psychosis,4,,-,approved,1957,
1674,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,
1675,cinitapride,small molecule,Peptide ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Oct2016_414,cinitapride,gastrointestinal disorders,4,,-,approved,-,
1676,cis-uca eye drops,small molecule,Aminergic ,agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0333,cis-uca eye drops,for ocular surface inflammation,2,2014,Completed,in trial,-,
1677,clozapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
1678,cyclobenzaprine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0082,tnx-102,"fibromyalgia, PTSD",3,2017,recruiting,in trial,-,
1679,cyclobenzaprine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD131,-,Anti-depressant,4,,-,approved,1977,
1680,cyclobenzaprine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2489,"cyclobenzaprine hydrochloride extended-release capsules,amrix",Muscle Relaxants,4,,-,approved,1977,
1681,cyproheptadine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD135,-,Anti-Allergic ; Appetite Stimulant,4,,-,approved,1961,
1682,doxepin,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
1683,droperidol,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_17,droperidol,psychosis,4,,-,approved,1970,
1684,eplivanserine,small molecule,Aminergic ,inverse agonist,,,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,721,"eplivanserine, sr 46349,ciltyri",insomnia,3,2009,discontinued,in trial,-,Sanofi withdrew application for fda approval 2009
1685,esmirtazapine,small molecule,Aminergic ,antagonist,,,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,732,"esmirtazapine, org-4420",insomnia; menopausal symptoms,3,2009,discontinued,in trial,-,discontinued by Organon
1686,flibanserin,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,801,flibanserin,sexual dysfunction,4,,-,approved,2015,
1687,flupentixol,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_393,flupentixol,Antipsychotic,4,,-,approved,1965,
1688,haloperidol,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_13,haloperidol,conduct disorder,4,,-,approved,1967,
1689,haloperidol decanoate,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_21,haloperidol decanoate,psychosis,4,,-,approved,1986,
1690,iferanserin,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0414,"iferanserin ointment, ven 309",Antihemorrhoidal,3,2011,discontinued,in trial,-,
1691,iloperidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1692,iti-007,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1048,"iti-007, iti-722",schizophrenia,3,2016,recruiting,in trial,-,
1693,loxapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,304,az-004,schizophrenia,4,,-,approved,1975,
1694,lurasidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0236,"cyclurad, d-cycloserine + lurasidone",schizophrenia,4,,-,approved,2010,
1695,lurasidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1184,"lurasidone, sm-13496,latuda",schizophrenia,4,,-,approved,2010,
1696,mesoridazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD331,-,schizophrenia,4,,-,approved,1970,
1697,methysergide,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD353,-,Anti-migraine s; Vasoconstrictor,4,,-,approved,1962,
1698,mianserin,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD363,-,Anti-depressant,4,,-,approved,1996,"Doesn't appear to be FDA approved, but analogue mirtazapine is "
1699,min-001,small molecule,Aminergic ,agonist,cyr-101,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0202,"min-001,  cyr-101",schizophrenia,2,2009,Completed,in trial,-,Can't find information if discontinued or not
1700,min-117,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0206,min-117,Anti-depressant,2,2016,Completed,in trial,-,
1701,minaprine,small molecule,Aminergic ,antagonist,,,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD368,-,Anti-depressant,4,,withdrawn,approved,1984,Not approved by fda - but used
1702,mirtazapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1295,"mirtazapine,remeron, remeron soltab, reflex",Anti-depressant,4,,-,approved,1996,
1703,molindone,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_12,molindone,schizophrenia,4,,-,approved,1974,
1704,nefazodone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD380,-,Anti-depressant,4,,-,approved,1994,
1705,nelotanserin,small molecule,Aminergic ,inverse agonist,apd-125,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0233,"nelotanserin, apd-125",dementia; Parkinson's disease,2,2016,recruiting,in trial,-,
1706,nemifitide,peptide,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,983,"inn-00835, nemifitide",Anti-depressant,3,2010,discontinued,in trial,-,Dates approximate - difficult to get info
1707,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
1708,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1709,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0200,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1710,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
1711,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
1712,paliperidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1558,"paliperidone er, paliperidone palmitate",schizophrenia,4,,-,approved,2006,
1713,pimavanserin,small molecule,Aminergic ,inverse agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1610,pimavanserin,Antiparkinson,4,,-,approved,2016,
1714,pimozide,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_20,pimozide,psychosis,4,,-,approved,1984,
1715,pipotiazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_378,pipotiazine,Antipsychotic,4,,-,approved,1980,
1716,promazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
1717,propiomazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
1718,quetiapine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1840,seroquel,Antipsychotic ; Anti-depressant,4,,-,approved,1997,
1719,renzapride,small molecule,Aminergic ,antagonist,,,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1734,renzapride,irritable bowel syndrome,3,2008,discontinued,in trial,-,Terminated due to insufficient over placebo in study
1720,risperidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD484,-,schizophrenia,4,,-,approved,1993,
1721,risperidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1770,risperdal,schizophrenia,4,,-,approved,1993,
1722,sertindole,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
1723,SL 650472,small molecule,Aminergic ,antagonist,,,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2074,"trelanserin, sl 65.0472",intermittent claudication,2,2006,discontinued,in trial,-,
1724,syn120,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0310,"syn120, Landipirdine",cognitive disorders,2,2014,Completed,in trial,-,
1725,temanogrel,small molecule,Aminergic ,inverse agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_24,temanogrel,acute coronary syndrome,1,2015,Unknown,in trial,-,
1726,terguride,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1981,terguride,"Diffuse cutaneous systemic sclerosis, Antihypertensive",3,2016,Ongoing,in trial,-,Difficult to get info; 10 year break before investigating again in Europe
1727,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,
1728,thioproperazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,Dopamine receptors,established,ASH_Oct2016_380,thioproperazine,Antipsychotic,4,,-,approved,1962,
1729,thioridazine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD521,-,schizophrenia,4,,-,approved,1962,
1730,thiothixene,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_19,thiothixene,psychosis,4,,-,approved,1967,
1731,trazodone,small molecule,Aminergic ,partial agonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2072,"trazodone extended release, dds-04a,oleptro",Anti-depressant,4,,-,approved,1981,
1732,trifluoperazine,small molecule,Aminergic ,antagonist,,secondary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_18,trifluoperazine,psychosis,4,,-,approved,1959,
1733,trimipramine,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_15,trimipramine,unipolar depression,4,,-,approved,1979,
1734,vabicaserin,small molecule,Aminergic ,agonist,,,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_22,vabicaserin,schizophrenia,2,2008,discontinued,in trial,-,
1735,volinanserin,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2172,volinanserin,Hypnotics and Sedatives,3,2008,discontinued,in trial,-,discontinued due to absence of demonstration of efficacy of volinanserin in primary insomnia with predominant sleep maintenance problems
1736,ykp-1358,unknown,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2226,"ykp-1358, Relenopride",schizophrenia,2,2008,Completed,in trial,-,Inferred dates
1737,ziprasidone,small molecule,Aminergic ,antagonist,,primary,HTR2A,5ht2a_human,P28223,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2243,"ziprasidone hcl, ziprasidone mesylate,geodon, zeldox",schizophrenia,4,,-,approved,2001,
1738,agomelatine,small molecule,Aminergic ,antagonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,87,"agomelatine, ago178c, s-20098,valdoxan, thymanax",Anti-depressant,4,,-,approved,2009,
1739,am1030,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0116,am1030,Anti-inflammatory ; atopic dermatitis,2,2015,Completed,in trial,-,
1740,amap102,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,148,amap102,Anti-inflammatory ; DMARD,2,2014,Completed,in trial,-,Phase 2 in Europe
1741,asenapine,small molecule,Aminergic ,antagonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
1742,bf-1,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,343,bf-1,Anti-migraine,1,2016,Ongoing,in trial,-,
1743,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,
1744,doxepin,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
1745,fenfluramine,small molecule,Aminergic ,agonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0273,"zx008, brabafen, low-dose fenfluramine",epilepsy; Dravet's syndrome,3,2016,recruiting,in trial,-,
1746,fluoxetine,small molecule,Aminergic ,antagonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1440,"npl-2008, fluoxetine",autism,4,,-,approved,1987,May be a bit tricky mode of action explanation but seems antagonist suits best
1747,levomepromazine,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD342,-,schizophrenia,4,,-,approved,1982,Approved prior to 1982 and then discontinued
1748,methylergonovine,small molecule,Aminergic ,partial agonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_26,methylergonovine,hemorrhage,4,,-,approved,1946,
1749,methysergide,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_25,methysergide,Anti-migraine,4,,-,approved,1962,
1750,mg01ci,small molecule,Aminergic ,antagonist,extended-release metadoxine,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0480,"mg01ci, extended-release metadoxine,",neurologic disorders; ADHD,3,2015,Terminated,in trial,-,FDA clinical hold
1751,minaprine,small molecule,Aminergic ,antagonist,,,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD368,-,Anti-depressant,4,,withdrawn,approved,1984,Not approved by fda - but used
1752,prx-08066,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1668,prx-08066,Antihypertensive,2,2008,Completed,in trial,-,
1753,quetiapine,small molecule,Aminergic ,antagonist,,secondary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1840,seroquel,Antipsychotic ; Anti-depressant,4,,-,approved,1997,
1754,renzapride,small molecule,Aminergic ,antagonist,,,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1734,renzapride,irritable bowel syndrome,3,2008,discontinued,in trial,-,Terminated due to insufficient over placebo in study
1755,terguride,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1981,terguride,"Diffuse cutaneous systemic sclerosis, Antihypertensive",3,2016,Ongoing,in trial,-,Difficult to get info; 10 year break before investigating again in Europe
1756,triflupromazine,small molecule,Aminergic ,antagonist,,primary,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD542,-,Antiemetics; Antipsychotic,4,,-,approved,1957,
1757,vabicaserin,small molecule,Aminergic ,agonist,,,HTR2B,5ht2b_human,P41595,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_27,vabicaserin,schizophrenia,2,2008,discontinued,in trial,-,
1758,agomelatine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,87,"agomelatine, ago178c, s-20098,valdoxan, thymanax",Anti-depressant,4,,-,approved,2009,
1759,amap102,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,148,amap102,Anti-inflammatory ; DMARD,2,2014,Completed,in trial,-,
1760,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
1761,athx-105,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,263,athx-105,Anti-obesity,2,2008,discontinued,in trial,-,
1762,bifeprunox,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,
1763,bupropion/trazodone,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0462,"lorexys, sip-104, bupropion/trazodone",Anti-depressant; for Hypoactive Sexual Desire Disorder and Female Sexual Dysfunction,2,2014,Completed,in trial,-,
1764,captodiame,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,Adrenoceptors,established,ASH_Oct2016_400,captodiame,anxiolytic,4,,-,approved,-,
1765,chlorprothixene,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD096,-,schizophrenia,4,,-,approved,1967,
1766,clozapine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD120,-,schizophrenia,4,,-,approved,1989,
1767,cyclobenzaprine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_32,cyclobenzaprine,spasticity,4,,-,approved,1977,
1768,doxepin,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1851,silenor (so-101),Hypnotics and Sedatives,4,,-,approved,1969,
1769,eplivanserine,small molecule,Aminergic ,inverse agonist,,,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,721,"eplivanserine, sr 46349,ciltyri",insomnia,3,2009,discontinued,in trial,-,Sanofi withdrew application for fda approval 2009
1770,esmirtazapine,small molecule,Aminergic ,antagonist,,,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_38,esmirtazapine,insomnia,3,2008,discontinued,in trial,-,
1771,fenfluramine,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0274,"zx008, brabafen, low-dose fenfluramine",epilepsy; Dravet's syndrome,3,2016,recruiting,in trial,-,
1772,lorcaserin,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1164,lorcaserin,Anti-obesity,4,,-,approved,2012,
1773,loxapine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_31,loxapine,psychosis,4,,-,approved,1975,
1774,methixene,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_35,methixene,Antiparkinson,4,,-,approved,1982,
1775,methysergide,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD353,-,Anti-migraine s; Vasoconstrictor,4,,-,approved,1962,
1776,mianserin,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD363,-,Anti-depressant,4,,-,approved,1996,"Doesn't appear to be FDA approved, but analogue mirtazapine is "
1777,minaprine,small molecule,Aminergic ,antagonist,,,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD368,-,Anti-depressant,4,,withdrawn,approved,1984,Not approved by fda - but used
1778,mirtazapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_29,mirtazapine,unipolar depression,4,,-,approved,1996,
1779,nefazodone,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_33,nefazodone,unipolar depression,4,,-,approved,1994,
1780,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
1781,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1782,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0201,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1783,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
1784,olanzapine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
1785,promazine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD462,-,Antiemetics; Antipsychotic,4,,-,approved,1956,
1786,propiomazine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD467,-,Hypnotics and Sedatives,4,,-,approved,1960,
1787,quetiapine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1840,seroquel,Antipsychotic ; Anti-depressant,4,,-,approved,1997,
1788,renzapride,small molecule,Aminergic ,antagonist,,,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1734,renzapride,irritable bowel syndrome,3,2008,discontinued,in trial,-,Terminated due to insufficient over placebo in study
1789,risperidone,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_28,risperidone,schizophrenia,4,,-,approved,1993,
1790,sertindole,small molecule,Aminergic ,inverse agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
1791,tedatioxetine,small molecule,Aminergic ,antagonist,,,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1173,lu aa24530,Anti-depressant,2,2009,discontinued,in trial,-,discontinued for strategic reasons
1792,thiethylperazine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD519,-,Antiemetics,4,,-,approved,1961,
1793,thioridazine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_34,thioridazine,psychosis,4,,-,approved,1962,
1794,tramadol,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,
1795,tramadol,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0676,e-58425,Analgesics,3,2017,recruiting,in trial,-,
1796,tramadol,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2055,"tramadol extended-release,raliva er",Analgesics,4,,-,approved,1995,
1797,tramadol,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2056,"tramadol hydrochloride,ultram",Analgesics,4,,-,approved,1995,
1798,tramadol,small molecule,Aminergic ,agonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2057,"tramadol,tridural, ryzolt",Analgesics,4,,-,approved,1995,
1799,trazodone,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2072,"trazodone extended release, dds-04a,oleptro",Anti-depressant,4,,-,approved,1981,
1800,trifluoperazine,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_36,trifluoperazine,psychosis,4,,-,approved,1959,
1801,trimipramine,small molecule,Aminergic ,antagonist,,primary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_37,trimipramine,unipolar depression,4,,-,approved,1979,
1802,vabicaserin,small molecule,Aminergic ,agonist,,,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_39,vabicaserin,schizophrenia,2,2008,discontinued,in trial,-,
1803,ziprasidone,small molecule,Aminergic ,antagonist,,secondary,HTR2C,5ht2c_human,P28335,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_30,ziprasidone,schizophrenia,4,,-,approved,2001,
1804,ati-7505,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,265,ati-7505,Parasympathomimetic,2,2009,Completed,in trial,-,
1805,cisapride,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD109,-,Parasympathomimetics,4,,-,approved,1993,
1806,metoclopramide,small molecule,Aminergic ,antagonist,,secondary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_40,metoclopramide,pregnancy,4,,-,approved,1979,is this a completely different indication?
1807,mosapride,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1337,"mosapride citrate, tak-370,gasmotin",Gastrointestinal reflux disease (GERD),3,2016,recruiting,in trial,-,"Not approved by the FDA, but in other countries for GERD. Trials for many other indications: diabetes, IBS"
1808,naronapride,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_41,naronapride,constipation,2,2009,Completed,in trial,-,
1809,prucalopride,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1665,"prucalopride ,resolor",motilitant,4,,-,approved,2009,
1810,prx-3140,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1671,prx-3140,Alzheimer's disease,2,2013,Completed,in trial,-,
1811,renzapride,small molecule,Aminergic ,agonist,,,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1734,renzapride,irritable bowel syndrome,3,2008,discontinued,in trial,-,Terminated due to insufficient over placebo in study
1812,suvn-d4010,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0094,suvn-d4010,Alzheimer's disease,1,2017,recruiting,in trial,-,
1813,td-2749,unknown,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1972,td-2749,motilitant,1,2005,discontinued,in trial,-,
1814,tegaserod,small molecule,Aminergic ,partial agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1975,"tegaserod,zelnorm, zelmac",motilitant,4,,-,approved,2002,
1815,velusetrag,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2145,"velusetrag, td-5108",motilitant,2,2014,Ongoing,in trial,-,
1816,ykp10811,small molecule,Aminergic ,agonist,,primary,HTR4,5ht4r_human,Q13639,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0641,ykp10811,for chronic or functional constipation,2,2014,Completed,in trial,-,
1817,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR5A,5ht5a_human,P47898,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
1818,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
1819,avn-101,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,290,avn-101,Alzheimer's disease,1,2009,Completed,in trial,-,
1820,avn-211,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,291,avn-211,schizophrenia,2,2010,Unknown,in trial,-,
1821,avn-322,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,292,avn-322,Alzheimer's disease,1,2010,discontinued,in trial,-,
1822,avn-397,small molecule,Aminergic ,unknown,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,2490,avn-397,Alzheimer's disease,2,2010,discontinued,in trial,-,Undefined or unknown MoA
1823,cerlapirdine,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_43,cerlapirdine,Alzheimer's disease,2,2009,discontinued,in trial,-,
1824,idalopirdine,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_42,idalopirdine,Alzheimer's disease,3,2014,recruiting,in trial,-,
1825,iloperidone,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1826,intepirdine,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_44,intepirdine,Alzheimer's disease,2,2016,recruiting,in trial,-,
1827,lu-ae58054,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1177,"lu-ae58054 , ly-483518, sgs518",schizophrenia,3,2014,Ongoing,in trial,-,
1828,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
1829,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1830,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0209,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1831,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
1832,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
1833,pf-05212377,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_45,pf-05212377,Alzheimer's disease,2,2012,Terminated,in trial,-,Terminated not due to safety concerns - may still be viable drug to investigate
1834,prx-07034,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1667,prx-07034,Anti-obesity ; nootropic,1,2007,Completed,in trial,-,Sold to undisclosed company in 2009
1835,rvt-101,small molecule,Aminergic ,antagonist,"sb-742457,  gsk 742457",primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmar2016_0106,"rvt-101, sb-742457, gsk 742457",Alzheimer's disease,3,2015,Ongoing,in trial,-,
1836,sertindole,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1838,serdolect,schizophrenia,3,2015,recruiting,withdrawn,1998,Not FDA approved but used in other countries; was withdrawn in 1996 but looks to be approved again in Europe and soon to market
1837,suvn-502,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1920,suvn-502,Alzheimer's disease,2,2015,recruiting,in trial,-,
1838,syn120,small molecule,Aminergic ,antagonist,,primary,HTR6,5ht6r_human,P50406,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0309,"syn120, Landipirdine",cognitive disorders,2,2014,Completed,in trial,-,
1839,asenapine,small molecule,Aminergic ,antagonist,,primary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,250,asenapine,schizophrenia,4,,-,approved,2009,
1840,bifeprunox,small molecule,Aminergic ,agonist,,primary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,356,"bifeprunox, du127090",Antipsychotic ; Antiparkinson,3,2009,discontinued,in trial,-,
1841,brexpiprazole,small molecule,Aminergic ,partial agonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1502,brexpiprazole,Anti-depressant,4,,-,approved,2015,
1842,iloperidone,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,951,"iloperidone,fanapt, fiapta, zomaril",Antipsychotic ; atypical,4,,-,approved,2009,
1843,lurasidone,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAapril2016_0237,"cyclurad, d-cycloserine + lurasidone",schizophrenia,4,,-,approved,2010,
1844,lurasidone,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1184,"lurasidone, sm-13496,latuda",schizophrenia,4,,-,approved,2010,
1845,ly2590443,small molecule,Aminergic ,antagonist,,primary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Sep2016_46,ly2590443,Anti-migraine,2,2008,discontinued,in trial,-,
1846,methysergide,small molecule,Aminergic ,antagonist,,primary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,NRDD353,-,Anti-migraine s; Vasoconstrictor,4,,-,approved,1962,
1847,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1476,"olanzapine/fluoxetine combination,symbyax (zyprexa/prozac)",Anti-depressant,4,,-,approved,1996,
1848,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,APR13_0013,alks 3831,schizophrenia,4,,-,approved,1996,
1849,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,MMAmay2016_0203,"alks 3831,  olanzapine + alks 33,samidorphan",schizophrenia,4,,-,approved,1996,
1850,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1475,"olanzapine,zyprexa, zypadhera, zyprexa relprevv",schizophrenia,4,,-,approved,1996,
1851,olanzapine,small molecule,Aminergic ,antagonist,,secondary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1515,"orex-003, olanzapine plus zonisamide sr",schizophrenia,4,,-,approved,1996,
1852,pardoprunox,small molecule,Aminergic ,agonist,,,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1563,"pardoprunox, slv 308",Antiparkinson,3,2009,discontinued,in trial,-,
1853,vortioxetine,small molecule,Aminergic ,agonist,,primary,HTR7,5ht7r_human,P34969,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,1171,lu aa21004,Anti-depressant,4,,-,approved,2013,
1854,nu206,protein,Orphan ,not available,,,LGR4,lgr4_human,Q9BXB1,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,2528,"nu206, r-spondin1",gastrointestinal disease,1,2006,discontinued,in trial,-,
1855,nu206,protein,Orphan ,not available,,,LGR5,lgr5_human,O75473,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,2528,"nu206, r-spondin1",gastrointestinal disease,1,2006,discontinued,in trial,-,
1856,avicine,vaccine,Protein ,not available,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,563,"ctp-37,avicine",Antineoplastic,1,1997,discontinued,in trial,-,
1857,buserelin,peptide,Protein ,not available,,secondary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,ASH_Oct2016_427,buserelin,LHRH analogue,4,,-,approved,-,
1858,chorionic gonadotropin,protein,Protein ,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,2529,"ml-04, LDI-100",Antineoplastic,3,2016,Not open yet,in trial,-,
1859,chorionic gonadotropin,protein,Protein ,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,1756,"r-hcg,ovidrel",Antineoplastic,4,,-,approved,1973,
1860,chorionic gonadotropin,protein,Protein ,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD099,-,Fertility,4,,-,approved,1973,
1861,chorionic gonadotropin,protein,Protein ,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,1904,"stem,ntx-265",stroke,4,,-,approved,1973,
1862,goserelin,peptide,Protein ,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD260,-,Antineoplastic s; Hormonal,4,,-,approved,1989,
1863,gtx-758,small molecule,Protein ,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,888,gtx-758,Antineoplastic,2,2012,recruiting,in trial,-,Other studies were terminated from FDA hold
1864,lutropin alfa,peptide,Protein ,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD311,-,Fertility,4,,-,approved,2004,
1865,menotropins,protein,Protein ,agonist,,primary,LHCGR,lshr_human,P22888,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD322,-,Fertility,4,,-,approved,1975,
1866,am-152,small molecule,Lipid ,antagonist,,primary,LPAR1,lpar1_human,Q92633,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (LPA) receptors,not established,144,"am-152, BMS 986020",Anti-inflammatory ; antifibrotic,2,2015,Completed,in trial,-,
1867,mc-1,small molecule,Lipid ,antagonist,,,LPAR4,lpar4_human,Q99677,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (LPA) receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
1868,mc-4232 + mc-1,small molecule,Lipid ,antagonist,,,LPAR4,lpar4_human,Q99677,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (LPA) receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
1869,mc-1,small molecule,Lipid ,antagonist,,,LPAR6,lpar6_human,P43657,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (LPA) receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
1870,mc-4232 + mc-1,small molecule,Lipid ,antagonist,,,LPAR6,lpar6_human,P43657,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (LPA) receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
1871,amelubant,small molecule,Lipid ,antagonist,,primary,LTB4R,lt4r1_human,Q15722,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,not established,ASH_Sep2016_302,amelubant,chronic obstructive pulmonary disease (COPD),2,2014,discontinued,in trial,-,Disontinued due to significant increase in pulmonary related serious adverse events 
1872,rx-10045,small molecule,Lipid ,partial agonist,,primary,LTB4R,lt4r1_human,Q15722,Class A (Rhodopsin),GPCR;Rhodopsin,Leukotriene receptors,not established,2317,rx-10045,dry eye,2,2014,Completed,in trial,-,
1873,txa127,peptide,Orphan ,agonist,angiotensin(1-7),primary,MAS1,mas_human,P04201,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,MMAmay2016_0617,"txa127, angiotensin (1-7)","Epidermolysis bulbosa, hypertension, muscular dystrophies",0,2016,Not open yet,in trial,-,
1874,txa127,peptide,Orphan ,agonist,angiotensin(1-7),primary,MAS1,mas_human,P04201,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,MMAmay2016_0617,"txa127, angiotensin (1-7)",for stem cell engraftment and thrombocytopenia,2,2012,discontinued,in trial,-,
1875,afamelanotide,small molecule,Peptide ,agonist,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,73,afamelanotide,dermatological,3,2009,Completed,in trial,-,Seeking FDA approval
1876,alb-127158(a),small molecule,Peptide ,antagonist,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,100,alb-127158(a),Anti-obesity,1,2011,discontinued,in trial,-,UK
1877,ap1030,small molecule,Peptide ,PAM,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,189,ap1030,Anti-obesity,1,2010,Completed,in trial,-,
1878,ap214,peptide,Peptide ,agonist,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,2538,ap214,post-surgical kidney injury,2,2008,discontinued,in trial,-,
1879,bremelanotide,peptide,Peptide ,agonist,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,383,bremelanotide,sexual dysfunction,3,2015,Ongoing,in trial,-,
1880,modimelanotide,protein,Peptide ,agonist,,,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,ASH_Sep2016_259,modimelanotide,acute kidney injury,2,2013,discontinued,in trial,-,
1881,srx-1177,peptide,Peptide ,not available,,primary,MC1R,mshr_human,Q01726,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,MMAapril2016_0099,srx-1177,Antineoplastic,0,2015,Not open yet,in trial,-,
1882,cosyntropin,small molecule,Peptide ,agonist,,primary,MC2R,acthr_human,Q01718,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,established,MMAmar2016_0275,"re-034, cosyntropin, tetracosactid",epilepsy,0,2016,Ongoing,in trial,-,
1883,cosyntropin,peptide,Peptide ,agonist,,primary,MC2R,acthr_human,Q01718,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,established,NRDD128,-,Diagnostic,4,,-,approved,1970,
1884,ap214,peptide,Peptide ,agonist,,primary,MC3R,mc3r_human,P41968,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,2538,ap214,post-surgical kidney injury,2,2008,discontinued,in trial,-,
1885,bremelanotide,protein,Peptide ,agonist,,primary,MC3R,mc3r_human,P41968,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,ASH_Sep2016_260,bremelanotide,sexual dysfunction,3,2015,Ongoing,in trial,-,
1886,modimelanotide,protein,Peptide ,agonist,,,MC3R,mc3r_human,P41968,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,ASH_Sep2016_261,modimelanotide,acute kidney injury,2,2013,discontinued,in trial,-,
1887,ap1030,small molecule,Peptide ,PAM,,primary,MC4R,mc4r_human,P32245,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,189,ap1030,Anti-obesity,1,2010,Completed,in trial,-,No development reported
1888,ap214,peptide,Peptide ,agonist,,primary,MC4R,mc4r_human,P32245,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,2538,ap214,post-surgical kidney injury,2,2008,discontinued,in trial,-,
1889,azd2820,small molecule,Peptide ,agonist,,primary,MC4R,mc4r_human,P32245,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,MMAmay2016_0297,azd2820,Anti-obesity,1,2011,discontinued,in trial,-,
1890,bremelanotide,peptide,Peptide ,agonist,,primary,MC4R,mc4r_human,P32245,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,383,bremelanotide,sexual dysfunction,3,2015,Ongoing,in trial,-,
1891,rm-493,peptide,Peptide ,agonist,setmelanotide,primary,MC4R,mc4r_human,P32245,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,MMAmay2016_0229,"rm-493, setmelanotide",Anti-obesity,3,2017,recruiting,in trial,-,
1892,ap214,peptide,Peptide ,agonist,,primary,MC5R,mc5r_human,P33032,Class A (Rhodopsin),GPCR;Rhodopsin,Melanocortin receptors,not established,2538,ap214,post-surgical kidney injury,2,2008,discontinued,in trial,-,
1893,ngd-4715,small molecule,Peptide ,antagonist,,primary,MCHR1,mchr1_human,Q99705,Class A (Rhodopsin),GPCR;Rhodopsin,Melanin-concentrating hormone,not established,1408,ngd-4715,Appetite suppressant,2,2008,discontinued,in trial,-,
1894,camicinal,small molecule,Peptide ,agonist,,primary,MLNR,mtlr_human,O43193,Class A (Rhodopsin),GPCR;Rhodopsin,Motilin receptors,not established,ASH_Sep2016_262,camicinal,gastroparesis,2,2014,Completed,in trial,-,
1895,kos-2187,small molecule,Peptide ,agonist,,primary,MLNR,mtlr_human,O43193,Class A (Rhodopsin),GPCR;Rhodopsin,Motilin receptors,not established,1078,kos-2187,gastrointestinal motility disorders,1,2006,discontinued,in trial,-,
1896,mitemcinal,small molecule,Peptide ,agonist,,primary,MLNR,mtlr_human,O43193,Class A (Rhodopsin),GPCR;Rhodopsin,Motilin receptors,not established,1296,"mitemcinal, gm-611",gastroparesis,2,2002,discontinued,in trial,-,
1897,samidoprhan,small molecule,Peptide ,antagonist,,primary,MOR,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,APR13_0013,alks 3831,addiction,3,2016,recruiting,in trial,-,
1898,agomelatine,small molecule,Melatonin ,agonist,,primary,MTNR1A,mtr1a_human,P48039,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,87,"agomelatine, ago178c, s-20098,valdoxan, thymanax",Anti-depressant,4,,-,approved,2009,
1899,melatonin,small molecule,Melatonin ,agonist,,primary,MTNR1A,mtr1a_human,P48039,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,NRDD320,-,Hypnotics and Sedatives,4,,-,approved,2005,
1900,pd-6735,small molecule,Melatonin ,agonist,tik-301,primary,MTNR1A,mtr1a_human,P48039,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1575,"pd-6735, ly-156735, tik-301",Hypnotics and Sedatives,2,2004,Completed,in trial,-,May still be researched
1901,ramelteon,small molecule,Melatonin ,agonist,,primary,MTNR1A,mtr1a_human,P48039,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1713,"ramelteon, tak-375,rozerem",insomnia,4,,-,approved,2005,
1902,tasimelteon,small molecule,Melatonin ,agonist,,primary,MTNR1A,mtr1a_human,P48039,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1956,"tasimelteon, vec-162",Hypnotics and Sedatives,4,,-,approved,2014,
1903,agomelatine,small molecule,Melatonin ,agonist,,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,86,"agomelatine , ago178c, s-20098,valdoxan, thymanax",Anti-depressant,4,,-,approved,2009,
1904,melatonin,small molecule,Melatonin ,agonist,,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,NRDD320,-,Hypnotics and Sedatives,4,,-,approved,2005,
1905,pd-6735,small molecule,Melatonin ,agonist,tik-301,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1575,"pd-6735, ly-156735, tik-301",Hypnotics and Sedatives,2,2004,Completed,in trial,-,May still be researched
1906,ramelteon,small molecule,Melatonin ,agonist,,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1713,"ramelteon, tak-375,rozerem",insomnia,4,,-,approved,2005,
1907,tasimelteon,small molecule,Melatonin ,agonist,,primary,MTNR1B,mtr1b_human,P49286,Class A (Rhodopsin),GPCR;Rhodopsin,Melatonin,established,1956,"tasimelteon, vec-162",Hypnotics and Sedatives,4,,-,approved,2014,
1908,obinepitide,small molecule,Peptide ,agonist,,primary,NPY2R,npy2r_human,P49146,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,2027,"tm30338,obinepitide",Anti-obesity,2,2010,Completed,in trial,-,Sweden
1909,peptide yy,peptide,Peptide ,agonist,,primary,NPY2R,npy2r_human,P49146,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,699,eligen pyy-3-36 + glp-1,Appetite suppressant,1,2009,Completed,in trial,-,
1910,velneperit,small molecule,Peptide ,antagonist,,primary,NPY5R,npy5r_human,Q15761,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,2144,"velneperit, s-2367",Anti-obesity,2,2010,discontinued,in trial,-,
1911,chenodeoxycholic acid,small molecule,Aminergic ,agonist,,primary,NR1H4,nr1h4_human,Q96RI1,Class A (Rhodopsin),Nuclear receptor,Acetylcholine receptors (muscarinic),established,ASH_Oct2016_413,chenodeoxycholic acid,gall stones,4,,-,approved,1983,
1912,adl5747,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,55,adl5747,osteoarthritis,2,2010,discontinued,in trial,-,
1913,adl5859,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,56,"adl5859, pf-04856880",osteoarthritis,2,2009,discontinued,in trial,-,
1914,alks 33,small molecule,Peptide ,antagonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,115,"alks 29, Baclofen+samidorphan",alcohol dependance; Anti-depressant,1,2008,discontinued,in trial,-,
1915,alks 33,small molecule,Peptide ,antagonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,116,"alks 33, samidorphan",alcohol dependance; Anti-depressant,2,2009,Completed,in trial,-,
1916,alks 33,small molecule,Peptide ,antagonist,alks5461,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,118,"alks 33, alks 5461, Buprenorphine+samidorphan",alcohol dependance; Anti-depressant,3,2014,Completed,in trial,-,
1917,alks 33,small molecule,Peptide ,antagonist,samidorphan,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0184,"alks 3831,  olanzapine + alks 33,samidorphan",Anti-obesity,3,2016,recruiting,in trial,-,
1918,alks 37,small molecule,Peptide ,antagonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,117,alks 37,motilitant,2,2011,discontinued,in trial,-,
1919,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2109,v1003,Anti-depressant; Analgesics; opioid addiction,2,2006,Completed,in trial,-,
1920,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,118,"alks 5461, Buprenorphine/samidorphan",Anti-depressant; Analgesics; opioid addiction,3,2017,Completed,in trial,-,
1921,butorphanol,small molecule,Peptide ,partial agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD070,-,Analgesics,4,,-,approved,1978,
1922,cebranopadol,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_264,cebranopadol,diabetic neuropathy,3,2016,recruiting,in trial,-,
1923,codeine,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD124,-,Analgesics,4,,-,approved,2009,
1924,eluxadoline,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1363,"mu delta, eluxadoline",irritable bowel syndrome,4,,-,approved,2015,
1925,fentanyl,small molecule,Peptide ,agonist,,,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,259,at3022,Analgesics,1,2011,discontinued,in trial,-,
1926,fentanyl,small molecule,Peptide ,agonist,,,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,783,fentanyl mdts,Analgesics,1,2009,discontinued,in trial,-,
1927,fentanyl,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,69,aerolef,Analgesics,2,2010,Completed,in trial,-,
1928,fentanyl,small molecule,Peptide ,agonist,,,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,782,"fentanyl lauriad, ba-041",Analgesics,2,2014,discontinued,in trial,-,
1929,fentanyl,small molecule,Peptide ,agonist,,,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,786,fentanyl taifun,Analgesics,3,2011,discontinued,in trial,-,
1930,fentanyl,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,303,"az-003, staccato fentanyl",adjuvant to anesthesia,4,,-,approved,1968,
1931,fentanyl,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,51,ad 923,Analgesics,4,,-,approved,1968,
1932,fentanyl,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,334,"bema fentanyl,onsolis, breakyl",Analgesics,4,,-,approved,1968,
1933,fentanyl,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,394,buccal fentanyl,Analgesics,4,,-,approved,1968,
1934,fentanyl,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,775,"febt,fentora, effentora",Analgesics,4,,-,approved,1968,
1935,fentanyl,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,780,"fentanyl (sublingual), kw-2246,abstral, rapinyl",Analgesics,4,,-,approved,1968,
1936,fentanyl,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,781,"fentanyl citrate,pecfent, nasalfent",Analgesics,4,,-,approved,1968,
1937,fentanyl,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,784,"fentanyl spray, intranasal,instanyl",Analgesics,4,,-,approved,1968,
1938,fentanyl,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,785,fentanyl sublingual spray,Analgesics,4,,-,approved,1968,
1939,fentanyl,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,787,"fentanyl transdermal system,duragesic, ionsys",Analgesics,4,,-,approved,1968,
1940,fentanyl,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2069,"transmucosal fentanyl,actiq",Analgesics,4,,-,approved,1968,
1941,hydrocodone,small molecule,Peptide ,agonist,,,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1686,pti-701,Analgesics,2,2006,discontinued,in trial,-,
1942,hydrocodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0193,hydrocodone,Analgesics,4,,-,approved,1943,
1943,hydrocodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0754,hydrocodone bitartrate with acetaminophen,Analgesics,4,,-,approved,1943,
1944,hydrocodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0010,"hysingla er, hydrocodone bitartrate extended release",Analgesics,4,,-,approved,1943,
1945,hydrocodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0082,"s-718632, extended release hydrocodone",Analgesics,4,,-,approved,1943,
1946,hydrocodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2254,"zx002, hydrocodone bitartrate",Analgesics,4,,-,approved,1943,
1947,hydromorphone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0261,"ltx-04,  hydromorphone hcl",Analgesics,1,2015,Completed,in trial,-,
1948,hydromorphone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1422,"nmed-1077,exalgo, jurnista, dilaudid",Analgesics,4,,-,approved,1984,
1949,ketobemidone,small molecule,Aminergic ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_352,ketobemidone,Analgesics,4,,-,approved,-,
1950,kp201,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1079,kp201 (prodrug of hydrocodone),Analgesics,2,2015,Completed,in trial,-,Difficult to get good clinical trial info for
1951,morphine,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1013,"intranasal morphine,rylomine",Analgesics,2,2008,Completed,in trial,-,
1952,morphine,small molecule,Peptide ,agonist,,,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,2,2002,discontinued,in trial,-,
1953,morphine,small molecule,Peptide ,agonist,,,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,
1954,morphine,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1207,"m6g, cee 04-410",Analgesics,3,2008,Completed,in trial,-,
1955,morphine,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1279,"mh-200, tak-453 sr, morphine hcl,anpec",Analgesics,3,2002,Completed,in trial,-,
1956,morphine,small molecule,Peptide ,agonist,,,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1335,"morphine/dextromethorphan,morphidex",Analgesics,3,2006,discontinued,in trial,-,
1957,morphine,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1984,
1958,morphine,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1334,"morphine sulfate,depodur, depomorphine",Analgesics,4,,-,approved,1984,
1959,morphine,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2051,tpm-1/morphine,Analgesics,4,,-,approved,1984,
1960,morphine,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0057,"egalet-001, reformulated morphine",Analgesics; opioid addiction,4,,-,approved,1984,
1961,morphine,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1333,"morphine sulfate,avinza",Analgesics,4,,-,approved,2002,
1962,nalbuphine,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,2,2006,discontinued,in trial,-,
1963,nalbuphine,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1374,"nalbuphine hydrochloride,  pw-4142",Analgesics,4,,-,approved,1979,
1964,nalmefene,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2766,srd174,pruritus,4,,-,approved,1995,
1965,nalmefene,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1375,"nalmefene, cph-101",smoking-cessation ; addiction,4,,-,approved,2013,
1966,naloxone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,405,"buprenorphine + naloxone capsule,nanobup",Analgesics,4,,-,approved,1971,
1967,naloxone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0089,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",Analgesics,4,,-,approved,1971,
1968,naloxone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,4,,-,approved,1971,
1969,naloxone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,406,"buprenorphine + naloxone,suboxone",Analgesics; opioid addiction,4,,-,approved,1971,
1970,naloxone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0921,"ox219, buprenorphine + naloxone sublingual tablet",Analgesics; opioid addiction,4,,-,approved,1971,
1971,naloxone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0646,"naloxone nasal spray, indivior",Analgesics; overdose/drug toxicity,4,,-,approved,1971,
1972,naloxone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0710,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,
1973,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,
1974,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1686,pti-701,Analgesics,2,2006,discontinued,in trial,-,
1975,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching
1976,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1998,
1977,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,4,,-,approved,1998,
1978,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1688,pti-901,Analgesics,4,,-,approved,1998,
1979,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0074,"pxt3003, baclofen + naltrexone + sorbitol",Analgesics; for type 1A Charcot-Marie-Tooth disease,4,,-,approved,1998,
1980,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,522,contrave,Appetite suppressant,4,,-,approved,1998,
1981,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2168,vivitrol,substance abuse,4,,-,approved,1998,
1982,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0085,eli-200,addiction,4,,-,approved,2016,
1983,nrp290,small molecule,Peptide ,agonist,,,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1444,nrp290,Analgesics,1,2006,discontinued,in trial,-,
1984,odelepran,small molecule,Peptide ,antagonist,,,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_263,odelepran,alcohol dependence,2,2008,discontinued,in trial,-,
1985,oxycodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,696,"eli-154, oxycodone (once daily)",Analgesics,2,2012,discontinued,in trial,-,
1986,oxycodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,
1987,oxycodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1546,"oxycodone hcl + niacin,acurox, oxyadf",Analgesics,3,2010,discontinued,in trial,-,rejected for approval by FDA in 2010
1988,oxycodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1547,"oxycodone, pti-821,remoxy",Analgesics,3,2016,Completed,in trial,-,waiting for FDA approval
1989,oxycodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching
1990,oxycodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0079,"rexista, oxycodone xr",Analgesics,3,2016,Completed,in trial,-,waiting for FDA approval
1991,oxycodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1545,"oxycodone art, eli216,oxynal",Analgesics,4,,-,approved,1998,
1992,oxycodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2068,transdermal oxycodone,Analgesics,4,,-,approved,1998,
1993,oxycodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0707,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,
1994,oxycodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,515,"col-172, extended-release oxycodone",Analgesics,4,,-,approved,2011,
1995,oxycodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,514,"col-003, sustained release oxycodone",Analgesics,4,,-,approved,2016,
1996,oxycodone,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0088,eli-200,Analgesics,4,,-,approved,2016,
1997,oxymorphone,small molecule,Peptide ,agonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1548,"oxymorphone hydrochloride, en3202,opana, opana er",Analgesics,4,,-,approved,1959,
1998,propoxyphene,small molecule,Peptide ,agonist,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD468,-,Analgesics,4,,-,approved,1957,
1999,pti-202,unknown,Peptide ,not available,,primary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1684,pti-202,Analgesics,1,2006,Completed,in trial,-,Not good information - may have changed names within Pain Therapeutics
2000,sufentanil,small molecule,Peptide ,agonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1909,"sufentanil transdermal patch,transdur-sufentanil",Analgesics,2,2015,discontinued,in trial,-,
2001,sufentanil,small molecule,Peptide ,agonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1910,"sufentanil,chronogesic",Analgesics,2,2015,discontinued,in trial,-,
2002,sufentanil,small molecule,Peptide ,agonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,243,"arx-03, sufentanil + triazolam nanotab",Analgesics; adjuvant to anesthesia,2,2011,suspended,in trial,-,
2003,sufentanil,small molecule,Peptide ,agonist,,secondary,OPRD1,oprd_human,P41143,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,242,"arx-01, sufentanil nanotab",Analgesics; adjuvant to anesthesia,4,,-,approved,1984,
2004,alks 33,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,115,"alks 29, Baclofen+samidorphan",alcohol dependance; Anti-depressant,1,2008,discontinued,in trial,-,
2005,alks 33,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,116,"alks 33, samidorphan",alcohol dependance; Anti-depressant,2,2009,Completed,in trial,-,
2006,alks 33,small molecule,Peptide ,antagonist,alks5461,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,118,"alks 33, alks 5461, Buprenorphine+samidorphan",alcohol dependance; Anti-depressant,3,2014,Completed,in trial,-,
2007,alks 33,small molecule,Peptide ,antagonist,samidorphan,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0184,"alks 3831,  olanzapine + alks 33,samidorphan",Anti-obesity,3,2016,recruiting,in trial,-,
2008,alks 37,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,117,alks 37,motilitant,2,2011,discontinued,in trial,-,
2009,asimadoline,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,253,asimadoline,Analgesics,3,2015,discontinued,in trial,-,
2010,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,405,"buprenorphine + naloxone capsule,nanobup",Anti-depressant; Analgesics; opioid addiction,1,2010,Completed,in trial,-,
2011,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2109,v1003,Anti-depressant; Analgesics; opioid addiction,2,2006,Completed,in trial,-,
2012,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,118,"alks 5461, Buprenorphine/samidorphan",Anti-depressant; Analgesics; opioid addiction,3,2017,Completed,in trial,-,
2013,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,422,cam2038,Anti-depressant; Analgesics; opioid addiction,3,2016,recruiting,in trial,-,
2014,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,333,"bema buprenorphine, buccal mucosa adhesive",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
2015,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,406,"buprenorphine + naloxone,suboxone",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
2016,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,408,"buprenorphine sublingual tablet,subutex",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
2017,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0047,"butab, rel-1028, oral, enteric-coated buprenorphine",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
2018,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,409,"butrans is a transdermal patch formulation of  buprenorphine, a partial agonist at mu opioid receptors and an antagonist at kappa opioid receptors. it is indicated as an analgesics to deliver continuous pain relief for seven days.  the efficacy of butrans",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
2019,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0516,"ox219, buprenorphine + naloxone sublingual tablet",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
2020,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,407,"buprenorphine subcutaneous implant,probuphine",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,2016,
2021,butorphanol,small molecule,Peptide ,partial agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD070,-,Analgesics,4,,-,approved,1978,
2022,cebranopadol,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_267,cebranopadol,diabetic neuropathy,3,2016,recruiting,in trial,-,
2023,cerc-501,small molecule,Peptide ,antagonist,ly2456302,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0074,"cerc-501, ly2456302",Substance use disorders,2,2016,recruiting,in trial,-,
2024,cocaine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD123,-,local anesthetic,4,,-,approved,1982,
2025,codeine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD124,-,Analgesics,4,,-,approved,2009,
2026,cr665,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,539,"cr665, JNJ 38488502",Analgesics,2,2004,discontinued,in trial,-,
2027,cr845,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,540,cr845,Analgesics,3,2015,recruiting,in trial,-,
2028,dezocine,small molecule,Peptide ,partial agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD157,-,Analgesics,4,,-,approved,1989,
2029,hydrocodone,small molecule,Peptide ,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_265,hydrocodone,Analgesics,4,,-,approved,2013,
2030,hydromorphone,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0262,"ltx-04,  hydromorphone hcl",Analgesics,1,2015,Completed,in trial,-,
2031,hydromorphone,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1422,"nmed-1077,exalgo, jurnista, dilaudid",Analgesics,4,,-,approved,1984,
2032,ketobemidone,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Oct2016_351,ketobemidone,Analgesics,4,,-,approved,-,
2033,kp201,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1079,kp201 (prodrug of hydrocodone),Analgesics,2,2015,Completed,in trial,-,Difficult to get good clinical trial info for
2034,meperidine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD325,-,Analgesics,4,,-,approved,1942,
2035,morphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1013,"intranasal morphine,rylomine",Analgesics,2,2008,Completed,in trial,-,
2036,morphine,small molecule,Peptide ,agonist,,,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,2,2002,discontinued,in trial,-,
2037,morphine,small molecule,Peptide ,agonist,,,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,
2038,morphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1207,"m6g, cee 04-410",Analgesics,3,2008,Completed,in trial,-,
2039,morphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1279,"mh-200, tak-453 sr, morphine hcl,anpec",Analgesics,3,2002,Completed,in trial,-,
2040,morphine,small molecule,Peptide ,agonist,,,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1335,"morphine/dextromethorphan,morphidex",Analgesics,3,2006,discontinued,in trial,-,
2041,morphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1984,
2042,morphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1334,"morphine sulfate,depodur, depomorphine",Analgesics,4,,-,approved,1984,
2043,morphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1903,statex,Analgesics,4,,-,approved,1984,
2044,morphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2051,tpm-1/morphine,Analgesics,4,,-,approved,1984,
2045,morphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0055,"egalet-001, reformulated morphine",Analgesics; opioid addiction,4,,-,approved,1984,
2046,morphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1333,"morphine sulfate,avinza",Analgesics,4,,-,approved,2002,
2047,nalbuphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,2,2006,discontinued,in trial,-,
2048,nalbuphine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1374,"nalbuphine hydrochloride,  pw-4142",Analgesics,4,,-,approved,1979,
2049,nalmefene,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2766,srd174,pruritus,4,,-,approved,1995,
2050,nalmefene,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1375,"nalmefene, cph-101",smoking-cessation ; addiction,4,,-,approved,2013,
2051,naloxone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,405,"buprenorphine + naloxone capsule,nanobup",Analgesics,4,,-,approved,1971,
2052,naloxone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0090,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",Analgesics,4,,-,approved,1971,
2053,naloxone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,4,,-,approved,1971,
2054,naloxone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,406,"buprenorphine + naloxone,suboxone",Analgesics; opioid addiction,4,,-,approved,1971,
2055,naloxone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0518,"ox219, buprenorphine + naloxone sublingual tablet",Analgesics; opioid addiction,4,,-,approved,1971,
2056,naloxone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0647,"naloxone nasal spray, indivior",Analgesics; overdose/drug toxicity,4,,-,approved,1971,
2057,naloxone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0711,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,
2058,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,
2059,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1686,pti-701,Analgesics,2,2006,discontinued,in trial,-,
2060,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching
2061,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1998,
2062,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,4,,-,approved,1998,
2063,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1688,pti-901,Analgesics,4,,-,approved,1998,
2064,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0075,"pxt3003, baclofen + naltrexone + sorbitol",Analgesics; for type 1A Charcot-Marie-Tooth disease,4,,-,approved,1998,
2065,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,522,contrave,Appetite suppressant,4,,-,approved,1998,
2066,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2168,vivitrol,substance abuse,4,,-,approved,1998,
2067,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0086,eli-200,addiction,4,,-,approved,2016,
2068,nrp290,small molecule,Peptide ,agonist,,,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1444,nrp290,Analgesics,1,2006,discontinued,in trial,-,
2069,odelepran,small molecule,Peptide ,antagonist,,,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_268,odelepran,alcohol dependence,2,2008,discontinued,in trial,-,
2070,oxycodone,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,696,"eli-154, oxycodone (once daily)",Analgesics,2,2012,discontinued,in trial,-,
2071,oxycodone,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,
2072,oxycodone,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1546,"oxycodone hcl + niacin,acurox, oxyadf",Analgesics,3,2010,discontinued,in trial,-,rejected for approval by FDA in 2010
2073,oxycodone,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1547,"oxycodone, pti-821,remoxy",Analgesics,3,2016,Completed,in trial,-,waiting for FDA approval
2074,oxycodone,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching
2075,oxycodone,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0080,"rexista, oxycodone xr",Analgesics,3,2016,Completed,in trial,-,waiting for FDA approval
2076,oxycodone,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1545,"oxycodone art, eli216,oxynal",Analgesics,4,,-,approved,1998,
2077,oxycodone,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2068,transdermal oxycodone,Analgesics,4,,-,approved,1998,
2078,oxycodone,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0708,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,
2079,oxycodone,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,515,"col-172, extended-release oxycodone",Analgesics,4,,-,approved,2011,
2080,oxycodone,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,514,"col-003, sustained release oxycodone",Analgesics,4,,-,approved,2016,
2081,oxycodone,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0089,eli-200,Analgesics,4,,-,approved,2016,
2082,oxymorphone,small molecule,Peptide ,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_266,oxymorphone,opiate dependence,4,,-,approved,1959,
2083,pentazocine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD419,-,Analgesics,4,,-,approved,1967,
2084,pethidine,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Oct2016_350,pethidine,Analgesics,4,,-,approved,1942,
2085,propoxyphene,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD468,-,Analgesics,4,,-,approved,1957,
2086,pti-202,unknown,Peptide ,not available,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1684,pti-202,Analgesics,1,2006,Completed,in trial,-,Not good information - may have changed names within Pain Therapeutics
2087,sufentanil,small molecule,Peptide ,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1909,"sufentanil transdermal patch,transdur-sufentanil",Analgesics,2,2015,discontinued,in trial,-,
2088,sufentanil,small molecule,Peptide ,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1910,"sufentanil,chronogesic",Analgesics,2,2015,discontinued,in trial,-,
2089,sufentanil,small molecule,Peptide ,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,243,"arx-03, sufentanil + triazolam nanotab",Analgesics; adjuvant to anesthesia,2,2011,suspended,in trial,-,
2090,sufentanil,small molecule,Peptide ,agonist,,secondary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,242,"arx-01, sufentanil nanotab",Analgesics; adjuvant to anesthesia,4,,-,approved,1984,
2091,tramadol,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,
2092,tramadol,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0679,e-58425,Analgesics,3,2017,recruiting,in trial,-,
2093,tramadol,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2055,"tramadol extended-release,raliva er",Analgesics,4,,-,approved,1995,
2094,tramadol,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2056,"tramadol hydrochloride,ultram",Analgesics,4,,-,approved,1995,
2095,tramadol,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2057,"tramadol,tridural, ryzolt",Analgesics,4,,-,approved,1995,
2096,trv734,small molecule,Peptide ,agonist,,primary,OPRK1,oprk_human,P41145,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0140,trv734,Analgesics,1,2015,Completed,in trial,-,
2097,cebranopadol,small molecule,Peptide ,agonist,,primary,OPRL1,oprx_human,P41146,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,not established,ASH_Sep2016_276,cebranopadol,Analgesics,3,2016,recruiting,in trial,-,
2098,ser100,small molecule,Peptide ,agonist,,primary,OPRL1,oprx_human,P41146,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,not established,MMAmay2016_0735,ser100,Antihypertensive,2,2013,Completed,in trial,-,
2099,HTL18318,small molecule,Aminergic ,agonist,,primary,OPRM,acm1_human,P11229,Class A (Rhodopsin),GPCR;Rhodopsin,Acetylcholine receptors (muscarinic),established,ASH_Mar2017_2,HTL18318,dementia ; schizophrenia,1,2016,Completed,in trial,-,
2100,naldemedine,small molecule,Peptide ,antagonist,,primary,OPRM,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Mar2017_1,naldemedine,opioid-induced constipation,3,2014,Ongoing,in trial,-,
2101,adl5945,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,57,adl5945,motilitant,3,2013,Terminated,in trial,-,Terminated lack of enrollment
2102,adl7445,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,58,adl7445,motilitant,1,2011,Terminated,in trial,-,Terminated lack of enrollment
2103,aiko-150,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,92,aiko-150,opioid antagonist,1,2009,Completed,in trial,-,
2104,alfentanil,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD015,-,Analgesics,4,,-,approved,1986,
2105,alfentanil,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0108,"ox51,  sublingual alfentanil",Analgesics,4,,-,approved,1986,
2106,alks 33,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,115,"alks 29, Baclofen+samidorphan",alcohol dependance; Anti-depressant,1,2008,discontinued,in trial,-,
2107,alks 33,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,116,"alks 33, samidorphan",alcohol dependance; Anti-depressant,2,2009,Completed,in trial,-,
2108,alks 33,small molecule,Peptide ,antagonist,alks5461,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,118,"alks 33, alks 5461, Buprenorphine+samidorphan",alcohol dependance; Anti-depressant,3,2014,Completed,in trial,-,
2109,alks 33,small molecule,Peptide ,antagonist,samidorphan,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0184,"alks 3831,  olanzapine + alks 33,samidorphan",Anti-obesity,3,2016,recruiting,in trial,-,
2110,alks 37,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,117,alks 37,motilitant,2,2011,discontinued,in trial,-,
2111,alvimopan,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD021,-,Opiate Antagonists,4,,-,approved,2008,
2112,alvimopan,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2549,entereg,opioid-induced bowel dysfunction,4,,-,approved,2008,
2113,anileridine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD027,-,Analgesics; Narcotics,4,,-,approved,1982,
2114,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,405,"buprenorphine + naloxone capsule,nanobup",Anti-depressant; Analgesics; opioid addiction,1,2010,Completed,in trial,-,
2115,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2109,v1003,Anti-depressant; Analgesics; opioid addiction,2,2006,Completed,in trial,-,
2116,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,422,cam2038,Anti-depressant; Analgesics; opioid addiction,3,2016,recruiting,in trial,-,
2117,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,333,"bema buprenorphine, buccal mucosa adhesive",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
2118,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,406,"buprenorphine + naloxone,suboxone",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
2119,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,408,"buprenorphine sublingual tablet,subutex",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
2120,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0045,"butab, rel-1028, oral, enteric-coated buprenorphine",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
2121,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,409,"butrans is a transdermal patch formulation of  buprenorphine, a partial agonist at mu opioid receptors and an antagonist at kappa opioid receptors. it is indicated as an analgesics to deliver continuous pain relief for seven days.  the efficacy of butrans",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
2122,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0514,"ox219, buprenorphine + naloxone sublingual tablet",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,1981,
2123,buprenorphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,407,"buprenorphine subcutaneous implant,probuphine",Anti-depressant; Analgesics; opioid addiction,4,,-,approved,2016,
2124,butorphanol,small molecule,Peptide ,partial agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD070,-,Analgesics,4,,-,approved,1978,
2125,cebranopadol,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_273,cebranopadol,"osteoarthritis, knee",3,2016,recruiting,in trial,-,
2126,codeine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD124,-,Analgesics,4,,-,approved,2009,
2127,dezocine,small molecule,Peptide ,partial agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD157,-,Analgesics,4,,-,approved,1989,
2128,difenoxin,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_271,difenoxin,recurrent infection of the gastrointestinal tract,4,,-,approved,1978,
2129,dihydrocodeine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_269,dihydrocodeine,Analgesics,4,,-,approved,1958,
2130,diphenoxylate,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD176,-,Antidiuretic,4,,-,approved,1960,
2131,eluxadoline,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1363,"mu delta, eluxadoline",irritable bowel syndrome,4,,-,approved,2015,
2132,ethylmorphine,small molecule,Aminergic ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_353,ethylmorphine,Analgesics,4,,-,approved,-,
2133,fentanyl,small molecule,Peptide ,agonist,,,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,259,at3022,Analgesics,1,2011,discontinued,in trial,-,
2134,fentanyl,small molecule,Peptide ,agonist,,,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,783,fentanyl mdts,Analgesics,1,2009,discontinued,in trial,-,
2135,fentanyl,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,69,aerolef,Analgesics,2,2010,Completed,in trial,-,
2136,fentanyl,small molecule,Peptide ,agonist,,,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,782,"fentanyl lauriad, ba-041",Analgesics,2,2014,discontinued,in trial,-,
2137,fentanyl,small molecule,Peptide ,agonist,,,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,786,fentanyl taifun,Analgesics,3,2011,discontinued,in trial,-,
2138,fentanyl,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,303,"az-003, staccato fentanyl",adjuvant to anesthesia,4,,-,approved,1968,
2139,fentanyl,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,51,ad 923,Analgesics,4,,-,approved,1968,
2140,fentanyl,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,334,"bema fentanyl,onsolis, breakyl",Analgesics,4,,-,approved,1968,
2141,fentanyl,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,394,buccal fentanyl,Analgesics,4,,-,approved,1968,
2142,fentanyl,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,775,"febt,fentora, effentora",Analgesics,4,,-,approved,1968,
2143,fentanyl,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,780,"fentanyl (sublingual), kw-2246,abstral, rapinyl",Analgesics,4,,-,approved,1968,
2144,fentanyl,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,781,"fentanyl citrate,pecfent, nasalfent",Analgesics,4,,-,approved,1968,
2145,fentanyl,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,784,"fentanyl spray, intranasal,instanyl",Analgesics,4,,-,approved,1968,
2146,fentanyl,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,785,fentanyl sublingual spray,Analgesics,4,,-,approved,1968,
2147,fentanyl,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,787,"fentanyl transdermal system,duragesic, ionsys",Analgesics,4,,-,approved,1968,
2148,fentanyl,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2069,"transmucosal fentanyl,actiq",Analgesics,4,,-,approved,1968,
2149,hydrocodone,small molecule,Peptide ,agonist,,,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1686,pti-701,Analgesics,2,2006,discontinued,in trial,-,
2150,hydrocodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0192,hydrocodone,Analgesics,4,,-,approved,1943,
2151,hydrocodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0753,hydrocodone bitartrate with acetaminophen,Analgesics,4,,-,approved,1943,
2152,hydrocodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0009,"hysingla er, hydrocodone bitartrate extended release",Analgesics,4,,-,approved,1943,
2153,hydrocodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0081,"s-718632, extended release hydrocodone",Analgesics,4,,-,approved,1943,
2154,hydrocodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2254,"zx002, hydrocodone bitartrate",Analgesics,4,,-,approved,1943,
2155,hydromorphone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAapril2016_0260,"ltx-04,  hydromorphone hcl",Analgesics,1,2015,Completed,in trial,-,
2156,hydromorphone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1422,"nmed-1077,exalgo, jurnista, dilaudid",Analgesics,4,,-,approved,1984,
2157,ketobemidone,small molecule,Aminergic ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Histamine receptors,established,ASH_Oct2016_354,ketobemidone,Analgesics,4,,-,approved,-,
2158,kp201,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1079,kp201 (prodrug of hydrocodone),Analgesics,2,2015,Completed,in trial,-,Difficult to get good clinical trial info for
2159,levallorphan,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD298,-,Opiate Antagonists,4,,-,approved,1982,
2160,levomethadyl acetate,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD302,-,Analgesics,4,,-,approved,1993,
2161,levorphanol,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD303,-,Analgesics,4,,-,approved,1953,
2162,loperamide,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD308,-,Antidiuretic,4,,-,approved,1976,
2163,meperidine,small molecule,Peptide ,agonist,,secondary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_270,meperidine,Analgesics,4,,-,approved,1942,
2164,methadone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD334,-,Analgesics,4,,-,approved,1947,
2165,methadyl acetate,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD335,-,Analgesics,4,,-,approved,1993,
2166,methylnaltrexone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD348,-,OIC treatment,4,,-,approved,2008,
2167,methylnaltrexone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1262,methylnaltrexone,opioid-induced constipation,4,,-,approved,2008,
2168,morphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1013,"intranasal morphine,rylomine",Analgesics,2,2008,Completed,in trial,-,
2169,morphine,small molecule,Peptide ,agonist,,,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,2,2002,discontinued,in trial,-,
2170,morphine,small molecule,Peptide ,agonist,,,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,
2171,morphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1207,"m6g, cee 04-410",Analgesics,3,2008,Completed,in trial,-,
2172,morphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1279,"mh-200, tak-453 sr, morphine hcl,anpec",Analgesics,3,2002,Completed,in trial,-,
2173,morphine,small molecule,Peptide ,agonist,,,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1335,"morphine/dextromethorphan,morphidex",Analgesics,3,2006,discontinued,in trial,-,
2174,morphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1984,
2175,morphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1334,"morphine sulfate,depodur, depomorphine",Analgesics,4,,-,approved,1984,
2176,morphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2051,tpm-1/morphine,Analgesics,4,,-,approved,1984,
2177,morphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0056,"egalet-001, reformulated morphine",Analgesics; opioid addiction,4,,-,approved,1984,
2178,morphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1333,"morphine sulfate,avinza",Analgesics,4,,-,approved,2002,
2179,nalbuphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,2,2006,discontinued,in trial,-,
2180,nalbuphine,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1374,"nalbuphine hydrochloride,  pw-4142",Analgesics,4,,-,approved,1979,
2181,nalmefene,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2766,srd174,pruritus,4,,-,approved,1995,
2182,nalmefene,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1375,"nalmefene, cph-101",smoking-cessation ; addiction,4,,-,approved,2013,
2183,naloxegol,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1419,nktr-118,opioid-induced constipation,4,,-,approved,2014,
2184,naloxone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,405,"buprenorphine + naloxone capsule,nanobup",Analgesics,4,,-,approved,1971,
2185,naloxone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0088,"naloxone nasal spray, lightlake therapeutics for binge eating disorder",Analgesics,4,,-,approved,1971,
2186,naloxone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1733,ren-213,Analgesics,4,,-,approved,1971,
2187,naloxone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,406,"buprenorphine + naloxone,suboxone",Analgesics; opioid addiction,4,,-,approved,1971,
2188,naloxone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0517,"ox219, buprenorphine + naloxone sublingual tablet",Analgesics; opioid addiction,4,,-,approved,1971,
2189,naloxone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0645,"naloxone nasal spray, indivior",Analgesics; overdose/drug toxicity,4,,-,approved,1971,
2190,naloxone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0709,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,
2191,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,
2192,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1686,pti-701,Analgesics,2,2006,discontinued,in trial,-,
2193,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching
2194,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,122,"alo-01, morphine sulfate and naltrexone hydrochloride,embeda, kadian nt",Analgesics,4,,-,approved,1998,
2195,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1336,morviva,Analgesics,4,,-,approved,1998,
2196,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1688,pti-901,Analgesics,4,,-,approved,1998,
2197,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0073,"pxt3003, baclofen + naltrexone + sorbitol",Analgesics; for type 1A Charcot-Marie-Tooth disease,4,,-,approved,1998,
2198,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,522,contrave,Appetite suppressant,4,,-,approved,1998,
2199,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2168,vivitrol,substance abuse,4,,-,approved,1998,
2200,naltrexone,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0084,eli-200,addiction,4,,-,approved,2016,
2201,nktr-181,small molecule polymer conjugate,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1420,nktr-181,Analgesics,3,2015,Ongoing,in trial,-,
2202,nrp290,small molecule,Peptide ,agonist,,,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1444,nrp290,Analgesics,1,2006,discontinued,in trial,-,
2203,odelepran,small molecule,Peptide ,antagonist,,,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,ASH_Sep2016_275,odelepran,alcohol dependence,2,2008,discontinued,in trial,-,
2204,oxycodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,696,"eli-154, oxycodone (once daily)",Analgesics,2,2012,discontinued,in trial,-,
2205,oxycodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1341,moxduo,Analgesics,2,2002,discontinued,in trial,-,
2206,oxycodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1546,"oxycodone hcl + niacin,acurox, oxyadf",Analgesics,3,2010,discontinued,in trial,-,rejected for approval by FDA in 2010
2207,oxycodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1547,"oxycodone, pti-821,remoxy",Analgesics,3,2016,Completed,in trial,-,waiting for FDA approval
2208,oxycodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1687,"pti-801,oxytrex",Analgesics,3,2010,discontinued,in trial,-,appears proteostasis therapeutics is repurposing pti-801 for cystic fibrosis CTFR drug in case any confusion in researching
2209,oxycodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmar2016_0078,"rexista, oxycodone xr",Analgesics,3,2016,Completed,in trial,-,waiting for FDA approval
2210,oxycodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1545,"oxycodone art, eli216,oxynal",Analgesics,4,,-,approved,1998,
2211,oxycodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2068,transdermal oxycodone,Analgesics,4,,-,approved,1998,
2212,oxycodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0706,"targin,  targinac, targiniq er,  oxycodone hydrochloride + naloxone hydrochloride extended-release tablets",Analgesics,4,,-,approved,2006,
2213,oxycodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,515,"col-172, extended-release oxycodone",Analgesics,4,,-,approved,2011,
2214,oxycodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,514,"col-003, sustained release oxycodone",Analgesics,4,,-,approved,2016,
2215,oxycodone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAfeb2016_0087,eli-200,Analgesics,4,,-,approved,2016,
2216,oxymorphone,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1548,"oxymorphone hydrochloride, en3202,opana, opana er",Analgesics,4,,-,approved,1959,
2217,pentazocine,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD419,-,Analgesics,4,,-,approved,1967,
2218,propoxyphene,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,NRDD468,-,Analgesics,4,,-,approved,1957,
2219,pti-202,unknown,Peptide ,not available,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1684,pti-202,Analgesics,1,2006,Completed,in trial,-,Not good information - may have changed names within Pain Therapeutics
2220,remifentanil,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1732,"remifentanil,ultiva",Analgesics,4,,-,approved,1996,
2221,sufentanil,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1909,"sufentanil transdermal patch,transdur-sufentanil",Analgesics,2,2015,discontinued,in trial,-,
2222,sufentanil,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1910,"sufentanil,chronogesic",Analgesics,2,2015,discontinued,in trial,-,
2223,sufentanil,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,243,"arx-03, sufentanil + triazolam nanotab",Analgesics; adjuvant to anesthesia,2,2011,suspended,in trial,-,
2224,sufentanil,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,242,"arx-01, sufentanil nanotab",Analgesics; adjuvant to anesthesia,4,,-,approved,1984,
2225,tapentadol,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1950,tapentadol,Analgesics,4,,-,approved,2008,
2226,tapentadol,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1951,"tapentadol hydrochloride, cg-5503, r331333",Analgesics,4,,-,approved,2008,
2227,td-1211,small molecule,Peptide ,antagonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1971,"td-1211, Axelopran",opioid-induced gastrointestinal side-effects,2,2012,Completed,in trial,-,
2228,tramadol,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,1685,pti-601,Analgesics,2,2001,discontinued,in trial,-,
2229,tramadol,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0678,e-58425,Analgesics,3,2017,recruiting,in trial,-,
2230,tramadol,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2055,"tramadol extended-release,raliva er",Analgesics,4,,-,approved,1995,
2231,tramadol,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2056,"tramadol hydrochloride,ultram",Analgesics,4,,-,approved,1995,
2232,tramadol,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,2057,"tramadol,tridural, ryzolt",Analgesics,4,,-,approved,1995,
2233,trv130,small molecule,Peptide ,agonist,,primary,OPRM1,oprm_human,P35372,Class A (Rhodopsin),GPCR;Rhodopsin,Opioid receptors,established,MMAmay2016_0607,"trv130, Oliceridine",Analgesics; post-operative pain,3,2016,recruiting,in trial,-,
2234,atosiban,small molecule,Protein ,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Chemokine receptors,established,ASH_Oct2016_425,atosiban,labor repressant,4,,-,approved,2013,
2235,barusiban,protein,Peptide ,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Sep2016_290,barusiban,Fertility,2,2012,Completed,in trial,-,
2236,carbetocin,small molecule,Peptide ,agonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,NRDD078,-,Labor Inducing,3,2016,Completed,in trial,-,Approved in Europe but not FDA
2237,epelsiban,small molecule,Peptide ,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Sep2016_291,epelsiban,premature ejaculation,2,2016,withdrawn,in trial,-,"Had no activity since 2009, then shows 2016 a phase 2 trial, but withdrawn due to change in portfolio prioritization"
2238,obe001,small molecule,Peptide ,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,MMAapril2016_0035,obe001,labor and delivery,3,2017,recruiting,in trial,-,
2239,oxytocin,peptide,Peptide ,agonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,2014,"ti-001, intranasal oxytocin",Analgesics,4,,-,approved,1980,
2240,oxytocin,peptide,Peptide ,agonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,MMA2016_0022,"opn-300, intranasal oxytocin",autism,4,,-,approved,1980,
2241,retosiban,small molecule,Peptide ,antagonist,,primary,OXTR,oxyr_human,P30559,Class A (Rhodopsin),GPCR;Rhodopsin,Vasopressin and oxytocin receptors,established,ASH_Sep2016_289,retosiban,premature birth,3,2015,recruiting,in trial,-,
2242,mc-1,small molecule,Nucleotide ,antagonist,,,P2RY1,p2ry1_human,P47900,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
2243,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,,P2RY1,p2ry1_human,P47900,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
2244,mc-1,small molecule,Orphan ,antagonist,,,P2RY10,p2y10_human,O00398,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
2245,mc-4232 + mc-1,small molecule,Orphan ,antagonist,,,P2RY10,p2y10_human,O00398,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
2246,mc-1,small molecule,Nucleotide ,antagonist,,,P2RY11,p2y11_human,Q96G91,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
2247,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,,P2RY11,p2y11_human,Q96G91,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
2248,cangrelor,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,428,"cangrelor, ar69931",antithrombotic,4,,-,approved,2015,
2249,clopidogrel,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,478,cgt-2168,antiplatelet,4,,-,approved,1997,
2250,clopidogrel,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,1619,plavix,antithrombotic,4,,-,approved,1997,
2251,elinogrel,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,701,"elinogrel, prt060128, adp receptor antagonist",antiplatelet,2,2008,discontinued,in trial,-,
2252,ins-50589,unknown,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,992,ins-50589,antithrombotic,2,2006,discontinued,in trial,-,
2253,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
2254,prasugrel,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,1640,"prasugrel, cs-747,efient",antithrombotic,4,,-,approved,2009,
2255,ticagrelor,small molecule,Nucleotide ,NAM,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,2015,ticagrelor,antithrombotic,4,,-,approved,2010,
2256,ticlopidine,small molecule,Nucleotide ,antagonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,NRDD525,-,Platelet Aggregation Inhibitors,4,,-,approved,1991,
2257,treprostinil,small molecule,Nucleotide ,agonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,MMA2016_0040,"transcon treprostinil, subcutaneous injection",Antihypertensive,4,,-,approved,2002,
2258,treprostinil,small molecule,Nucleotide ,agonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,2767,"treprostinil inhaled/oral,tyvaso, viveta",Antihypertensive,4,,-,approved,2002,
2259,treprostinil,small molecule,Nucleotide ,agonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,2768,"treprostinil subcutaneous/intravenous,remodulin",Antihypertensive,4,,-,approved,2002,
2260,treprostinil,small molecule,Nucleotide ,agonist,,primary,P2RY12,p2y12_human,Q9H244,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,established,NRDD537,-,Antihypertensive ; Antithrombotic,4,,-,approved,2002,
2261,mc-1,small molecule,Nucleotide ,antagonist,,,P2RY13,p2y13_human,Q9BPV8,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
2262,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,,P2RY13,p2y13_human,Q9BPV8,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
2263,mc-1,small molecule,Nucleotide ,antagonist,,,P2RY14,p2y14_human,Q15391,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
2264,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,,P2RY14,p2y14_human,Q15391,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
2265,Denufosol,small molecule,Nucleotide ,agonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,990,"Denufosol, ins37217",rhegmatogenous retinal detachment,2,2004,discontinued,in trial,-,
2266,denufosol,small molecule,Nucleotide ,agonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,614,"denufosol tetrasodium, ins37217 respiratory",cystic fibrosis,3,2009,discontinued,in trial,-,
2267,Denufosol,small molecule,Nucleotide ,agonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,991,"Denufosol, ins37217 intranasal",cystic fibrosis; perennial allergic rhinitis,3,2009,discontinued,in trial,-,
2268,diquafosol,small molecule,Nucleotide ,agonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,644,"diquafosol tetrasodium, ins365 ophthalmic,prolacria",opthalmological,3,2009,discontinued,in trial,-,
2269,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
2270,suramin,small molecule,Nucleotide ,antagonist,,primary,P2RY2,p2ry2_human,P41231,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y,established,ASH_Oct2016_346,Suramin,African trypanosomiasis,4,,-,approved,1916,
2271,mc-1,small molecule,Nucleotide ,antagonist,,,P2RY4,p2ry4_human,P51582,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
2272,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,,P2RY4,p2ry4_human,P51582,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
2273,gc021109,small molecule,Nucleotide ,agonist,,primary,P2RY6,p2ry6_human,Q15077,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,MMAfeb2016_0055,gc021109,Alzheimer's disease,1,2015,Completed,in trial,-,
2274,mc-4232 + mc-1,small molecule,Nucleotide ,antagonist,,,P2RY6,p2ry6_human,Q15077,Class A (Rhodopsin),GPCR;Rhodopsin,P2Y receptors,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
2275,mc-1,small molecule,Orphan ,antagonist,,,P2RY8,p2ry8_human,Q86VZ1,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,1227,mc-1,cardioprotectant,3,2006,discontinued,in trial,-,"Had been mislabeled with trial name as mc-4232, but this is mc-1"
2276,mc-4232 + mc-1,small molecule,Orphan ,antagonist,,,P2RY8,p2ry8_human,Q86VZ1,Class A (Rhodopsin),GPCR;Rhodopsin,Class A orphans,not established,1227,mc-4232 + mc-1,cardioprotectant,2,2005,discontinued,in trial,-,
2277,oc000459 ,small molecule,Lipid ,antagonist,,primary,PD2R2,pd2r2_human,Q9Y5Y4,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,1466,oc000459,Anti-Allergic,2,2016,recruiting,in trial,-,
2278,obinepitide,small molecule,Peptide ,agonist,,primary,PPYR1,npy4r_human,P50391,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,2027,"tm30338,obinepitide",Anti-obesity,2,2010,Completed,in trial,-,Sweden
2279,tm30339,small molecule,Peptide ,agonist,,primary,PPYR1,npy4r_human,P50391,Class A (Rhodopsin),GPCR;Rhodopsin,Neuropeptide Y receptors,not established,2028,tm30339,Anti-obesity,2,2008,discontinued,in trial,-,
2280,am-461,small molecule,Lipid ,antagonist,,primary,PTGDR,pd2r_human,Q13258,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,146,am-461,Anti-inflammatory,1,2011,Unknown,in trial,-,
2281,iloprost,small molecule,Lipid ,agonist,,secondary,PTGDR,pd2r_human,Q13258,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,ASH_Oct2016_435,"iloprost,ventavis",Antihypertensive,4,,-,approved,2004,
2282,laropiprant,small molecule,Lipid ,antagonist,,,PTGDR,pd2r_human,Q13258,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1300,"mk-0524a, er niacin/laropiprant,tredaptive, trevaclyn, pelzont",for counteracting niacin-induced flushing,3,2007,discontinued,in trial,-,Side effects
2283,laropiprant,small molecule,Lipid ,antagonist,,,PTGDR,pd2r_human,Q13258,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1301,"mk-0542b, extended release niacin + laropiprant +simvastatin",for counteracting niacin-induced flushing,3,2007,discontinued,in trial,-,Side effects
2284,vidupiprant,small molecule,Lipid ,antagonist,,,PTGDR,pd2r_human,Q13258,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,not established,ASH_Sep2016_307,"vidupiprant, AMG853",Anti-Asthmatic,2,2009,discontinued,in trial,-,
2285,ac-100,peptide,Lipid ,not available,dentonin,,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,29,"ac-100,dentonin",dental ossificant,1,2010,discontinued,in trial,-,
2286,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAapril2016_0157,"rayva, alprostadil + ddaip.hcl",Raynaud's Disease,2,2014,Completed,in trial,-,
2287,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,128,"alprostadil,alista",sexual dysfunction,2,2006,discontinued,in trial,-,
2288,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,130,"alprostadil,topiglan",sexual dysfunction,2,2004,discontinued,in trial,-,
2289,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,129,"alprostadil,femprox",sexual dysfunction,3,2008,suspended,in trial,-,
2290,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,2039,"topical alprostadil cream,alprox-td, befar, vitaros",sexual dysfunction,4,,-,approved,1981,
2291,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmar2016_0296,"helios insert, bimatoprost ocular insert",Antiglaucomic,2,2016,Completed,in trial,-,
2292,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,359,"bimatoprost,  agn 192024,lumigan",Antiglaucomic,4,,-,approved,2001,
2293,carboprost tromethamine,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD081,-,Abortifacient,4,,-,approved,1965,
2294,dinoprostone,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD172,-,Abortifacient,4,,-,approved,1977,
2295,iloprost,small molecule,Lipid ,agonist,,primary,PTGER1,pe2r1_human,P34995,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,952,"iloprost,ventavis",Antihypertensive,4,,-,approved,2004,
2296,ac-100,peptide,Lipid ,not available,dentonin,,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,29,"ac-100,dentonin",periodontal ossificant,1,2010,discontinued,in trial,-,
2297,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAapril2016_0158,"rayva, alprostadil + ddaip.hcl",Raynaud's Disease,2,2014,Completed,in trial,-,
2298,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,128,"alprostadil,alista",sexual dysfunction,2,2006,discontinued,in trial,-,
2299,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,130,"alprostadil,topiglan",sexual dysfunction,2,2004,discontinued,in trial,-,
2300,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,129,"alprostadil,femprox",sexual dysfunction,3,2008,suspended,in trial,-,
2301,alprostadil,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,2039,"topical alprostadil cream,alprox-td, befar, vitaros",sexual dysfunction,4,,-,approved,1981,
2302,dinoprostone,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD172,-,Abortifacient,4,,-,approved,1977,
2303,misoprostol,small molecule,Lipid ,agonist,,primary,PTGER2,pe2r2_human,P43116,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMA_jun2017_001,misoprostol,hemorrhage,4,,-,approved,1988,
2304,ac-100,peptide,Lipid ,not available,dentonin,,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,29,"ac-100,dentonin",periodontal ossificant,1,2010,discontinued,in trial,-,
2305,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmar2016_0298,"helios insert, bimatoprost ocular insert",Antiglaucomic,2,2016,Completed,in trial,-,
2306,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,359,"bimatoprost,  agn 192024,lumigan",Antiglaucomic,4,,-,approved,2001,
2307,dg041,small molecule,Lipid ,antagonist,,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,629,dg041,Platelet Aggregation Inhibitor,2,2006,discontinued,in trial,-,Iceland
2308,dinoprostone,small molecule,Lipid ,agonist,,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD172,-,Abortifacient,4,,-,approved,1977,
2309,misoprostol,small molecule,Lipid ,agonist,,primary,PTGER3,pe2r3_human,P43115,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,ASH_Sep2016_312,misoprostol,hemorrhage,4,,-,approved,1988,
2310,ac-100,peptide,Lipid ,not available,dentonin,,PTGER4,pe2r4_human,P35408,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,29,"ac-100,dentonin",periodontal ossificant,1,2010,discontinued,in trial,-,
2311,bgc20-1531 ,small molecule,Lipid ,antagonist,,primary,PTGER4,pe2r4_human,P35408,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,347,bgc20-1531,Anti-migraine,2,2009,discontinued,in trial,-,
2312,dinoprostone,small molecule,Lipid ,agonist,,primary,PTGER4,pe2r4_human,P35408,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD172,-,Abortifacient,4,,-,approved,1977,
2313,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmar2016_0297,"helios insert, bimatoprost ocular insert",Antiglaucomic,2,2016,Completed,in trial,-,
2314,bimatoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,359,"bimatoprost,  agn 192024,lumigan",Antiglaucomic,4,,-,approved,2001,
2315,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0719,"eye-d, controlled-release latanoprost insert",Antiglaucomic,1,2014,Completed,in trial,-,
2316,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1436,"nova21027,catioprost",Antiglaucomic,2,2015,Completed,in trial,-,
2317,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAfeb2016_0059,"roclatan, rhopressa + latanoprost",Antiglaucomic,3,2017,Completed,in trial,-,
2318,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1095,"latanoprost + timolol,xalcom, xalacom",Antiglaucomic,4,,-,approved,1996,
2319,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1096,"latanoprost, (sustained release, punctal plug delivery system)",Antiglaucomic,4,,-,approved,1996,
2320,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1097,"latanoprost,xalatan fixed flow device",Antiglaucomic,4,,-,approved,1996,
2321,latanoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1918,sustained release latanoprost,Antiglaucomic,4,,-,approved,1996,
2322,ncx116,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,378,"bol-303259-x, ncx 116, pf-03187207, Latanoprostene bunod",Antiglaucomic,3,2013,Ongoing,in trial,-,
2323,pdc31,peptide,Lipid ,antagonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0526,pdc31,pre-term labor; dysmenorrhea,1,2010,Completed,in trial,-,
2324,tafluprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0794,"taflotan, tapros, zioptan, tafluprost, saflutan, de-085, mk-2452",Reduce intraocular pressure,4,,-,approved,2012,
2325,travoprost,small molecule,Lipid ,agonist,,primary,PTGFR,pf2r_human,P43088,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,2071,"travoprost + timolol,extravan, duotrav",Antiglaucomic,4,,-,approved,2001,
2326,apd811,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0283,apd811,Antihypertensive,2,2014,Ongoing,in trial,-,
2327,beraprost,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,337,beraprost,Antihypertensive,3,2011,withdrawn,in trial,-,"No longer marketed, but may still be available"
2328,dinoprost tromethamine,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD171,-,Abortifacient,4,,-,approved,1981,
2329,epoprostenol,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,NRDD206,-,Antihypertensive ; Platelet Aggregation Inhibitors,4,,-,approved,1995,
2330,iloprost,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,952,"iloprost,ventavis",Antihypertensive,4,,-,approved,2004,
2331,misoprostol,small molecule,Lipid ,agonist,,secondary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,202,"apl-202,isprelor",Labor Inducing,4,,-,approved,1988,
2332,ralinepag,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,ASH_Sep2016_314,"ralinepag, APD-811",Antihypertensive,2,2014,recruiting,in trial,-,
2333,selexipag,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,1831,"selexipag, act-293987",Antihypertensive,4,,-,approved,2015,
2334,selexipag,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAmay2016_0747,selixipag,Antihypertensive,4,,-,approved,2015,
2335,treprostinil,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMA2016_0038,"transcon treprostinil, subcutaneous injection",Antihypertensive,4,,-,approved,2002,
2336,treprostinil,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,2767,"treprostinil inhaled/oral,tyvaso, viveta",Antihypertensive,4,,-,approved,2002,
2337,treprostinil,small molecule,Lipid ,agonist,,primary,PTGIR,pi2r_human,P43119,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,2768,"treprostinil subcutaneous/intravenous,remodulin",Antihypertensive,4,,-,approved,2002,
2338,alx1-11,protein,Peptide ,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1646,preos,Anti-osteoporotic,3,2005,Completed,in trial,-,
2339,h-pth 1-34,peptide,Peptide ,partial agonist,,,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2153,viaderm hpth 1-34,Anti-osteoporotic,2,2009,discontinued,in trial,-,
2340,ostabolin-c,peptide,Peptide ,agonist,,,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1530,"ostabolin-c,  zt-031",Anti-osteoporotic,2,2008,discontinued,in trial,-,Change within company direction
2341,parathyroid hormone,protein,Peptide ,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2012,"bn-003,capthymone,thpth",Anti-osteoporotic,4,,-,approved,2015,
2342,parathyroid hormone,protein,Peptide ,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2799,"air parathyroid hormone, air pth",hypoparathyroidism,4,,-,approved,2015,
2343,PTH analog,small molecule,Peptide ,agonist,768974,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,10,"768974, parathyroid hormone analog",Anti-osteoporotic,2,2011,discontinued,in trial,-,
2344,teriparatide,peptide,Peptide ,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2252,"zt-034, teriparatide nasal spray",Anti-osteoporotic,4,,-,approved,1987,
2345,teriparatide,peptide,Peptide ,agonist,,primary,PTH1R,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2252,"zt-034, teriparatide nasal spray",Anti-osteoporotic,4,,-,approved,1987,
2346,alx1-11,protein,Peptide ,agonist,,primary,PTH2R,pth2r_human,P49190,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1646,preos,Anti-osteoporotic,3,2005,Completed,in trial,-,
2347,h-pth 1-34,peptide,Peptide ,partial agonist,,,PTH2R,pth2r_human,P49190,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2153,viaderm hpth 1-34,Anti-osteoporotic,2,2009,discontinued,in trial,-,
2348,ostabolin-c,peptide,Peptide ,agonist,,,PTH2R,pth2r_human,P49190,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1530,"ostabolin-c,  zt-031",Anti-osteoporotic,2,2008,discontinued,in trial,-,Change within company direction
2349,parathyroid hormone,protein,Peptide ,agonist,,primary,PTH2R,pth2r_human,P49190,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,2012,thpth,Anti-osteoporotic,4,,-,approved,2015,
2350,abaloparatide,peptide,Peptide,not available,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,ASH_Sep2016_345,"Abaloparatide, ITM-058, BA-058",Anti-osteoporotic,3,2012,Completed,in trial,-,
2351,parathyroid hormone,protein,Peptide ,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,MMAmay2016_0745,"natpara, npsp558, parathyroid horomone",Control hypocalcemia,4,,-,approved,2015,
2352,teriparatide,peptide,Peptide ,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,MMAmay2016_0763,"cp046, intranasal teriparatide",Anti-osteoporotic,4,,-,approved,1987,
2353,teriparatide,peptide,Peptide ,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1983,"teriparatide, inhaled air",Anti-osteoporotic,4,,-,approved,1987,
2354,teriparatide,peptide,Peptide ,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1984,"teriparatide, pth1-34 nasal spray",Anti-osteoporotic,4,,-,approved,1987,
2355,teriparatide,peptide,Peptide ,agonist,,primary,PTHR1,pth1r_human,Q03431,Class B1 (Secretin),GPCR;Secretin,Parathyroid hormone receptors,established,1985,"teriparatide,forteo, forsteo",Anti-osteoporotic,4,,-,approved,1987,
2356,serelaxin,peptide,Peptide ,agonist,,primary,RXFP1,rxfp1_human,Q9HBX9,Class A (Rhodopsin),GPCR;Rhodopsin,Relaxin receptors,not established,MMA_2017_003,"serelaxin, relaxin, RLX-030A, SUN-Y8002",Heart failure therapies,3,2014,Completed,in trial,-,fda refused approval
2357,serelaxin,peptide,Peptide ,agonist,,primary,RXFP2,rxfp2_human,Q8WXD0,Class A (Rhodopsin),GPCR;Rhodopsin,Relaxin receptors,not established,MMA_2017_005,"serelaxin, relaxin, RLX-030A, SUN-Y8002",Heart failure therapies,3,2014,Completed,in trial,-,fda refused approval
2358,akp-11,small molecule,Lipid ,PAM,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,MMA2016_0028,akp-11,psoriasis,1,2016,Completed,in trial,-,Australia
2359,apd334,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,MMAmay2016_0282,apd334,for autoimmune disorders,2,2015,recruiting,in trial,-,
2360,asfotase alfa,enzyme,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,ASH_Sep2016_303,asfotase alfa,hypophosphatasia,4,,-,approved,2015,
2361,cpb-307,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,MMAmar2016_0127,cpb-307,autoimmune diseases,1,2014,Completed,in trial,-,
2362,fingolimod,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,794,"fingolimod, fty 720,gilenia, gilenya",Multiple Sclerosis,4,,-,approved,2010,
2363,mt-1303,small molecule,Lipid ,antagonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,MMAmar2016_0211,mt-1303,autoimmune diseases; Multiple Sclerosis; Crohn's disease,2,2015,Ongoing,in trial,-,
2364,ponesimod,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,1630,ponesimod,Anti-inflammatory ; multiple sclerosis,3,2016,recruiting,in trial,-,
2365,rpc1063,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,1790,rpc1063,Multiple Sclerosis,3,2015,recruiting,in trial,-,
2366,siponimod,small molecule,Lipid ,agonist,,primary,S1PR1,s1pr1_human,P21453,Class A (Rhodopsin),GPCR;Rhodopsin,Lysophospholipid (S1P) receptors,established,ASH_Sep2016_304,siponimod,chronic progressive multiple sclerosis,3,2014,Ongoing,in trial,-,
2367,rg1068,peptide,Peptide ,agonist,,primary,SCTR,sctr_human,P47872,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,1749,"rg1068, synthetic secretin,secreflo","autism, schizophrenia",3,2004,discontinued,in trial,-,
2368,secretin,peptide,Peptide ,agonist,,primary,SCTR,sctr_human,P47872,Class B1 (Secretin),GPCR;Secretin,Glucagon receptor family,established,NRDD493,-,Diagnostic,4,,-,approved,2002,
2369,cur-61414,small molecule,Protein ,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,2823,cur-61414,Antineoplastic,1,2010,Completed,in trial,-,
2370,glasdegib,small molecule,Protein ,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,ASH_Sep2016_343,glasdegib,Antineoplastic,2,2016,Completed,in trial,-,
2371,ipi-926,small molecule,Protein ,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,2824,"ipi-926, Patidegib",Antineoplastic,2,2016,recruiting,in trial,-,Continual inhibition as mode of action
2372,itraconazole,small molecule,Protein ,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,MMAmar2016_0140,suba-itraconazole,Antineoplastic,4,,-,approved,1992,
2373,sonidegib,small molecule,Protein ,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,1101,lde225,Antineoplastic,4,,-,approved,2015,
2374,tak-441,small molecule,Protein ,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,ASH_Sep2016_344,tak-441,basal cell carcinoma,1,2010,discontinued,in trial,-,
2375,taladegib,small molecule,Protein ,antagonist,ly2940680,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,MMAmar2016_0177,"taladegib, ly2940680",Antineoplastic,2,2015,recruiting,in trial,-,
2376,vismodegib,small molecule,Protein ,antagonist,,primary,SMO,smo_human,Q99835,Class F (Frizzled),GPCR;Frizzled,Frizzled,established,2822,"gdc-0449, hedgehog pathway inhibitor",Antineoplastic,4,,-,approved,2012,
2377,dg3173,small molecule,Peptide ,agonist,,secondary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,632,dg3173,hormone replacement,2,2014,Ongoing,in trial,-,
2378,lanreotide,small molecule,Peptide ,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1088,"lanreotide ,somatuline autogel, somatuline depot",acromegaly,4,,-,approved,2001,
2379,octreotide,peptide,Peptide ,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1508,"oral octreotide actetate ,octreolin",Antihypertensive,4,,-,approved,1988,
2380,octreotide,peptide,Peptide ,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,421,cam-2029,Antineoplastic,4,,-,approved,1988,
2381,octreotide,peptide,Peptide ,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,981,"injectable octreotide acetate,sandostatin lar",Antineoplastic,4,,-,approved,1988,
2382,octreotide,peptide,Peptide ,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1470,"octrotide,atrigel",Antineoplastic,4,,-,approved,1988,
2383,pasireotide,peptide,Peptide ,agonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1567,"pasireotide, som230",Antineoplastic ; acromegaly,4,,-,approved,2012,
2384,yttrium-90 edotreotide,peptide,Peptide ,antagonist,,primary,SSTR1,ssr1_human,P30872,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,2232,"yttrium-90 edotreotide,onalta",Antineoplastic,2,2010,Not open yet,in trial,-,Issue with drug not being available
2385,bim23a760,small molecule,Peptide ,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,358,bim23a760,Antineoplastic ; treatment for acromegaly,2,2009,discontinued,in trial,-,
2386,dg3173,small molecule,Peptide ,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,632,dg3173,hormone replacement,2,2014,Ongoing,in trial,-,
2387,fx125l,small molecule,Peptide ,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,831,fx125l,Anti-Asthmatic,1,2009,Completed,in trial,-,Great Britain
2388,lanreotide,protein,Peptide ,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,ASH_Sep2016_283,lanreotide,Antineoplastic,4,,-,approved,2001,
2389,octreotide,peptide,Peptide ,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1509,"oral octreotide actetate,octreolin",Antihypertensive,4,,-,approved,1988,
2390,octreotide,peptide,Peptide ,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,421,cam-2029,Antineoplastic,4,,-,approved,1988,
2391,octreotide,peptide,Peptide ,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,981,"injectable octreotide acetate,sandostatin lar",Antineoplastic,4,,-,approved,1988,
2392,octreotide,peptide,Peptide ,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1470,"octrotide,atrigel",Antineoplastic,4,,-,approved,1988,
2393,p2045,peptide,Peptide ,agonist,188re-p2045,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,MMAmay2016_0746,"p2045, 188re-p2045",Antineoplastic,1,2014,withdrawn,in trial,-,Withdrawn due to PI left study institution; had 10 year break in research
2394,pasireotide,peptide,Peptide ,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1567,"pasireotide, som230",Antineoplastic ; acromegaly,4,,-,approved,2012,
2395,vapreotide,small molecule,Peptide ,agonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,2124,"vapreotide, debio 8609,sanvar, docrised",liver cirrhosis-related variceal bleeding,4,,-,approved,-,
2396,yttrium-90 edotreotide,peptide,Peptide ,antagonist,,primary,SSTR2,ssr2_human,P30874,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,2232,"yttrium-90 edotreotide,onalta",Antineoplastic,2,2010,Not open yet,in trial,-,Issue with drug not being available
2397,octreotide,protein,Peptide ,agonist,,primary,SSTR3,ssr3_human,P32745,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,ASH_Sep2016_284,octreotide,growth hormone excess,4,,-,approved,1988,
2398,pasireotide,peptide,Peptide ,agonist,,primary,SSTR3,ssr3_human,P32745,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1567,"pasireotide, som230",Antineoplastic ; acromegaly,4,,-,approved,2012,
2399,dg3173,small molecule,Peptide ,agonist,,primary,SSTR4,ssr4_human,P31391,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,632,dg3173,hormone replacement,2,2014,Ongoing,in trial,-,
2400,octreotide,protein,Peptide ,agonist,,primary,SSTR4,ssr4_human,P31391,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,ASH_Sep2016_285,octreotide,growth hormone excess,4,,-,approved,1988,
2401,bim23a760,small molecule,Peptide ,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,358,bim23a760,Antineoplastic ; treatment for acromegaly,2,2009,discontinued,in trial,-,
2402,dg3173,small molecule,Peptide ,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,632,dg3173,hormone replacement,2,2014,Ongoing,in trial,-,
2403,lanreotide,small molecule,Peptide ,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1089,"lanreotide,somatuline autogel, somatuline depot",acromegaly,4,,-,approved,2001,
2404,octreotide,peptide,Peptide ,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1509,"oral octreotide actetate,octreolin",Antihypertensive,4,,-,approved,1988,
2405,octreotide,peptide,Peptide ,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,421,cam-2029,Antineoplastic,4,,-,approved,1988,
2406,octreotide,peptide,Peptide ,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,981,"injectable octreotide acetate,sandostatin lar",Antineoplastic,4,,-,approved,1988,
2407,octreotide,peptide,Peptide ,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1470,"octrotide,atrigel",Antineoplastic,4,,-,approved,1988,
2408,pasireotide,peptide,Peptide ,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,1567,"pasireotide, som230",Antineoplastic ; acromegaly,4,,-,approved,2012,
2409,vapreotide,small molecule,Peptide ,agonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,2124,"vapreotide, debio 8609,sanvar, docrised",liver cirrhosis-related variceal bleeding,4,,-,approved,-,
2410,yttrium-90 edotreotide,peptide,Peptide ,antagonist,,primary,SSTR5,ssr5_human,P35346,Class A (Rhodopsin),GPCR;Rhodopsin,Somatostatin receptors,established,2232,"yttrium-90 edotreotide,onalta",Antineoplastic,2,2010,Not open yet,in trial,-,Issue with drug not being available
2411,amphetamine,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,413,"c105, levo-amphetamine sulfate",cognitive dysfunction; ADHD,2,2008,Completed,in trial,-,
2412,amphetamine,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,MMAmay2016_0357,d-amphetamine transdermal system (d-ats),cognitive dysfunction; ADHD,2,2012,Completed,in trial,-,
2413,amphetamine,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,MMAmay2016_0658,"hld-100, reformulated amphetamine",cognitive dysfunction; ADHD,2,2017,Ongoing,in trial,-,
2414,amphetamine,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,1862,"sli 381, spd 465,adderall, adderall xr, adderall ir",cognitive dysfunction; ADHD,4,,-,approved,1996,
2415,methamphetamine,small molecule,Aminergic ,agonist,,primary,TAAR1,taar1_human,Q96RJ0,Class A (Rhodopsin),GPCR;Rhodopsin,Trace amine receptors,established,1167,low dose intravenous methamphetamine,neuroprotectant,4,,-,approved,1943,
2416,aprepitant,small molecule,Peptide ,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,209,"aprepitant, mk-869, fosaprepitant dimeglumine, mk-0517,emend",Antiemetics,4,,-,approved,2003,
2417,av608,small molecule,Peptide ,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,278,av608,Anti-depressant; irritable bowel syndrome; antispasmodic,2,2006,discontinued,in trial,-,
2418,casopitant,small molecule,Peptide ,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,436,"casopitant mesilate, 679769,rezonic, zunrisa",Antiemetics,3,2009,discontinued,in trial,-,discontinued due to safety data
2419,homspera,protein,Peptide ,agonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,1907,"substance p,homspera, radilex, viprovex",idiopathic pulmonary fibrosis,1,2011,Ongoing,in trial,-,
2420,netupitant,small molecule,Peptide ,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,MMAmay2016_0499,netupitant + palonosetron,Antiemetics,4,,-,approved,2014,
2421,orvepitant,small molecule,Peptide ,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,ASH_Sep2016_287,orvepitant,unipolar depression,2,2016,Not open yet,in trial,-,Trials had been terminated in 2009 due to assessment of isolated events of seizure during program
2422,rolapitant,small molecule,Peptide ,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,MMAmay2016_0753,"sch 619734, rolapitant",Antiemetics,4,,-,approved,2015,
2423,tradipitant,small molecule,Peptide ,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,ASH_Sep2016_286,tradipitant,alcohol dependence,2,2016,recruiting,in trial,-,
2424,vestipitant,small molecule,Peptide ,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,2148,"vestipitant, gw 597599",tinnitus; hypnotic,2,2012,discontinued,in trial,-,
2425,vofopitant,small molecule,Peptide ,antagonist,,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,2170,"vofopitant, gr-205171",post-traumatic stress disorder; hypnotic,2,2008,discontinued,in trial,-,
2426,vpd-737,small molecule,Peptide ,antagonist,serlopitant,primary,TACR1,nk1r_human,P25103,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,established,MMAmay2016_0635,"vpd-737, serlopitant",pruritus,2,2016,recruiting,in trial,-,
2427,saredutant,small molecule,Peptide ,antagonist,,primary,TACR2,nk2r_human,P21452,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,not established,1810,"saredutant, sr 48968",Anti-depressant,3,2006,discontinued,in trial,-,Sanofi-aventis discontinued due to reprioritization of RD portfolio
2428,mle4901,small molecule,Peptide ,antagonist,azd4901,primary,TACR3,nk3r_human,P29371,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,not established,MMAapril2016_0263,"mle4901,  azd4901",for Polycystic Ovarian Syndrome,2,2016,Ongoing,in trial,-,
2429,talnetant,small molecule,Peptide ,antagonist,,primary,TACR3,nk3r_human,P29371,Class A (Rhodopsin),GPCR;Rhodopsin,Tachykinin receptors,not established,1943,"talnetant, sb 223412",schizophrenia,2,2006,discontinued,in trial,-,
2430,boxaban,small molecule,Lipid ,antagonist,"hepatoren,  vasculan,  ifetroban",primary,TBXA2R,ta2r_human,P21731,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAjun2016_0011,"boxaban, hepatoren, vasculan, ifetroban",Treatment of asystemic scleroderma; hepatorenal syndrome; asthma,2,2017,Not open yet,in trial,-,
2431,ridogrelum,small molecule,Lipid ,antagonist,,primary,TBXA2R,ta2r_human,P21731,Class A (Rhodopsin),GPCR;Rhodopsin,Prostanoid receptors,established,MMAjun2016_0002,ridogrel,for the prevention of systemic thrombo-embolism; adjunctive  to thrombolytic therapy,4,,-,approved,-,
2432,protirelin,small molecule,Aminergic ,agonist,,primary,TRHR,trfr_human,P34981,Class A (Rhodopsin),GPCR;Rhodopsin,5-Hydroxytryptamine receptors,established,ASH_Oct2016_408,protirelin,Diagnostic,4,,-,approved,1976,
2433,thyrotropin alfa,protein,Protein ,agonist,,primary,TSHR,tshr_human,P16473,Class A (Rhodopsin),GPCR;Rhodopsin,Glycoprotein hormone receptors,established,NRDD522,-,Diagnostic,4,,-,approved,1998,
2434,vasoactive intestinal peptide,peptide,Peptide ,antagonist,,primary,VIPR1,vipr1_human,P32241,Class B1 (Secretin),GPCR;Secretin,VIP and PACAP receptors,not established,288,"aviptadil,invicorp",sexual dysfunction,3,2016,Completed,in trial,-,Difficult to get info; trials in Europe
2435,vasoactive intestinal peptide,peptide,Peptide ,antagonist,,primary,VIPR2,vipr2_human,P41587,Class B1 (Secretin),GPCR;Rhodopsin,VIP and PACAP receptors,not established,288,"aviptadil,invicorp",sexual dysfunction,3,2016,Completed,in trial,-,Difficult to get info; trials in Europe
2436,vasomera,peptide,Peptide ,antagonist,pb1046,primary,VIPR2,vipr2_human,P41587,Class B1 (Secretin),GPCR;Rhodopsin,VIP and PACAP receptors,not established,MMAmay2016_0630,"vasomera, pb1046",Antihypertensive,2,2016,recruiting,in trial,-,
